var title_f19_21_19792="Active flexion extension exercise for frozen shoulder";
var content_f19_21_19792=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/EM/83384/Act_flex_exten_frozen_video.mp4?title=Active+flexion+extension+exercise+for+frozen+shoulder\" style=\"width:288px;height:528px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Active flexion extension exercise for frozen shoulder",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 285px; height: 465px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This exericse to improve shoulder mobility and strength in patients with frozen shoulder is performed after motion has begun to improve.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tore Prestgaard, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19792=[""].join("\n");
var outline_f19_21_19792=null;
var title_f19_21_19793="Sports mechanism for proximal humeral fracture";
var content_f19_21_19793=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F58495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F58495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sports mechanism for proximal humeral fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 351px; height: 418px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blunt trauma from contact sports may result in fracture of the proximal humerus in children.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sarwark JF, King EC, Luhmann SJ. Proximal humerus, scalpula, and clavicle. In: Rockwood and Wilkins' Fractures in Children, 6th edition, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19793=[""].join("\n");
var outline_f19_21_19793=null;
var title_f19_21_19794="SSC and LS";
var content_f19_21_19794=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80593&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80593&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar squamous cell cancer and lichen sclerosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 321px; height: 359px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19794=[""].join("\n");
var outline_f19_21_19794=null;
var title_f19_21_19795="Tetrahydrozoline (ophthalmic): Drug information";
var content_f19_21_19795=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tetrahydrozoline (ophthalmic): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?5/62/6116?source=see_link\">",
"    see \"Tetrahydrozoline (ophthalmic): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F15512123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Issues Warning on Accidental Ingestion of Imidazoline Derivative Eye Drops and Nasal Sprays",
"     </span>",
"     <span class=\"collapsible-date\">",
"      October 2012",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The U.S. Food and Drug Administration (FDA) has issued a warning that accidental ingestion by children of over-the-counter (OTC) imidazoline derivative eye drops and nasal sprays may result in serious harm. The eye drops and nasal sprays involved in cases of accidental ingestion contain the imidazoline derivatives tetrahydrozoline, oxymetazoline, or naphazoline. Serious adverse reactions (eg, coma, bradycardia, respiratory depression, sedation) requiring hospitalization were reported in children &le;5 years who had ingested even small amounts (eg, 1-2 mL). These products should be stored out of reach of children at all times; parents and caregivers should note that not all products are packaged in child-resistant packaging. If a child accidentally ingests these products, parents and caregivers should contact a poison control center at 1-800-222-1222 and seek emergency medical care immediately.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       For more information, please refer to:",
"       <a href=\"file://www.fda.gov/Drugs/DrugSafety/ucm325257.htm\" target=\"_blank\">",
"        file://www.fda.gov/Drugs/DrugSafety/ucm325257.htm",
"       </a>",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9600043\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Murine&reg; Tears Plus [OTC];",
"     </li>",
"     <li>",
"      Opti-Clear [OTC];",
"     </li>",
"     <li>",
"      Visine&reg; Advanced Relief [OTC];",
"     </li>",
"     <li>",
"      Visine&reg; Original [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F9600166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Adrenergic Agonist Agent;",
"     </li>",
"     <li>",
"      Imidazoline Derivative;",
"     </li>",
"     <li>",
"      Ophthalmic Agent, Vasoconstrictor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F9600141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Conjunctival congestion:",
"     </b>",
"     Ophthalmic: Instill 1-2 drops in each eye 2-4 times/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F9600142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9600159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic, as hydrochloride [drops]: 0.05% (15 mL); 0.5% (15 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Murine&reg; Tears Plus: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Opti-Clear: 0.05% (15 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Visine&reg; Advanced Relief: 0.05% (15 mL, 30 mL) [contains benzalkonium chloride; contains polyethylene glycol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Visine&reg; Original: 0.05% (15 mL, 30 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F9600106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptomatic relief of conjunctival congestion",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9600031\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Visine&reg; may be confused with Visken&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Accidental ingestion: Serious adverse reactions (eg, coma, bradycardia, respiratory depression, sedation) requiring hospitalization have been reported in children &le;5 years of age who have accidentally ingested even small amounts (eg, 1-2 mL) of imidazoline-derivative (ie, tetrahydrozoline, oxymetazoline, or naphazoline) eye drops or nasal sprays. Store these products out of reach of children at all times. Contact poison control or seek medical attention if accidental ingestion occurs.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F9600109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Frequency not established",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypertension, palpitation, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Transient stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F9605804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to tetrahydrozoline or any component of the formulation.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F9605805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease, including hypertension and coronary artery disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Endocrine disorders: Use with caution in patients with endocrine disorders, including diabetes and hyperthyroidism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For ophthalmic use only. Stop use if vision changes, condition worsens, or symptoms persist &gt;72 hours.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300128\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9600117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Altazine Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $3.59",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Tetrahydrozoline HCl Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $2.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Visine Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (15 mL): $4.04",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F9625212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, heart rate, symptom response",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10962007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Allersine (MY);",
"     </li>",
"     <li>",
"      Azoline (IL);",
"     </li>",
"     <li>",
"      Bano Ocular (PY);",
"     </li>",
"     <li>",
"      Berberil N (DE, TW);",
"     </li>",
"     <li>",
"      Eye Relief (IL);",
"     </li>",
"     <li>",
"      Insto (ID);",
"     </li>",
"     <li>",
"      Murine Plus (EC);",
"     </li>",
"     <li>",
"      Murine Sore Eyes (AU);",
"     </li>",
"     <li>",
"      Oftan Starine (FI);",
"     </li>",
"     <li>",
"      Optizoline (HK, SG);",
"     </li>",
"     <li>",
"      Santo (ID);",
"     </li>",
"     <li>",
"      Stilla drops (IL);",
"     </li>",
"     <li>",
"      Vasopos (CZ);",
"     </li>",
"     <li>",
"      Visimax (DO, SV);",
"     </li>",
"     <li>",
"      Visina (CO);",
"     </li>",
"     <li>",
"      Visine (AE, BE, BF, BG, BH, BJ, CH, CI, CN, CY, DK, EG, ET, GH, GM, GN, GR, HN, IL, IQ, IR, IT, JO, KE, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, PE, PH, PL, QA, RU, SC, SD, SL, SN, SY, TN, TR, TZ, UG, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Visine Advanced (NZ);",
"     </li>",
"     <li>",
"      Visine Advanced Relief (AU);",
"     </li>",
"     <li>",
"      Visine Classic (CZ, EE);",
"     </li>",
"     <li>",
"      Visine Clear (NZ);",
"     </li>",
"     <li>",
"      Visine Original Eye Drops (AU);",
"     </li>",
"     <li>",
"      Visubril (AR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F9600134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stimulates alpha-adrenergic receptors in the arterioles of the conjunctiva to produce vasoconstriction",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F9600135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Duration: Vasoconstriction: 2-3 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9937 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-3836C529BC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19795=[""].join("\n");
var outline_f19_21_19795=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15512123\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600043\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600166\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600141\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600142\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600159\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600106\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600031\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600109\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9605804\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9605805\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300128\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600117\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322512\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9625212\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10962007\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600134\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9600135\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9937\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9937|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/18/24867?source=related_link\">",
"      Tetrahydrozoline (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?3/55/3956?source=related_link\">",
"      Tetrahydrozoline (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/62/6116?source=related_link\">",
"      Tetrahydrozoline (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_21_19796="Gastric volvulus";
var content_f19_21_19796=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F83731&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F83731&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 495px\">",
"   <div class=\"ttl\">",
"    Gastric volvulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 475px; height: 674px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A: Organo-axial volvulous results from rotation along the long axis of the stomach from the gastroesophageal junction to the pyloris.",
"    <br>",
"     B: Mesentero-axial rotation occurs with rotation along the transverse axis such that the pyloris rotates above the gastroesophageal junction.",
"     <br>",
"      C: Combined volvulous results from a combination of both.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19796=[""].join("\n");
var outline_f19_21_19796=null;
var title_f19_21_19797="Telmisartan and amlodipine: Patient drug information";
var content_f19_21_19797=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Telmisartan and amlodipine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/46/21223?source=see_link\">",
"     see \"Telmisartan and amlodipine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9508268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Twynsta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F13265581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Twynsta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10023128\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10023130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10023129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to telmisartan, amlodipine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10023134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10023135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High potassium level. Signs include feeling weak, lightheaded, dizzy, feel like passing out, or have numbness or tingling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Kidney function that gets worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10023137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699070",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of high potassium.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10023132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10023133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10023138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10023139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12312 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-C0D21FD3A5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19797=[""].join("\n");
var outline_f19_21_19797=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9508268\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13265581\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023128\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023130\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023129\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023134\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023135\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023137\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023132\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023133\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023138\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023139\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/46/21223?source=related_link\">",
"      Telmisartan and amlodipine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_21_19798="Endometrioma sonogram";
var content_f19_21_19798=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F77161%7EENDO%2F82183&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F77161%7EENDO%2F82183&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endometrioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transvaginal ultrasound image of the right adnexa showing an endometrioma of the right ovary. The homogeneous echo-pattern of the cyst contents (ie, \"ground-glass\" appearance) is characteristic of an endometrioma (short arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Thomas D Shipp, MD. Copyright &copy; Thomas D Shipp, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endometriosis of the ovary",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 252px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD8AUcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5V/A0fnijpRjjNABycClHTrikpKAHZIyRxntQDjoKTt70UAKPb6UZJ9/rSA9e1Lx6mgAByMYHSjPA4/8Ar0nU9qOnQ/jQA7cAc4H09KUEk5GS3bjpSIpY4HPtWhBarGm6U8jovrQBVghaT7qk+44xWhBYqsYaRuP7opTJ8m1FVAPSpmkdoVjj6Z60AJlYh+7jQe5609Z5dp/eMF7jNTWWk3Vwy+WhYn26V1mn+BriZBI8iID1DUAcU5Yjg5NNKH+End7V6UvgSFdvmTjnrtFXF8DWMJDO5cegxQB5OYWJJ6+ppxQYGRhh6cV6dq+laLpJUSROzMPXpUGnWei6nN5UVu6kclzQB5yisQDzx1GKUjPTg+tevDwjpjRny8kj9ajbwdp2Sjq3PftQB5EUK4G3PHfpTgB9ccdK9Ym8GaceEZ8Hqe4qCXwBabVxMyj1oA8qbO/eRwP1q3M8DIjRAg45zXcT+AG3D7Pcq314NYt54N1KJigjLY6460AcwJmAxncPcUbLeUYZCrAfeU8VbuNKurcnfE6joeKpvCyjv+NAEEloyjKMrj261WZCvBGPTIq7hwc8+lK0m7/WIHz3NAFDvRycnGD0q41vG4JjYr7GopbaRD03AdxzQBCaQ9+1KwIOCMfWigBOpz+FLSHB4NAGM0ALRSUtABRRRQAZNFFFAFXtSUUUAFLSUUAFLSUooAKOtJS49OaACpIYWlbCipobNm+ZztXvVvai/LGMKKAEjRIfugFsY3H+lLgk8ZNT2trJcyBY1JJ9s13fhvwZvCzX5Cg8hO5oA5HTNIur9gkUJ9M4ru9H8HRW2XvSHIHAFdXa6fDbRhbaNUQdcdasiEFl2PnAztoAgsLS3tABHHsJ74q48TEHG3n0pkswgizIyrjpmsq98R2VoDHHmRz3XsaBGvGoWMq7deuTg1T1HVLbT1DA793YetcreeJLu63JDAAmMZxk1SisNS1HmONyT2waBjta1O1vrjfMhGeorOjvCjn7J+6K+nU102n+ANX1AZMJA7k1vWPwo1OQZYeX6UAchbeIrqAbJcPmugs9fgl2xyEqO3tW+vwfvHHzy9O+OtO/4U7qWQ8Uo3DjBoAjtriC4K+S67cYyKmMYaRpCV2KMY9apyfDnxNpxLW0Tse4FQC11/Tw8V9ps4RvvMAT+NAGggM3zRcY7UzYxZtw6dfWoY9Rt4gA4kiAHRlxmqtxr1lBLvYO+ew70AXpLNJQBLEJAw7rWVfeFtOnBZ7fys9NvUVYi8S2kr7ZGdAOnFaVpcxX0e22YOT1Y+lAHBXvgqF3Itp+T2btWJd+C72IkR+W6jsDXe63qcFkGVFO9epFcc3imVrr5WVFU85PJoA5+fw3fRH5YHP05qncadc2xCNGwPfIr0Cw8X2rsFkURuT94Hit9RZX8O/CS7upAFAHibh/M+YfiRRhTIFkRStes6h4c064J2R7Gx/CaxL7wLIxDWWGBGeeooA4aSCIEFFXHbFRGKMjIjB/St258P3kEhVreTd7CprXw1ezuAsDD1zxQBzqwQMhBRgfWq7W6FsI/wCdeiR+AtWktd9vp80w/vIpNZV34M1WDAn0+4jJ5G6MigDjWt5AOBn6VEylThhg10cujXMZAZCMfzFVJY9vyTJn+dAGNRV97NWAMbhfZjRQBi0UUUAFLSqpY4UZNWIrRmwXYIP1oAq09I3kOEUsfatKO3gQ/dLc8E08sVOF+XHHFAFaLT2ODMwjXvnrViONEOIl3Y7mnLFI+CqnnvXTeHvDFzqLr5agJ3ZuBQBzoglkPTI9a3dD8N3V7Iv7vZGersK9F0rwlp+n/vLpfNKjOSeBXO6n4pNlqLRx+WlopwASORQB0ui6FZ6TGCsYkl/vEVvu0ZQHqT29K4yw8Y6bOiK9wkTZxjNUNb8QzmfFjdAxdcgc0CO+M0dumZiAprltb8SpGzJZbWY9DjpXHtfXl42JJZDziul8M+Db/WZ1CxHaTywFAzEW4vtRuQGZ2OeAD0rsfD/w71DVCrygxqxznvXsfgv4WWenxI91EGm6liOlel2ukQWse2OMccAYoA8l8OfDGztVV7tC47iuwtfDNhaEeXEikegro7mNkJIUsBwB6VmyOS4Urj1NAia2toIsAIqgDHStO3ghJ+UZFY0d0UlAGGHrWpZTDzdxI6Y4NAzQ+zoB8qAj09KnhjR88cCpLfYwyGyamMQYgjIYUCGKidgMCoZbaKbho1Ze5IzmrOCvDHPuBTgBt+UdelAHP33hTR70EXFjCxbjIXFchrHwe8PXm5oonhc85Q8V6iqZ6Hv0pSoAHGM0AfOGv/BC7jRjpl15i9lYV51rOkeJPChaOa2IjX+IDivtQoOoGB9ay9Y0i11K2aK5hR9w7igD4A8T65fTQBJDszweOTXHOxY5Lcn2r1n9oHQoNB8Sm3t8BW+bA7c15I/y845x1xQMXzCuCmc54IrqfDOvT252bst7+lc3b273DbYQS2M8Urwy2zjIZG7UAe0eHtftrpgr7El9+9dWpwcoFKmvnexvJROu5yGB4Oa9O8OeJB9mFvcOzOvAz3oA7jfFubegGOBntWlaw2QiBK5Y/ex3rnoZZPLEkm1WP8J5rUtZ5UKqgUMeTx0oA93+Gsiy6Au2Ly1Q7QK1PE2mxX+mXCSohBQ4Yjlar+AYzH4YtGYYd13Nx3pPiDetY+F7yVSdxXbkUCPkXxParbanNE0u7DECuX1K0IQ+UvmAj06V1t4yT3jtJGXcn+LtVKONoJmAIJ9BzigZ588EiHLIwz60V6Hc2cc9urSxfMTx2ooA8ZAycCrcFpkbpjtHYdzUkEPlYOMt6+lWUhkmYFQSCcdOtADflC7Y0C/zNEaljg4GK29P0ffKiyEqrccDNey+D/gW+uW9vfPcC3t3wdzDJP4UAeJWenzSuGghMo6D3rXt9Av7xtsdg6ds7Tivq/8A4VZpGh6GfIYtPGv+s24yfpXCX+mRIx2zvG6HoM80Aec6N4HihVHvhI5HJQDvXb21tHbW8aCARwoP4amWGZSvOUXq2etUvFGpfYdNkZQApXAyaAPP/HPi1rTz7e1f5WGxcd/evJZ5nmlMkhJY+9aHiK5a51OU9h6VlUAOB9OvXOauWd/NCVXcSnpVIDJpVBPQZoA+gfg74YPiHbLKge2OCW9K+oPC/hqy0i3SO3jAI7kV4H+yJezTR6hYTKxjQiRGPQHoRX1EAAegoAjKBQOCfpTJmyCAeMc9qnPNU7l1A6nHTmgRm30qImNwz61zl9MrMfL5UdavatdRxMxViT6YrkptRiDs7x4IPBJxQBemvWUrsi4B4JNMj1GSGVZJNpUtjapzj3rLm1NQqjYpz1OaoPdtK2Y+MnGccUAen6LrEciqplG484zXUwTCRAwx0/SvD7e7e0Ksw5H8fXn0rpdK8WNasA+XjPbPNAHqQwT068gmmsoPK/L36dawLDxNYThSZNj91PWr761YqpZ7hF/GgC9uII3AAfpT/r35NY7+INOAwblSfbrVGXxbpke796wx2A60BY6bOAScUyRgqknHrmuKufH9nGrCKJ3OOMd657WfG09zAUiVk3jA9aAsfPv7UltIPHj3O4tFIgKjrj2rxNj2we/Ar3Xx34cvNcvB5lzJO7nI3fw1lad8GZ58Nc6pBCDztIJNAzzDQtRbTb5bhUBUDBVh1rR1bWrfU8+dbBGzwU4r0m8+G2g6XayRz38k1z2cgKF/CuTn8OWNtHIiMJsn72eaAOf0yzs3xN5p45IxXTaS1tJdqqgZ9awIrOOEtHHkKK3tB0xpZ0fDEGgD1C2skWzTaS+RwSM1v+FNNF5qUMTxsxYgdOlYWj284ijjR/kHGCeRXqvwx03fqQmkfd5S5x1x+NAHqdpAILeOJBhEAXiuK+MNwYNCiAAKl+Qa71chRjnv9K84+OMQfw5CWOAJOvpQI+fNYaMMJFXBz9M1naVEjCSYpjnvSXjLKx8vdIS2AM5q6rSRRCNGVSPzoGDxgL5v8PHFFJu4dtxc57jiigDyHTrKS5lVQM59K7Cw8OzyqNiCNFGTzzir2maOtkikrmRvvCte3LRH5Qw7HOMUAQabYxW7I5OCCOccV9RfCzWU1PQY4gAr24CEDntXzTukMhaF0HsCK9U+CeozQ669vOxEc6nHzdxQB7dqsXnWEyDklTXiWrJuu3BKjHtXu7LuUqe/H4V4x8QNGksNSd4RtjkJYe1AkcNrFwbdwfM5HJUA15b4y1S4vneGPeIFPJI616debYlldk8x8e+a808RSNOrpHbFGJyaBnIJoEmqNusnQuR0Y4rSg+GXiGdvks/l653DGKZpck1rMNvBH4V2ll4pu4IwQ8pAGMbqAMPT/hjMscjarcpCF6CNd1W9F+Gdrd6hDE+poIWYA/Lhq6iz8TQ6hZSQzApcHlec1kWt3NbXhfcQVIOaAPqL4X+E9I8KaUINIQbmH7yVjlnPvXeKdwyK8s+GXiiDUNNjjB/eqPmya9HS6UR7h0oET3E4iXmuZ1vVMRkjj6dak1m/Xb87EDHSuE1nU5C2PNVIiOARQAzUdVluJHjjVwq9HI6Vz91cv5mGUSBerGmzXkjMqm7x7YzkVG8cyYG5WR+4oGSsd6LJyxHYUebkYOAPTuTVUo8JO3c+f4V7U0fOoPkurKfXrQBYiLMdjv34Hp9a1LZBC4ZXO0jk9cVhQykXcivE8e5Qdzkbfp9auxzR8LExPqA3egDZheMlzHkY/iNQXxDIFldjgZBXoPeo4ZmSMqkYUY9ckmqN1NcgN+7ba3BA60ASC+kQ7Uc5Xhs9TULSNK/ms+7HbviqgjkZM3IKr2AHP51atUj3uYgSAOd3U0AOjnk83CK20jggc0NbOqtvIjUnqxyas/2g625UCNQOOnNZz3JicOB5xPXJHAoAQxRRMzAFyOSD0NMsrq8vmc4EMQHQ9cVaDvcW7iNNhAzk81y39o3dpqIhuF8xG4AHAoA53x2GtNUSNWeYuPXrWZ/Z9yLaSV4MKoyd1egXNjA9zFPLbLIV+782cUanaSXNpIiBVjdcdOnFAHmmm6et3IrfuwM4IHNehaPYW9siIyqpx1zXI6Fpvkai0JWQuG4zxXe2umu3MhJJGevFAFm0tYw/+sVYyeQDya9j+GdpHHYyzp/EQK8kt4ET5YwC4OMNXvHg60NroNrGwCsV3GgDcXn5cnHvXmfx9wnhWMjg+ZXpYIGcfhXnPx0Kf8ItH5nIMo4FMR836fCWjEzAYzgKtXYoDM+JCQi9+9Mjk+fy42EY9+oq3Mf9HxDKzsPvfL1pDHJGx+6+F+mKKb5TyLhZNgHr1ooAzCsb7QGfK+1H2TDsfNckjvjAo8yQk5UDHB+XFP2b49rDHfORkUAM8uOOUAPGWx83OK7HwRepp2uWMscTkmQA/NxzxXBXMnlcSRjg8MBWpoM3kalZTPKQfMGPTrQB9jRsG2sOhGawfGmn/btJkKAGSMZANa+mSGSwtn7MgOc1YkUOjIcYIximSfOupWsyylSiKO5ArlvEehtJ+8xu9SOK9R8W6VeWuoyjKrCxJVgo6VyU8MzI6Tcp0XjFIo8Y1Sya0nOemelVftUaqVZee2K9B1zQjOpZlAUdz3rzu8stuoLC44LYHNAE+lRtd3qomUbPGBXpc/hUvYK6OTc7fmBFYWieDprW8hu7S62ugDEbelekW18o/czh/MYY3Y60AchoD3+hXCSpG0ag5Yc817d4S8WpqVmmUKueNuK4yM26qV8sMCecncarNFcWs6zaYG+U5K44FAHpOsyLIN8rZHdcVxV8IZWcbsf7/QVs6Zf/AG+1DSyjzAOVxzmqOp2D7izHIPO2gRgSLHD9zY4OAT3FU8SuSFbao9RVua0UF8KVz7ioEjlt/uxSMucZFAyu0kcYMglcsOOhxVYSLI3nC5IPv0rQLuuCsbEL2NQTR3MoL26uUz128fSgCuZWmk/eyIVzwMcmtGKNDtI2op43VAYJS6mQoCDyo4zV7apKqkbEZ6ZoAFhKk/vm2kcYWrDWm4KY52kbHPOKngR4ztZGXOe+RUcp8mT70jy44RV4zQBUW3kiY79r9uTmtq3sld9LMiqsU9pLLLtJ+Yq0vPtgKv5VjyZiwbgbXPZRkiiO7uVgktjcXYtJTzD5jKjfVc47UAU32csrmTPY4AFV3kVeignpgHpUksCBmKWbuBjgvhTTsABj5Eca45weaAKsKSCUPFcE5GNgHQUahpjyqswI3jrVu2kAkKxA7sZ561JfQzyQKd7gDnGOtAGEYMYWFvLcep609rciVTcTNz0xzipvlixJOwQkHgjkVStZrq8uWiitnmaQhVKjkkngAetAEMUkYvpfKU7R0citmCBTAC00jA8gg4qtDpVxYahNDcRNFMh/eRyKQwOOMirsRZdqSscdxtzigDofB+lfbdThj2Fl3ZbJzxXu0CiJFVRhVGMVwfw10oRwfbWDfMMLuFd4zDp60CHAE4J6HivPPjLLG2j28Ug+cvuH4CvQgeOvSvG/ilqgvdaNtEfMS3XbtA796APKCYhJIZLf5e79KS3lF0shtysUacFu9JrtzO0JjiG6Rjt4HQVVtbBYbcBzJyOo70AWgyxkbpTL9RRUCJHGygl2bnjFFAET2sbj99IdvbLU37NGFPMe3s2OakSJSSqTAj+63epBZyTZXdhenyrxQMqPFDsJTyT35JNYtxqCx6lbK67VBG7tjmteGzurSZ1DoI88bzz+VRXduHkZnCbhxjGc0AfW/gq6W88LabPGSVaFcd63R65zXn/wY1Jb3wXbRgjfbnyjz09K752wM8UCOa8bae11ZeZEMyL6eleTXcZWQRT3JAB+4oFe+PGJImWTBDDB9q8i8YaTLY6i4VFERO4OUHH40AcZdpDcKV2OV6ZJrhZtHjfxHFsjVwDk816LIWIKhVKf3gMA1kSxww3XmoDk9jwAaBl+2QBjHL8uB/Ae1PYpERstpSw4WSQg1XGpQi6UTAhWGNynip3ieNPPQeZu4Ck9qANSzljCrgPu/iIUfzqSWeRkYxgqpPJYgcVjR3lx52ySfyYhy20Uuo3+IB5ToMdd/FAGnoWrC01EQNC0gJ4xzmvRBYR3cQlaL5sflXjuhX7SanGyzeYAeQgzXuHhyfdaqHUlj0z3oAwbjRI9oxCuc5yVxVKTRJ522RcKDz716PLbrIAWX5aj+xjGIwBnvigR56nhsJ8xtXd/VjxTZ9KkDbYrbCjpgcV6H9mcgDf25prafGMLvbA9DQB49f6HNFMXuY2KDJO09qhE9rGAIoX3D+8TXpPiC122zgLnrz6V5fqt3LbTMsCKWPcDINAyS4uPOcKcIoGSA1WoJLfygGnYt6Z6VlWo3IWngBdvvEcYpn2q0gdh5IDDgNk4oA0pZHWP938vPDE9RVGZy64mY7yepNVDewsCGeNjnoWqUSRMN4eEL2O+gCN/9HZSXVlBwNzHGKdJGbllZGUDHar9v9mfDObd8DoecGo5ZYi+C6kdMIuKAGJAYSHeZRnjA5OKp6rL5FvlXeVjwp6YrqPDuiSarqS29pCfnG5nbkIvcmumvfBGiaN52peKtSij0qBsoGbYH74bvnr8q8n17UAef+E/DOo+J5B9khPlKcPcTDCRn0z/ABH2H6V6LDHoPw+gdbUf2lrjDDOcDYcdD/cHsMsffrXMan8TE1S0+weEov7P0pBsWVAEkIz/AAgcIP1+lctDG7zs4kkcMec88+tAGjrOoXes6pJfag0bXLYA8ldqqozgepxnqSaueGtEu9W1BF3qqK2WGOQKk0vSL7UJVS3t8gcEn+teq+FdCTRrPacNO3LNQBqWdotpbpFBwFGMdqnDAtgjDD1pxpkzpHEzSEBAMkmgDM8TarFpGlTTucNtIQepxXzvqmsfbLu4cO27ruHc12PxH1572WRULNAuQqnt715RbSG5maNHwjdSo5FAEtkZTLLK2WbPUjpUyLLcMuLnBA5A7VYEcKJtj80svVjUKiIyEAFj6jgUCEjMitguBj+LoTRTp1I6AsxooGZ7TbCVjG84zxgCm+dKDlI2YnqQ+7H4VaFnFE487gYyPm60oSAMBGrHufSgRSlmvCVLRIBnOSMkVYKPLtzE4I74A4p8weS3dUIWTBxtbjNZ2lX8of7PdeYJg2Mf3vxoGeo/BTVv7O8QzaezbLa7XKqTz5n/AOrNe8dThe3Ir5XjllhnjuII1hlhYOpyQc/WvofwX4hi17SopwVFwoxKgbofX6UCOijOF5I+hrO8Q6SmqWTJgeaB8pIq/gE5GT7VIr5bBFAHh2p6bd2U+2RlUKe44rNuLGWWLHm5J6NgAD869n8S+HYtXhYhjFN2Ze9ec32gPYyNHP5zYHBPSgZykUEm8x5tiBxluT+lDJHEwkeZFnOQqBeK0LmyhWFmjYJjrgZJqhBb/avmimkCLx/q+c0AV3nLOQGjC9clMZrmvE1v8xdrwB2HAHQ++K6O+jyPK88bQen3a8/8YXphAWN1ZgCPvZoA2fhmsK+Io0a9ZmLfd2kg19QaXbxxpGyMSfpgV8YeEPEFzp+oK6GMP/eNfTvgnxF9vsULXQZ8dCaBHpyMFj56UjSjHTjvms2O5Zk+UNj+8RWdqmtQWaZZt7AdBQBr3F1FCCDIAa53UfF2m6cjNdXSqoOOvWvM/if8QJD4duo9JZUuvXvj8K+U9W8Qareu4ubud+vBY4oGfaOo+JI9Wt3+wFXibjeXrm7qF44/NkljKjJAAzXhvwe1eWKS7iuJpChUFVJJ5r1TVNQdLJOSjsvAB60AQanqsj5VCwx0wnArClvJhGyyy7sngAdazbuS4kkLSXAGRkgNxUFs5ZgqyEt1yR0oA1ftZRd5RcHjOafHh23Ssu70zjj6VRthH5my5LOB93sKvpKEAdEjlcnbhvSgDb0ue2PyRjL5wQK6nSbK51O4itrVFR+pLHARR1Zj2ArkLK4mRxse2gPXIXJrc2K0JJfLAZz0z+FAHrVh4h8M+EdMFpb3n2+4HMzwYcu3qTnAHoM8V418c/H6eKtMh02C1hiRZPMjkJLSg4IPPTBz0x2FVdXOovbmW2SIQ9AAvNcDrWnap9pMqR/vFG7pQA/wGr2moGCZnkHHTpmve/Bvha61aYXZc29oOgxjNeLfCdbjVPEMenqqLPNJ+8yOVXPNfY1hapZWcVvEMLGoUUAQ6VpsWnQBIhk4+9jrV4fSk3DOM80tABXG+OtcFrC9sn3QP3hB6HtXV3s4trSWZuiLmvA/GmuCa5kR5VEjk71U0Acl4pvri9Bjtyz8ncw6YrL0G1kgYFHKSHuR0rSeA7w8T+UMH7x4NU0ILlJHk2g/w96BFyW3LSmSW5DE8BUOATUchijIUOobphaktpPn+WBAo7sMZqq58slmSNsHPHWgZB5dyVOyTcM/iKKebtUDblMZzRQBVVGLM8jlSvYDP5VaxhNySyIMdCtSpKzAKi4HdzwKneOKaMB7phj+4B/OgRTdwoXy43kYdSwxWdfWt3qc4dH+zlOfStxBbLkK8rnHBLDNKskTIw+zO2P77c0AZsDNFD5VzJJMwGAVbrXX+B9XfR2SRT5JDZOGzkehrnZLZJEU/ZZWbttPAFU4LsWchT7LJtXrmgZ9SeHfENrrFurQPhyOVIx+VbectuA6e9fPPhLxBLvjKokSL05IavYfDniOPUCIbjEcvY54agR1CkkZPA7VBdWsF2hSVA6nrxUhb5goJ+tKD8vXn0NAHM3fhNJMmCQJkfd2DFcX4l8Parp+97S1WVMcuP8AAV64GBOM4xTWQOpRhweo7UAfIHjvU7uzRYkULKfvFeorziCb7Q7i+YkDpn1r6M+M3w9uIg+q6Dbh4MFpogCSD6j1FfO0i+dcRwLGySk7SMUDKhnjglyqDjpgZr0j4ceJ5LO9Tz3XbxgHisJvCc6iIk7FPLNnGBVmXSPsUyvBblhjlmJoA+jJfH8M8SWlmuZNoDPniuQ1rTdb1OZmjvnSJhnap61w3hAO98rvA5Genava9NTzIESONlbHOe1AjyqTwvLnF1b+bt4Zs9awr3wdpFxKftWlFEX+KNsFq+ibbQDOS2AiHrzWB4l8FSpEGspXbJ5VuRQM8xtvD+gWCQrpNobcYHmBmyx/Gna+qpDGohJX+8TnApfEWg6jp0wuGISIHJ71S1O8haBHheSUkc5HAoAxozbL5kkcXPqw4pjytMwHk/LjDY449ajurtA2HlUBuyLnmqxlaUfut2AOSeKALot42UBTn3Y9KepRUGxmCg4JC/eqmI3Vd5kCsOdu7mpftE7Hakrn6DOKANa1vfJB8rbtHJBXJrXtNQkuI0LAjnA2jk1yLO4AzKwJP8GMmtDTC5DbWkTHO5jg59qAN3zb6SaW3MYSPOQrHBHvWhpen3t48lvbW/mykcuRmvPobx7nVQiSzvKX2nnrzX1L8NtBGkaFGZhuuZQGYkcj2oAxfhh4Ah0G5k1W7jiN7IMKQOVB616STgUi45x602VtqH3oAieTM67ckVYHIz/Oqdsdzkhs4NWxnPtQI5L4mXi2+gtE0zRGToVPJxXgMlhEJWlnnKu3Qnk16l8U9Sjk1BoCWXyRjI55ryO6Ch8vKSc8EnrQMhlEeSMu69NpNSW77MmSIqO2TTTLbKhWeQKfVOag8+IHBkZ05xxQBYadpItzRuWHAHoKpSTSRktGoB9e1ONxJIqlNyxAdR1JqEyKAN0YyRzz1oAVZTKpBRS394iipQ8mdymJV7huhooAavmOy5UHPRSnJ/CnxQtJIQq7TnvgAVTtrq5ucEO2emV/xq1GmHHmukr9wxxQBoIrRxBVS3LjuTzToopXYtIgUf3g4/lVSOFWBfykJPHyPgYq1b/Zo1P7thxggNmgQSJcEKsN6I17gdc1XWARu3m3G8tzljkGrNxFDIqrHIYo8dj1qtHDbxyLtILdy/Q0DJ0tJSizrLsYdlPArpNF15I0SKcS+YCMMgPPpXNC5gEpzOjEdEUZArQtZj8sjOse3kBetAH0B4S1o6pZgTKVuIgAQRjI7Gt0nGTkflXifhHWxa3q3KvdNjhkwcMK9ntpkuII5ozlHXcKBDbuRkAf5j64qxFIJEDZIz+dRuocbW6GmQfxAE4HbHSgCwVV4yjDIYYIIrgNT+Fnh271BtRitBFcjJG37ufpXe5Pc0snXAJx60AfNXjWC80mK6hNmN27CHGc+9cZHrV4tt5V5F0U43D+VfTXjbwvb6va+f5e6aMZAzjNfO3xBsLe0YkBowARgNnBoGHwh1W61LxA1rGyEZ4z1H0r6X0qwcKnnFTxXx18ItVXSvGEL8/M20V9Qar4tWxi3Rtl8ZAx1oA9CRFRQqgACkljWRCr9DXIeHfGlvfwqLlDFL0OeldbBKkyBkORQBRvNFsrm3eOSBWDAjkZr558W6MbHWLmzDMI9xIA7ivpivOPiloaTwG9s7Tzb1R2PagDwUwBVZYYcsOvm9qIlDJ+/MbIPvAN0rWlEuS11CImH8LcZrPkWQMxFijL1GDxQAsUkMbZis0Y46v0pgedhuZEjH91T1pXM7RDeYYl28etCo6RAtKOeu4dPpQBSlWIzFDuT/aq5aNFFbyN564XOGJzUa20lywGzC5yG6bqsalpc32EwwRQRrJ/GetAB8J9J/t7x3GPODxIxdwp5wDX2BCuyJVA4AwBXzt+zr4cXT9Qu7t5g82dmAK+ixwB7CgQiggt9aZcDIHp0qX8ark/PkknmgBtpEIg20HnnNTzOI4ndjhVUkn0pw6fSue8dah9g0KYqcSP8o5oA8c8XNDe6pcTG83uxJC5xXKyJahsNDIxHXnjNXNQxPcu0kW5WOflOCOKzNjo5VZQMc8dDQA1pLaNWItyGyTgisyacOw3QARHnFWJ7hyWQSnb3OM0sccyou5FkPZh6UDIYmfawhUeUf756UskbmL53iCjqByac8bdVRUboSDVYRxhgI3YyD1oAcECMrPKHB4Ax0oprCOR1Mh8pu4zRQBXjjeVstPIFX+IcU+KFPMKjzJcnOW4pwtZjn53UdTuI/lU1sHziS5l44+UcUANWJYA2LjLHqo/lTopJlyBcqgI+63pUxjhQjdkbcEnuaCsWCUhZ17hhQBKkjuqhrsSsvYYAH41MuXbc80MbAgEZ5qlG9v5jDy8KeyrxRJOyFfKh2J0yFzn3oEbKzWdsw2gyuwxn1pfKV0WVojEpPPPNZFjqEauxJkV88M3Y/Sr/mtMCxl80dyWwKAL9rcbXHkhy+eDk/rXr/wz1w3cL2U8gLr8yKO3tXiDF2UFFXAPA3kLWzoeoXWk3EN1FNbROCDhSWz7UAfSdFUNC1KLVtMhu4GDBxzjse4q/QMXGV/pRSCigBGAZSGGQeor5i/aIhGl3hWG2ISbnPavpwOpJGehxXmvxl0mz1XSitxGPMQfKxHSgD5Y8LaK7L9vV9k0bblVRzXp/hvxM+rj+zkgLXnQFzzXAaxLcaZA1vby/Jg/cqx8K9Y+w+LLSe6chC+Dx/WgD6K8NeELm2iWXUXJbG4AdBXoWkqIoAgOQKhaRX08SRfMrKCOaq6VdZnZdjj60CNu4lEULMTwBWGA944yPlz3Na1wgnAQfdFPhjCfKFXFAHJ+K/AtlrVodirHcAHaw9fevD/Eei6z4anZb6EywLwGHQivqFccgY+lV76wtr63aG6hSWMjGGGaAPkEeINPYMJ1Nvjg/KSacde0kEKrFl7Z/nXsnjz4RWt/DLPpKxRSkZ2kcD6V4Xq/hS60eR7e6RAwOCaBly68W28MYSwiV2/vE9KXRNZubgyyXMyohyD9PauOexDX+15CkQ7qOK6/SoLB3itrcEkY3FhxQB7t8Emil052hjO3dksRjJr1oHlQP17VxPw4tjZaPBFlPLxkBRiu0DfMDjHvQIkX6fhUe1t2AOTTlPyjrn3pxfv0HrTEDH5T3xXk/wAUNSF7dfY1YrFDwW7Zr0rV7tbPTbm5kYgRRs/5CvknWvGs91rcyqWkLuSVYcHJ/wDr0hpHQ3DW5izFlZB3ZutUEeRkfBRVB9efxqqkxkiR5FVJAPu1D9q+UAKpDcNj1oGPuJniXcxj90XvUK3DOqbA2c4OeMUTLKzZkliAPYcUmNud037sjAwOtAFr7OzsfNI7Ec81BNAXXAUcnrnFI0S4O65YAjjjNQFedqOWHp2oAZeBoJNjLnI4PaipVY7sjAXHAbpRQBWN0XGEhDnrkZJqWOeVo/3zLGg/hWqq2iqgbzpAe4SnxB4sxospXuXAoAsLeliWVZGz3cdPwqdXmmVzGqnd1LkcVEAyJnEKnoCVJNPeLdDmZY5iD/GNtAEgkt4sJPOpPogzipHnhQbYixHq2aqwBYlLrBAoJ4GOacZIQo3xknHHzYFACO9qzEyIrD1VScVLbzRxsSF8xFAJOMZpyJbyOI0jAGOTninw2pSNTC4Cg9DxmgCe2vI7k4VMRgjIxk1pxxnPmW8MRVf75wRVBtxYg4YkdFPFCTbAQUO/P3Vk4xQI9K+Gmu/YtRNvK5+z3Bxt52q3rmvYhXy19tltWwUbhty7HPy/Wvdvh34mTXNKWOaSM3cQ2sFYHI9aBnX0UlGRQAwoA5YAZP8AOqWr2UV/atHKoIZe4q9I2FyDg+lNlPBA4+lAj5f8eeFU0vUZQA725bIwOgrmr7R4YrVbmzwhQ5znmvoX4h6a1zp8zxwB2AyAa+f9Ue4tpREkIZT1AGcUDPa/hN4yi1LSIrOdi0kXyktXpcTRsdyAZ9QK+RrC7n02+W5gxGw5ZfuivVfDvjwTwRxmUJKeDzQI9tRuDk/jSNMN2AR19a4q28QF48R3EYJ9881paZNI8yNJJv57dKAOlfDZIbkjHFS9qiR1MfBHFPBB78etACnkHI46V5T8btHt5tIEyRqJc4Br1UnC5A4rzz4sTgaHcZcKduORmgD5bZJPNMMJAYnnjPNdb4as1tbmHz9pLY4IzzVLRLNftUjMp35zyOD9a7Xw1Zi71aGPYrAMCcd6BnvfhlMabBmNVwg+7WznpmqOmKsNrHGBswBxVi4kEaxk93AoEWM+3FJIwUMxICjufSkrz/4u+JpNG0VrazkC3U6kZB5AoA8++L3xFutQu5NA0ZStruxJOp5JHb6V55pmmmEGeNVnnbqXHINLp1gF3T3EzNNKd3Pqea044AgQLIqg9cnkUDInEroftARFx6VTAeN1OFK9AVPNacsMPmnZd+YOpGKrOkT8EKGbpg80AVZQhQmVu/8AwIVEBbAEh246GpJYViYu0e4465qGadEDeco2A9SMUATJLAM+XHnvknvTJJNsJKqAB1J5zWDqXiKztGYxqWkHOO1ctqPiW6usquEU9ADQB2t9qtrbj94yKw4wOQaK8wlmklYmRyzHrmigD1q3ZZIyzMwOcAVYBhUfPKRxg4JzXn+meLHyi3AVMcbhz+ldLY6hb34zHKXOenSgDc823QsI9pI6ZJNMeUNGFG9+eARTQFiKhmhiBHAUbmP1qSE7U3RxnOf9Y386AJobOYfvdgDAdDzUkcCKpluDHnHMYGT+dVhCX+Zrkbj1OCKfGFiX92N2TjJH8hQBKxc7SiKqHlR2p/75/vsFXttGB/8AXpqiQkB3IOf4lxt/Cp45UjUm4ZZQOmBQIZDDEGDKM44xzV2ARRks52gjHC1Tinjl3b02P2C9atKs4C+Ui5HcmgCSeaG5t2iCbExySOT71g2+o6p4YuRc6DOy4O5wF4PtzW2Jt8vlySqCOoFTJDDLCYlcqSOCy8UDPV/hh8T7PxTb/Zr/AG2mpJx5bHh/pXpKtkZJBr4w1zTLnT72O9s5GSZG3blG3pXvfwj+IC69YCz1ORVvIwAGP8dArHqTMTkAdacpDKf1piv78dc4oX7x28elAijqduJrd0IXcRgZrwHxXo09lrDhp8fMWwqcYr6KbnOehrnfE/hyLV7R1DFJv4WA5FAz5+udKF0jESgOwwRjkfhVOPTYreM+XE80oHXpiuo1vQ9Q0S5YSJLJCD99Vzmsu7tAdkzTuM85GevvQM2/CKTrcJAEUIcFy55Fev2KqtuhJGMda8n0a3Z/Llj3GVfY/NXb6RLq7EL5OTjAz0FAHawXAVSH/SpkuUZsK3f6VjxQXbRbmAD98dKt2WnsGDOxJ9aBGlczqsWSRx3Jrzfx3cLNbNCON3U9q7HWbSV4GjRiOOoFchN4P1G9LO86lT0z6UAeWzWe+RY1kjLdBs7mvWvht4VFhbfa7pAJn5AJ5qfRvBul6GwuLv8AfXB5z/CK6ayvIuVQ5UH8qANdEUbSKS6VSi7sYDA/jWXJqyD93aKZZT+Qo8Qa3aaNpElzqM0cTqhYKTyW9hQA3xN4lsNAs5JbuZBIBkJnk186eK9dfxFqzXlz8iu2FAOcL7VieKPFV14i1SUuQ4LdAaTTLc5QTlUA5GTmgZeR03DOdynhsdRRJbwtcGZsnjOAauRW0Slir70boD2qOa3V8YGCpzhe4oEV45A/yIiA9MHvTXgMcW/KhhnJPb8ag1fUbXTLfdKmMdFzya891jxZc3ZZISUj7CgDpNX8TW+noyQkSyenXFcTqev3l9kM5RPQVkyOzsXc5J5JpgYFsA5oGOdmYku2T3NMYf7WD2pSBx6dMUdFG0f/AFqAA7u3P6UUmWBBbAHfmigCHJLZUc1IssseMSFTnoKhBOPTNA6Z5x70Ablj4gu7QAJLuI/vcit2DxxcOoWcLwcfKK4facZ/Sgfe59e1AHp9h4nsZPlc7GznLHpW1barZTA7ZxITwMNXjQbC9dppyTPG2UZsfXFAHt63MZ+VISy45w2TUkd0ypsW3CqOpJzgV4/Ya7eWqkLKxHpu61u2fjm5gKj7MmBwSOSfxoA9JZpvO3xRDBH3x1NTJBgN9pujvf8AhHWuIs/G0Mj/AL3ehPpXQ6deW96CIZF3HqxYZNAGuEs44gsUillPJwTSxzZeMo0zMvbpTDaQQkNldwH96n/aMqojjb0LLwKBE00ivE3nsg83jEmTiuZSKa3m83T3kWSM5AQEVusjMuNgx1z1NV3sZzMsqyvjGXJOPwoGereDviXb2+kJBrokSeMAB+u4V6BpWv2GpwwzW1wu1zjaTg1833VpEVQuWXPJIPNRaXqt7o9yr2k26QHcpc5x+FAH1RcTCGMu2SB6VSXVrUtt3gN2FeT+F/i5c3er2+n61ZCJJWCeao4OfWvULzRbO8lSVAEcchlNAD3vLeYeXNErBicgis5/DWhzBpJLTAY568VsxadDGQzfM4H3jWbqF3pkLNbzahFHKeoLdKBEttY6VCmyERoqfStaFIQoaMKRjgiuM1bRZbzTp00+bd5i8So3SpPDF7e6ZpCWV9bTGWPKq+Mg+9AHbKo4BwfcU4BQDnjjBOa8w1r4hRabLKk8oBX0GMVH4Y+INzrd6kOm2c9zHnDS44FAHeeKtUfSdHku4UDtHgYNcZp3ibU9VfzI18qDH3ccmu7kthf2flX0Yw3LKOarPZ2GlWcsixrEir1oApWri5gWK8lVGfgBjgmtGDSoYbcJExHqe5rxvxJqC3GpC4ZmbY3ytu6D8Kni8a31lgRXnmR44BOfwFAz1i6Np4e024vJEcpGpJ55P0r5t8Y6lfeJdYlvr9mWJmIigBztWul1jx1qmrRtbSMqwtxgda5e4Zo87GQD+IY70CMxdOtoHDK6BvvEj1q9BIzvvkVHBHAXtVaWFJWkfcyHHPoTVOa/g06LM0pUZ6etAzfBlBXylCoeSGOKwvEHieLT4iI/nm5H0NcrrniwzgxWO5FxjcTya5CaZ5WLSMT9TQBc1PVbjUJWeV2OecZrPpCRnBPvRntkZoAYSFznce1NJBKknj3pcFsjcB7UuFQ5JOaAF3AjcCcUpIQUzfuJB+7ikyNpCnd7EUAK7YAJGePXBopsfbB+b09KKAI/alyMdKY3XtilHQcYz60APA3YywHFNpPbvS0AFKOeBmgZIHYdM0ucAjjPqKAFK7cFuQfSkVsHp+VIvPHTNO2p/f8A0oAd5vB45qxb3MqENHKysP7pqsMAddoJ7dxTlYBWCgkDvQB0+keK7yzcediZB2fmut0/xvbTsq3H7pQMkCvLYmLtzwvrTiQDjIzQB7npusWF0+2O43FugzWncyI0ahiMN6Gvn+2upbdswuVb1BrY0/xRqNoR+9ZwOQGOaAPWI4ZgziRWG77obmq95aOv7yVwjgkBa5a28fmV1F3EQ4/iFbv/AAkun3UI2yK8nGQx6UAalqXQCY7SqjJJ7/Suuj+IWrW1miQshjC7Rxlq4CK/WfYkcyDaOgNTKQVIZsMOgHfFAHZzePdQuyh+1yRoeGGcYqrJJ9quTI7pIGOfMPJP1rkdjRsJdx5PIPenx3RjZnklAU8bTQB654P8RrpVysdzIRbSHaeeB7ivVYJ4bmNXidJEIyCDmvkK+8TPawsIyJME4Lc4+lGj/Ei+tAEiv5FJPGTwKAPqbW/Cuja0uL+xhc+u3Bq3pGkadoVl5GnwR28Cc8DH4k1xHw28d2GrWSRX+rRtfgcox210/irWdKt9FnN7eRJGV5AcZP0oAfrPivS9LgMktwj+iocmvN/E/j5NVjMaN5duO2eteVeNPF9lLIy2hZtp+UHoK89vdeu7mTO/A6YHSgD1rVNWD4KyRqrfw56e9ZE+r2cKbWnUTHsory261S4cAGRuPeqr3btJksT+PNAHqQ1u0RlJl2dSTVK+8VWcROJDIScZx0rzVpXbq7H8ajPPWgDr9W8YtP8A6hNnYmubvL+e8cmaQt7ZqmSCCTjApMnIIGQRQA4nr60zdjJGTxnBpzDIOePfNIu1BjPHWgBpIOOg9c0pTqePxPekzuRgRk08ZzggEYoAYeqqGxzyenNABfAIGBSAqMKV5xzxQq71ABwe4FABt6FDziglpBgdfSr9vYSN80jCKMD7z8Cp4PLjkxaRGd/77DAFAFS3sZJF3PiNTzufiitmHTJ7qQfaN8hPRE6CigDAlsHjXzI8Oh/iU5qqcjOeK2tQhWxcNbFlJGcZyKfYqmoA/aI0yB1UYNAGDnP5daXvV29tUhbCFuhPJql2oAUAnucDtSHpntTmOCQOnSmjg0AGPXjvTsrs4zuppOTRQBIg3ZwSAKCOQCMDqaRiUJVScUo4DHJOMcGgBygdOnuOhpR84yOPcCn0x2IdQOhoAN+AcnkngU7d0zyTwcUyQBVJHUnmnk4ZQOhoAdQjMpyrEfpRTOrnPT0/KgC9b6jcwH93Kwq5Dr97E4ZZCSD3rDicsxz9aeGJZh2GKAN1vEl67ZZyBjoKq3GsXUv/AC0I9fesuNi6kn1p4A2/jQBaFwzg7nOPQmoZX5+Un8DUdMk6UAXIb6eAgwSMmOhBOas3mtX90qrNdSuO4ZiRWYpyAfaigB5kctuZiTSFiep4NJTCcSKuBjFAD6XCkDHBA796bTGJ2Ag4J/woAf5e08k56cnrTiAFBB59KapyAfao3crwMelADtyg445/WmgkgAHBBx+FI3SMetPZQFJHUDrQAhwz9eF61G6nd0xmhWI3HvinwktnPagCME7SM9PepEDuoCpk8AGr1hbJNKFbIHtVq9k+xSLHbqqjH3sZNAFSPTG2eZMwijHqeasoEXizhaRu8jjipLO3WdfOmZ2fryeK0I1HlgL8mTj5eO1AFH7MZGD3cu9ieEFXka3to91wwt4x/CPvN9BVLV7h7DK24UFv4yMt0rlpp5ZmLSOzE9yc0AdNf+KZUj8rSwbWPPLg/vG+porlKKAP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial CT scan of the pelvis in a 29-year-old woman demonstrates a well-circumscribed, low attenuation mass (arrow) in the left pelvis immediately posterior to the uterus. This mass was found to be an endometrioma of the left ovary at surgery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19798=[""].join("\n");
var outline_f19_21_19798=null;
var title_f19_21_19799="Cutaneous involvement ILCL";
var content_f19_21_19799=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F81381&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F81381&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Skin biopsy intravascular large cell lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 196px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) A few vessels located deeply in the subcutaneous fat show intravascular proliferations.",
"    <br>",
"     (B) Large cells with large heterochromatic nuclei are seen in the lumen of a blood vessel. A reactive infiltrate of lymphocytes and plasma cells is present around the adjacent fat lobules. This infiltrate may be mistaken for a panniculitis.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19799=[""].join("\n");
var outline_f19_21_19799=null;
var title_f19_21_19800="Urinary sediment in acute tubular necrosis";
var content_f19_21_19800=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F56438%7ENEPH%2F65729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F56438%7ENEPH%2F65729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Photomicrograph showing urine sediment with muddy brown granular casts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 252px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD8AXoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6hox3oorwjUK4nxxoc8sMl5azYCxsNhHC5Hp359a7aorsFrWULjcVOM9M4rGvSVSLubYetKlNSifKy2VlbapAlyiIF3BhGvzZJ/lmvU/h9rAFzBZNO0srEqkat8qIO2PWqHirwhJDJLqljGi3kqmN0YZUnvirnw10yx0+4W8uZGFz33LgBsdBXlSmpWu9T6OtOM6La1PXc4XJqpd3gt4t+VI/PipX+dN6tgEd+mK4/wAQDT8yWAY/aTiRSD97vg12YivKEbxPAw1FVJ2Zw2u+KNd1bxukej2M8ltaKHK9FY/jx0/nWcNC13xGl/L9m8uC4lJ2uchADjGDXTjxBa+H5hkq8bqxmfZtAwOnNa0fi5rfSba4stNa+Nyw2pbsM4PU/hXnqq5yTat5nu+/QjalG/Yp6J4G0Twxoss2q2yzPIQWG3IB7EelTaPpel6s4tIYlcQqxV15EZJ4FReNfEeNDkGpq1nJKpjWDGWyemfT615pZ+MY9It2sEnuDeOAZHi+VW56g+1Np1JXSbsFGlVnTcpStJ/cbPiU6R4KVFsrNvtrSB/M6uzbvmyvpjJqz4j0yzgvmv4WS6sr2ITxz7gGQ91X25zzW5/wlOlxapHeT29vMzW20sdpkyccfiKg8OSp4i+1G4so4dLuJGEKoPm2jrx6HH61nz2jdr5nQvaQtKaskvvPN9VvRot+BoLhIJoMXrsQzFs9c/pW/b/EkeGPDRt4rUXkjffulcBQSOg45rV8ceFNFtNPcaZKYZQR5qggsEz3z7npXkHxGt106NbVid4VZWKd1I+UY9a7MOqdeSiOry1KLn0Ni/8AiNfXWjqsMUCTu4iSTA3k+p9BWD8PbTU/+EzW6uZ/sUFvl55mPGAOR+NR+Dl0jU1R7m2WIcK8xOCrZA/ya9at9Mjsl1q6u3SbT1t8GeRQGAGQMrj6c45rerKOHUqUI2bM4xU+WcnotjB1O20PUvEEN/boksTrndGdoBU847mq3jeewv7a4urLT4roxIrTXEzkOhGQeD1J4H4Vly306+H0tNGexaOIyXcM7nDouT8q5+p4rK8PeJbLVVe11PSb++1aW4UoYjlQO4C9ySKiFGS99aqPn0/AuVSKai92bvw/8UHwP4bvL21WX7Uw3PA5wFUng4/KqnxZ8WTfETwlHdNmKOxYNscDO4jk8Vn+PNa0m4kngW2u4L2FTE1u67djcDBz268e1cKdVFnb3OmibMNxGC+PmGR0Aruw9OUv3tmpXv8AI4q6op2dmrW+ZxeW83bnIqwGeFkzkY5Aq7aCG2uXFwAylSFPXBqaDT2vmdrZo2wBlTn5a9iU0t9jxY0ZP4dz6t+GXjZvF3gqz0jTNKiM9rAsM08/3FPQbR3OOa5zxz4QZtOnSecS3aEsHcALs5LHPYdhXN/swajLD4yfR1nCwXKPvU4wSo4x719JXvgOwvIBZTSSmwzvKbvnY5+6W/u187Ww9WGIbp7Kx6dLFU6UbS6r/hz4r0h5tOuxPZ+S4jzjeOB7n/GsS+Ek7XMjycuxf5VwMnnpX038QvhCuhaZeX/hUJJGyHzYJuWAHOVP9K8E8SeHdU0zQ7a5vFb/AEg7j8vKjoOa9GlWjz66N6eYnFVaV4apXfoZvgjUYbTUxFexSusjBW2kg4zyK+5PCng3w5p+mwy2GnxSJMqyK8y72wQDjnp9K+J/BumnVfGFnb2skcRX52achRheTz64r7i8EwXVpo6LeSxshx5O18/LjgVniZR9vFW3Ry1OZUPi2f3mpZ6ZpulLJJZWdtajBLNHGF46nOK+avivqx8V3f25pfO0+B3SKGJ8EDoMg+uM17n8VNWfTfCl1HbjdcToyBQfmC4OSB/nrXyBo+o3S20sd1ArwiQyM38W30qZJt+50/U0wMF8dTW+xg60J4/Kh+75nQBuAM960tHsPNjkiu4pnnMeYHLYQ/U1eWR9clRbCzBgtyC77CfLAPeum8U+LNNfTIIbCJbiQIscqBAMEDgj2rSdWekFHX8jqjCHM530Of0fw1czXt0+9ZRAmXVeAp7g+9XoPEVlZ3SWYjRhMhEgiPf8a4W91e5gvp2hnnQs3CtlSfqBxXXWfw38Ran4c/4SKCxuJNw3x+Umcgdx7UToretLR7ErEqKtTjt8zjdfjaXUDEYUjUnOU5496zra3NvcOojVucDcD69a9h8CeANevLS8kufDc1wZ4iiSzLtCse49xXumh/BPwrb6Da2+pWbTXojXzphIQS/fHtmtliVH3Er2OKrGMWpt6s+LUsne8EEsZ+Y8jHP5V6R4G+H+lXOjXup+JdRawtIiVgg25kmbHYd6+o9L+HHhjStQ+2rYlpANqtPh1Uf/AKu9VviDr/hXQYoY9Qto55IRnyYY1YohGM+grCri5zjaOnz1FT5OZJa/I8l8ZafocHwhe58NWrZBjSSRSSU5w2T6mvMbPxSbxrfTp4pJ1VAEErFgG7YHSun8UvdCNWtzJZ6Deyhl0qBzuKHu31rj9UtRbQb0h+yxiXCso+fOP8KyoKDjaWrbPQcakXzdEfQ/wr1O5sfBOp3Fw88rQRkBAuAPYE/hXNXfxkt49XfU4NHmWMQraHJwGfOSSfbnj0rkINSuLjQJdO0i8uoVTDyCV8LnHP1+lZnifTtTi8I6M95ZXAtZn8wiJcFn7Hp1xWdKMef3urIq0lG7Oi+IutRa/qd74g023aO0tkRBcRjDPKy42nHpXlPxM0S6s3snuAxkaBXKsfmUH1FfTnwa8BCf4eTwa7EVjv281UIw6H+8fevE/i9pOpSa5qMG15XtW+zqY1J3Iv8AGfrW+Gk4VFbZf1/mYTlCcHBbnh/GRnpTD1OK1hZSBMeW3X72ODVY2ign7/8A3zXtqaPMdNn6fGiiq9zeQ27okkih36LmvFlJRV2CTbsixVPUdQtbG1kmupAI14bHJ/Kuf1u9uLiaSBZIUtwPvE9D+FYerXcmmaMrKEuFkhK4kbOCBXnVcwV+WCO+jgXKzk9zE+InjsxWckdjCkaIdySOv3vw9K4XS9SGparp0F/eyxGSYHbG/wAgz3OO1UvEuo3cunwQNatIQm6RiMYXuPpXOeF7h7vVre0ibygziRinoDx/hRGHPBze57UKUaX7uJ9Oa5fyWlvaQLcFNqgSsnKkcd/fNeM/ELxtJBrEemaUgjlWX55gfX0NTfFHxk2n6aNIsGlmuXi+eVlxjnoD3ryHRYpbrVEv9TEkoHLdfmNLD0HUXtqu3RGNKn7OShHfqzudehvb+O4uNU1mIRKwHlHp07VufB7xvpegX2oJfIwtmQKj9cFfQe9Yt1rVrbWTT3enqiy/KvlncM9ufWuLk8V2kOuXM8tgTC/BjJAO7uenetaNOc4tcu3odOKVNe7J2T33PXPiL42OvarpKQWvl2CygtcFckgkYGPypniLSNMm1LyXnMl1LGoDKhyhxnt1HevI9Y1xtUurJtMTy0Vvlt1YsV+v1r1bwvrE1+traXEMX9vMfkeVxsUYIAI9cVhiaU6cYz6637muGcIpxp/CvuMnX9FvZmtbDySs6NhryRgoIA45FdXBd3tp4bjhhjiiuwqxjYxboOxHriuk8OaZcvpcsGueTJNJIUkYfNuXuDnpU2s2FnZm6stNsCdPWBYS6rjymJ6lm6+vFcEqvOkn0ZbxEXU5bXf4HH6tIJPDVpNbgm8uXzKw5249SenPavH/AB1bXU7m7nd2O4CRlU9untXsV3cWd3bT2VyohjtCN0sIJJPXOc98VheP5bTTvDVlcLLnUbgFZIFIYbOccflXVgqjpzSS1ZWIjF02ptnBaK+m6doU8wvbcMUVzHIMkODkD9Kz/GXjvV/FetfbLjy7e2SIQiC3BEZA9Rnn8a5jUgPOQKA64wxA71paPo09zcWWn3V3Fa287llMnBBx1P8AKvdVKFP95N3fmeLUnOs1GCtbTQyNG1KcXsUTzmGFZN2eo61vSXU1tdR3FjP5VyZS8bR/K3Hf2qrPpr6VqvlSwLdpC+G3KdrD14pvi9wkqG0BIZdzk/KQfQDsK0bjUmuXZihGVKlJzezMzVdRmluWknm8yZ2LvKTlnY9ST3NUYVXfl22sRhT9aYInuJkDqqbuBnpiui8K+F9R1zVrWCws5JwzhcxLwMnHJrobjTjrocVp1JaIbrHhW/j0Cy1iS0kS1nXbHIR8rAcVh2cV3HDKIj5QPysfUV95eLfBtle+BbbS47NJE0+NWitl4Vyo5X8ea+PfEaaZJqs8tlFLawAtGLZgThwcZz0rmp4iTfJJef8AwDSFOFVc8Hbpb9TE8OXd7oWuWdzY7hfQSCUSIcnjmv0D8P6kmr6FY6hGQVuIVk49SOf1r4g0K0GlFBc2+9bwD98W+cL/ABYHfFev6f8AFLTtH03TtG0i+e3t7dWMk9wm5mTggD0J5rCvXbn7quXUwV6a1s/P+vQ7b4y+JmhtY9Mjl2Q3aHcynBXB9fWvAE0fVNX0m7DSyNCW8uBpZ+Rg88Vp6v4/8Na/qn2a6t7y3sNjfvVcsRJz84Hv0/GsDTDFdRT2NlcSvsQyxHeTvc9BjoDXPGNVLmkrPfVHZQVKMeSLujgtXs59G1aW0ZlaaI4JRsj869G8P/EHxJpOn2s635kjhKhbVySAMYyAelec6mLlNVcXcbrcqcMrda6LwvoGrawtmLeKSSAzCPKruIJPTHWvTrcvInUaPPox5pSjFP0/zOut/F2v+JtZnmvL+SX906QK/IXcOVB9KvfD3wuL++ltXYTXEBDzKASqqffvW18Mfhn4lt/F8q6np5FhCxO6QbEb3Fe0eE/DY8O+IdTlvmtFjmRXR402jHOVP0/rXlYio7uNLZ21OuFaFKCv8SvoeK+M/BVxo0V1JYG5t5b/ADttIY2HQe3Y15zptlFa6dO19bXH2rcQOeg9SPavrrx54j0ay0Hz7+5eEsdsSRcysfp2rwmz0ePx3q8yoJbPTreJi8si85/x71NOtKmmpv3e5pRkqvvtWavoeQzQS6lqOIFXyEI3SMOffmvvbwpLYyeHNN/stozaC3QRhPQDFfE0ehz2/wBsitpYJShYNGzBXABwK9l/Zyu2iM15fXvlQn9wsTONufYfrXZVqpWa2Wn3nHXw7lC733PovFFIrK6hkYMp6EHIparQ8o4b4t6jqWmeDrybTZoIZNp3M6liV9APX3r5Il1q91G6P22cPEzjzZNu5j7Zr6/+LGkalrPgq/tdEVWvnUYU8Fx3ANeceAvA2keG/DL3+p6cTdmLdOLkDG8dACeK5pVFQTurt7HpYWzine1tz5y1G9kfWAtleXCQxgYMz5IwPT061si0ubq+t1nl8yHcDlnyCcc49/Wsb4hXE154gudSMNtaiWTC28P8I7U3w5LLNqFqNQnYx4KxtniMeuK7nC9NSXY2hV/eOL7n0p4H+F+jajHZ3cscrQeWrS/vP9a3UfgK9fuND06eW0kktY2NqcxAjIXjHSvLvg1a3eieGp0a8Z0uM3C5wRGnbb7mvWNIujfaTaXOSDNEr5x6ivNoOFRuLd2jnxvtIzvsjMmkvbfxAlmNv9m3EDbSqktG4/8Arfyrz74g+E9VvtPv7m1MNv5IIe5c4kkjA5P4g4r11m2B3cYCjqBk4rjL67PiHRdWtZ/Mt1dGOM4KqO1VU5YWcjKjOd/d+Z8+/ErUtI0zTtMstFhtIGt4AWdkBcsR39zXjr6sC7H7KnJ96teLoQ+pTSC4zH5rqVP8OCeK5EvJngn8zXqYbDxjDua1684ysfopqPi2wguXtrm6S2bqqk/ORjr7Vly2E18Tfyzu7FdsexSAFPSsiXwidcvY7mM7fKAX5hggj19a9Ns7b7PZxwsd5VQpOOv4V4CjPE630NJyhhbcm5kXGlQG3iNyUxs2tlQM9+fWmad4ethO1yWba44h42rUfiuSdIM2sTSOn3UxwenftSw6ikYXfcET4BKbenHQ4rDmpxqWlEF7V004y3PKvjVpX9kxG6tbiZQFIMIGdy5968O0Se6stajaKJ3kYAjABJHpX2R4g8PWnivRWt9Qyu8fLIg+Za5Cw+FmnQW8ETQhZ7djtmUcyDsc9u1dsJexp2Ubp7HRRxcXb2krOJ87+MNdGpy232iNoxn72Pu+w5robHwVDf6bY6lZaqZYJQPNXzOEYjGDz1rvvif8MtPGhR3FtcGK9EhKq4P7zPUcDrXjaxatokZjCO4ZwAVbO1h7U4y5qajSfK10PRpVFVk52vF9bdjqtR8I3GnajaCWeO/tEbJVX4PTt2rJ+Iegfa/ENvDBZwrGUEjrEc4Hc1Y1hteuAl7exyOxT7sQKZAGOT69KytMuL5riEXVldLAzY80nBA6YzU0vaJqpzJtXOmag4qnNblm18Pf2DBPq1q0Zt4D8w/iGeg68eta3w4ibxH4lEc0yiZisjzoASQPT0OKu3OlXVrYJBY2ksVpcSgTNMA+5ccH6V3/AIA8NaV4d1C1uIldzt5OOQT/APXrCriU4Pmd5PZ/5inH2SbholfTzN250e70jUoWtbp5bGZyXEq8g455qpq+qXFj8P8AVLq1s3aTcxQyt97JwCR7cY+ldk77rq5mlnYRoMpG2AIxjk+9CXWk6poTRebCq3SmNPMHylz6Z964qUVKejVvzPJliJOK5lfa7R8j2mrXbam6Tz+WzjLIrD5TnP412kGgWfiLR7u91SfydQLZtJVJKyAHkFR0zXC+KNHfS/EeopcJ80dwVYxH+HPb6560ktzexz2lha3n2e3dSYyzMCuezMK9qdLntKm7Heqj5Gpq56TqHgg/8I15tnbQXWo2U6I0cC7vMUgHdn3zXL+IPCUumpLqUsKxB23fZ5m/eYxzx2FfRfw7gm0X4e2hYRTXTxAghuHYjjJrwf4wLr0euo11CgSKACeWCQsZdxJxj29K5qM586jzb3/r5mEK/tJSTWi/T/I8g1HUrqAFWU7eqEHJArJbejLuuRKWTJB7D0q3eMXu5UVdzyvsCuMFa6bQ/hpruo6p5FtCJWRQzNnOPTnpXuupToxvN2POlCpWb5dUvwK/hayNxpkUkbGa4EuwxNGcon94Gvq34I6XpPh3wc0nnxs5lLvKw4XPQAnr/jXl2qaAng3Sba0gkguri8CrcqRlVb1Bxkd811fgsLeacttdGSFJ9paN3wqYxh1PvjjivFr4tyftI7XO+eHUqPJftdnttzqdnAIzPOkaydGZgB+tfMPx08LadpF+dQ0u7EyXUzMtvkFQTyQD6VteLPG+nza5eWmoyv5NttWGUqy+Y2ME8dcmuY8YaZd63qVjdtHIdPjYRxRqpC7TgkgH604Yio5p1NP+G2MaGB9nFyi/6/4BxVxcR6k9tJeTwhLeHcVJIIC/wjHHNYz3Z12Z7bCwLNKCjHGFUDua7/xX8G9S0uxg1G5vrK1tbiYIqO5GM8gY7jFaPibwjFY+B4tQs7BHEYaASqp3O/8Af4HTqRXWq1KHLy6328h3lVTu0kvxKfwc8LeH7hb2LxhJFG7YMAeUD5Dkce+e3WvoH4e+CPD2h2zW9tZW800LkrLIoZsEnB574r4bRrhHkbzHU24zkN0NaVh481zTr+C8s9Ruxcx/xtKxJ+vPNazwVSdTn5rrt0OGddOHKrx/r5H1x8ZfA+hPaXPitrESapaqm2NRhJ23ADePT39q8s0PxBJ4Z8QwGFIZZLhvOezgXaInx9Oea6r4VfHSw8UWseg+MYNt26eWbhVzHL/vDsf0r0GD4VaBBqw1SyMkcxwwK4I9eK58RSafK1fTb+unoVhsQqUOWo9zcsPE0V3YwzTxTwTqgeWJVOVPp9DXmfjvxTqF1cSAabcR6dvHlmfjLDrn/CvX7izm+ZYVi2kBd4GGAxUF1oSXl5p09yylbQsxi2ja5IwCfpXJyVpytLUinWo0nzpHg/izw9Lf+CrrxBqsUkUiFTHJG2VVMjt6ViHx5DF4JlsLO4jlumAChR83bI9/TNfTPiPRLbXfD93pFwCltcJsbYMYGQf6V83/ABj+H+meHvDSfZY7eC9EoEbiX52X1P8A9auhUIR5YVLvX5I2p4uVVuyseOeJNekn8QzXcFobdnUDb05xya0NN8T3S3FpZW8EcbzFVkGCdxz19s+1Zi6LfW0/2mcO8SH53PzcVoaZp1xq+vE6WIomi/eI0jYzjpx6mvQkqSjbokCVa93u3sfVPhLV7zSrq3tJrm1/s0RqVhH30B7knrXqKsGUEdDzXzF4y1rxFpkGkHXLa1W6uNoU2i5ZQORx+Ir6N0C7F3pVozS+ZKYUZ89ckd687COUVaTunt8jHHwjpOK16l9mCqWbgAZNeCfG7x/Z6ZozaLo1wbnVrlsvnkRLnJGPWvcdWimuNPuI7ZzHMV+VvevkP4w6ZOdYh1LUrWS0/gdx/EQf4R/jXRZSqxUtjHDxvFtPU8yuonvtQDTYW4fI24xyBxXoPwt8L2EUt1eeJUnktvJbZGqnB/2uKzvDq+Hp5riVmuVkCFo5Jeikev5Vf8Ga1q2t6lc6UrH7FP8AuzIq4YrngZHTJq8TUnKDjHRLf/gHfRp04yTbu3tb9TvfC19PGlrZX6C3jCbPmmJYQk8ZA6cHqa+jdJEA022Fpj7OEAjwcjbjivGfhxayS6/daRdaT+8tGRZ7qRMmReuPyr2m5ubXT7cNPLFBCowNxAA9hXHh1aTm9DDMJ8zUFqZ+vagbeazso5UinvCwR2GRhRk/zrxX4peLLPQ4rlL66uLjUlJA8j5FZenOO2K6nUtZi1XxS1zLqC/YfIK2sQHX+9+PFee+LtO07WtD1aLVWWwnVi9oz8ySkf3vb+VZTnGpWXNexthqDpwb6nhMsEWtXl3cKhijYlo4wxJGazmsFBI+1p+VaVpp2pW7yJZ79xjJkfsErlHaQOwLHOa+ggru0XojlqS5UnKOrP05jRY12xqqr6AYpx6UUVwW6HAUpLASvmSWQjBG3tig6darkmNRxgnpkCrjEhSQMn09a4Pxn4ivdPt2hKNBMzjDjkbT16Vx1YU6evLds6qCqVpcsXY6y81ax05I1vrmGAsPlycAjtVyCaOZcxOjjAbg54PSvDNVv7rX7ix0q5McFky8ORtbIGSfatXwbfRaB4g1CKGW41FAhAMQBAI7Hn2rFYrVcx2Ty1qF09TofiRafaL6yYSufmxsU4Kn2+teTa5pyyeME8lvtMsJBeMHk+g47j1rd8W+IL/xPBe3Fi8trPbt5cduy8g+pPT1rxa38caxpGuG/iP+kqx8wk/fIPepp0J1pynB/I9OjU+q0YxqHvetWr3A/wBHaeJgAJ45RgKCP06dfaucYW154bu4YLkGFJQZFlUc84OPb6VTuviYdb0Ke4gdrbVQqxzox+WRSDnA9jXP6L4kujoGphprZY4ItgLN87EngAe1c0MLUivRo7KVW8UpdT0w+HL6LS4/LQyWkjAr5OSdvGcA9v8AGtid4dCFybh5Y2SETKHHBGMYHv7V5V4R+JuuXf2ewknSU7lEh6bVGOB9cV67qGnp4jtlF1aPazqAyMJC24deB6f4VjXoOk1Goc/tpS1n8Pkcn4n8UpZWNh9vmkF3dlnYMcIiHoD2PFcpD8TnEdhp0VrC6CVmDGMllGcf49KofEG51S4vW027sgsSuIxclTh9vQD0qPRfCEhW2v7maNr24m8sQ7QNox0+prrpUaMKfNU3ZryuVlHZFPUNHk1zX9W00R3NzqKMJkmhAChMZwQfT+laGvaDBbK63hjaOO0U+aTghx2Few+BPAl9afbtX1MQxalN+7hiHzqsQ4GemSefzqn8VPDy6n4ZvUumSGWGHfFGQFye31zjFXOpUhKF9I6foc8MVSlOUI2f9aHhNpqWo6bc21lFe3FvbzKJI4pZSy5DZB9qdrXiVg99bXFw80hcbsybkQcZZT1ribVJfNaaSN/OT5IlYk7+eF9qoata3MupkhTGW5dc+vXNeosLCU/eZlPFSjTvGJ22mTeH0u7AahHNOIpXaadR1BHX8OtepaDd2+q272Hg6C+eWc5lnlOwKOR1PU9a8Q0uQ6fCt3qMKPHAwWNQcMue5Xv04qzpPj680aKWHSru6tbd3Z9i7ckk8DOOlY1sHKt8GtvPQPrUYR96yb6W/M+m9N8MXOqWU+iatpr2ksZWSO6WTzQQepDHv7VkT+G9F8V3T28+q3Njc6e5t0ijG04U8nOOQah034uz3/gdXt7iNdYjVVdDHtIx9eDkCuCg8QatrHiBL+XUbeNJQvmGIkYXPI47+tcDouGsdGgoxq1bqTsvLX8zX8ff2H4eKafqMa6zcSKptWLBCq55yQOua634aa14WsdOsYrjU0nunDrKkzDMZ9APTtXgfxJ12w1TW7yK3nnlgtlMcDueS3UnA7VymhgmW1YzL5kjkGNfvke9dlPAc9FObae5nWrJy9mne/XZ9j6L/aH+KWlW1rZaToTWt9cxv5rttDpFxgD64rzCx+OviOGzSwEdrJa7CrRzJuDEgjP/ANb2rg/Glq9teos0TJJ/Ecg/QcVz8WQCxUnsMV6VLC0ZwUmrnmVJToydLojRmulTccqzSZyD3zWKzfvQOn0NXZtwgTMZCHOCfX0pq2TNbNLtG0dfau2NonPPmm7E+k3ElpcrNFI0RHV1PIFfb3wO8fWHiTRLbSvPZr+0hVcv/wAtAB2+lfCcDvHJk4I9DXsn7Pnim18O+Kw19NFFbyqq7mHOScf1rlxkNPaLdGlG04um/wCmfbeKK5fxF478P+HdQtbTWL5bc3MfmRyEFlIz6ivNfjp8XotC0u0tvCOrwHU52LuyKHKR49xgE1zq0naJzqnI6f4tfFO18ACGGS0a5u5uVUOAAvqa+X/iD8SJfE8LvPbyCWWXzFkc/dUdAtcT4q8Tat4n1Br7XL17qfG0Ox6fh2rKzJcghnyI14+ldEMLFWlPdHRCpyJqHU7/AML67BHpbi5ldiR+8QN99fTHrVbRJrKTUpWhvZbS1f7ozlk9MmuHtCW3HdhEHNT6XDNeXYhhVmLnoKbw0VzO9rm8cXKShG17Hv8A4XTSvFmqWGmQ6jfyXcakvNKxIOOy59q+odEMAtIobYMUgQRFj3xXyV8KbWUXMb6dFOLxG2Oqgk49u2TX1xpVkLK1XOd5GWGe/wDU15UY2r8sdUjTHO9OLluzhbnx5qcXjy40g6dHHp1um+Sdw24DsfTmuv13QNJ8T6cIdVtI7mFhlSw+Zc9we1Lrnh2w1kf6WsiscbmifYXA7MR1FayII41RBhVGAK35Zcz5tjglOFk4aM8r1L4YaBp2janbaalqk8yll88BinsO4FZHw78GaL4b8QeZqN1ELuVN0VtngEH7x9/St7XdHmhmvdQureQ3chO+SFiAQPu4Hpx0rkjOt9DZanbTFdQhU+fGkZ+UDs3p0ry51ZKTWtj16VJzglzantVwsFpb3VxZpH57IXyuPmNeB+PvEGuX2iXUHkStcPKDiIEoqk8gN3PPNZVzrGueJ9T+yaBcX122/wAsCFsLGnOQ3/169X8MaRq2j6ZpNlqNml3eLOSXVhtjXbyzep4/Suht6O3yMI040L3d2c/8N/ClysumrqmmfNGjM87HIGemPeuC+MV5faH49ubu6tY7mwhjVYYTgbV9eO+a+oLdiVK7wSO4Hyj2ryD4zeGrW507UtV1dz9j2EEx/eBHA49M1VNRg7yV7kRryq1NXa2x8mXHil5tdaZY1Szmly0RHG3PSulkv/C7OzfYk5JPQ1wU8FuJXVGJw2FJHWupj0aIRrulTOBn5RXr1qdNW3RWFnVlzLRn6FUlFLXKeUJUM1vFM6tKqsV6AgVyvxH1C/0rT7e508lnM6LtOSPxx2rzfxp8SGk8Rx6RLCY4IQPNdH+83B46Vzzqbxtex10MLKpZp2uejeNPCOm6svnyokUqqQHUlTXH+FPDekLqdrFo13cW7FGa4OMbuOhzwT3rkofiGs3i6Eaqbmy0VgqrEz7l4/veorpPEXxO8O2d9FYafcQzI7APJCuUxjPavOrQm5+7F23t0PVpQqU4Km3q+vYr+NvDlx4TVbsahLPpVxMGmk2Auh98dRXlPjzTYWT7Qhj8iYmRQiKGJ44616ynxG0HUJ7zSriFDbmIjbnhuM8Z6GsFvBel6j4PdNPuo2vmcybS3zFc8D2pwrKlNSkmjspqbpONXV/12PJBo9u0Gn3JuJPLuH8s4wdlb9/pmjp4W1SymQf2xC4lSYyghkx0pNT0hPC1/YyhFlOctEW3BSe5rp/Dy2LatcwR2FnLNOmZWI3qhz0B4wa6alZtKaba3/EtU4q6drnI/DXRdNv5mm1O/FsAEMYPBLg9jX0+LnTNM0GG+adSkPyFmOepwf515xrWkeHvDdl9on09J08zcFJAZW7gH0qlLLFNb/ZxFINMkk81ogflXPTk9ea4K9X28vaa2/rYSwqrRjFOyW/mM8cXt3rniO3isLlTYHhYhgAHPDnj/Ir0/wCH3h/TP7PiuZvLvb6I7WmZMAMPQH6dRXlmvRXV55Mmn2q2zhgJFQANtB5OPp+VaPjH4g3fh7RZLTRp4knlA8x2XEkK7ccdgferw0k5wTV9xYzDydHkpOx634n8Y6N4dGy+u1+0EEiFAXYD1IHQfWvm34jfEW61vUWktlaFUGFZQQQB7H/PNYi602oXQklJ8qULulkO4t7msXxRD5MwWO43jeVDKwOV/wD1e1el/EmlNGVHAxwtN1IO77/5EOmStJuvY2W7KEOYjwW7elTPa3D2c2otYLIPNGXbqFrU8N+EpJLI3DyC0tmcMJNhzjvgfhXo3jW30vTPCswBj8vyV/1S8yyHv6ZxzWVXExjUUYa3djrVN+z9/TT8e55JqkGiX0KGGCSG63Atsk8xAMferkLuztQWkUnaNw3buXHY47VevsRIWwI4VyuU4b23etWPB9rFeao9vOqhmjYhZHABGO2e/evSh+6g5XdkebVSr1FCyuyn4fvmuJJI9VuJNiR/uyDyD2x61r+IttpodibBXjDFgysdpJ9cfjWpYeF9Nj15WSO4FpEm+Te65xjgjB5rhvFl8J9VaOGR3tomxHls5XPWlBxrVU4bLUmopYag1U3ehnrMVZmmjLseMY6VG6TQThozhh8wKkcZqSG9UQ+W6k5YZJ7D0rRsrQ61rNtaxFURiqu2OMZrtcuW7ex5sYe0sou7Z6RJY2p8B2V1cPbPO8TsA/3t1eSxF1eREj2hzjjkj6V7HaeEVju5bC+meK1kBS0kbhcjqOelefax4euNOLFzlDKyJMgOHx6V52DqwTlHmvfU9bMKNRqMmtkc79oC2vlsC5RmIJPTOKqAzG2cKW8oHJHbNTWkMX20JO5EYPJxVnU41TCQKRG5DImece4r07pOx4tnKPM35GcSZGUHBx8o4pWUq3yE7lHPbFW4HMRVooxjqyv61WvZmld22hM9gKpbmbVldl+fWb68too7qZ5vJ4V5HJIHYfSs+6umnky5O73NQlJGgEm1tinBPSkHJORn0zTUUtiZTb3IySZMEkCpsOE+UEg8emaYkRdzkYPXOa2ba5s4rWWNkZ9ycZ7N7U5StsOEObd2Mm1hdiw/ujOM10Hh/UI9PuRcW8gSdcBUKZB+prEhdmlO0DJGBnvVyOwaUuC6pKozjPX1rOolJWkaUXKLThuel/DvxfdeFdeOszF7uXaSIQ21CT1zX1B4A+KemeLFRXgexnY7cSOGUt6A18ZaAtncWUiH7TJqHCw7GAT8a9F03WW0/TdLghtWjWCYGeXbghwR3rzK94S9xanoKhGvDmn2/U+y6KyfCurQ63odrfW7+Yjr9/GNxHU1rVUWpK6PIlFxbixkiCRCrdCMGubsPBmm2V1ezRtMRdDDISNq+4HrXSSyCNGZv4QTgdeKpaRq9jrEDS6fcRzKjFWCsCVI7GspU4SfvIuE6kE+V6GZ4b8MaR4Ss7g6fD5YZmllkPU965Dxl4wvdA1iKZbSe6tLvHkqg6gDnn+Ec16bcmMQMZgDH/FkZH415J8f9f0rw14ZjneOKe9mJit4y2MKfvEY7Y/nWc6bbUYI2oTTleoXPFXxTsPBXhqzm1KANqN3kw2sBHA65JPbpzXzP8UPiZrPii7kilme009yGFpE4Kt7n3Nch4z8T3XizWftd3JhIkEcSDhUQdAKxrXZLIzXLMeMgg85r0MPhvZwTqasJyjzPk6joJIY9Tja8UyRMQ3B7V2Y1vR1ADQyFhwSGODXnaCSS5ATLOTgVqf2Ze/3B+IFdFalGTXMy8PiKlNPkX4H6CSePNDglhW6ufIjmA8qRgSrfl0/Gult7mC5RXt5UkVhuBVs8Gvn7wpcWOs3iWt0dkcR2Krxg/N1xn8K62XUp4pPs2mXKbolLOpQ5UDHT0r5r6/KD5Zo9CtlMb2ps9F8S2tze6TNb2Qj85+A0h+77189+NvAN7DPJf8A22CaUsQ6DgjA/wDrV6z4c8V3N9MlrsLL5Y2uOQx9c1zHiS9nsteuQIfMhOPM4yoz0470quKvLmp79R4PDTpydKfqeAX+ja/dILyWCVbVUIjJ/u96yLGEW08bSfK4PrzuPtX2f4as9PuvDvkAxS71IIPbv0zXC6tp2ixeJrS511LKJ7fcDtjGGA6Fq3WOaik46PsXDlnUla949zxnTvCGq+ILJpbG0uBMZgGkZCAB9a9e8IeDrHStQsrDUlzcXSMuUbowGT3yKmvfiroyXUum2JIQrsV1O3Bx1/CpPAfjLQJ9bSFWd7+RCqytlwx9j68VzVZVZtKStE2dSfJKUVZ/ibWr+C9E0aCNr23bULdywdZSN+cZyOmaw/Cfg6P7Fcy6Pi3tLmMu7TDewbdwMnoQBXql3bHUYYRMqqyEk99vpXP65rukeDLUi8u/LSYsWZhuwfTA6Zqp0/etH4WcFPFzcbXvM4/xveWlxZW+lx29rfzyEJJIHwF28E8Zwa5dtJ1CDWV0YmVYFjWUBuQV67c8+9YureMbZ79/sZWJGYu7If8AWqWzgDFem+ClfxTYMzTKpicF0AKkrj7pPc8DmuZ0qkUly7nsRqLDwvfRbmXDbahLq10thYpbWzRhfOnbJZu5wR0xXmHxW8KazY67bfaViEdwg5Ukq+P4T6f/AF6+lbzS0GjXH9lzbZ1UmMsA2COxH1rhfE90LnRLOee2lup52EOyTA+boSD2/CnSlLDSUranPTxP1l8vT8TxLRvDkurXENqsUkQJ8qExqSA3rxXf+Lfh1Y+GNOsJbu8ill3L5sZjyxORkLzzXWjxVb+FLOCIRqt0z7n85PkjX/eHX0rH8R+PIfEEllKbKeBHBiWSZAER854PXnAreVeU4cyOiLrSrJRVod+5AJyvnTWdsbqzDLn/AJZgKR0CnkVz/wAQPEDzeELjS4dNS2gMgdJ2YMRx90DtVODWZ9O8UXNu8qX1tLIFYREsEzgDNaHxA8P3mmwWB1iGKW0jbztjcM47Lkd6xpUuSpFteZ01XCa5W9fM8OtockB0DFh5bAA446/jV/w4iWWrPJ58aXEe75Zed4xwMVu/EzVrKWz2abCtrNv3eXGMED0Y9683S7nklVSvltxk4xX0NJSr07vS54tacMLVSWrR7d8OdFm+2ajqyraNDaRMxRnIDAj7v5V4t4mmsptVupdOieKB5GIRjnbz0zW8l7qFrpupRW97LDBJtkkj38SgdCfWuUQLtZncNu+bAHQ08LRcJynJ32RjjqvOoxtYqMPY44r1H4VaBLd6fqWqgbBaJiPn779cfpXnelWsuoXiW8MTyySMFWOMZJ9hX2H4B+Gt14c8K21sltHLd3o3SNM2RbkjPK9+OPrU5lWcafJDd/kZZfyQqe1nsvzPCrq71yXQIXuZ8xtOzKnUhh1rR8ZLrVz4N0+2l01IoJXEsU0b7nC9MYHT1r6E8L/Cex0zVWvtSljvSG3JH5eFBI5JBPrVzxD4Xt9JjvbrQWtba9mXfi4G5UA5JA7CvPqSlTtUUFo79v6/rQ7XjKdR+yUm7o+I74Q6ZG0NmHkeVCkhkXHPqM1X0eybULsR3HmkhCVWMfMa2/FM2sa9rR8yDz5VLLGYocBxk5IxWn4Ssb6w1sLqkO1zEV8x22KigHPPrXrSq8lK7+K3c44UvaVlGz5b9tDgZ2fzDEuQAxADcN+Nbmm6INSslaKTz7p5QjRKCWA9aivdFuXlmlhXeEkxhepye1J4cvbvR9UMtszIy5yQD+Wa1nJyjeD1MoU+Sdqq0Z0fjHwSvhzRUujM0kMjeWQRtYNjOCK5/wCH/h0+J/FNlpjP5cUz4d/7oAzmvaNe8Kxa98LtO1f7TdfPL5jQFSVGepyTUn7PuladBNrc2mst5rSxjyY3QjapOPzzjNedHGSWHk73ktDoq4eHtk0vdR4z4w0X+yPEl9p1sFdYJDGHzwwHesdNHu5smGMvgZbHYV9VeHvCfgbU9Xlk8Rzxx6hDOQ1vPNgsfQj0zUvxks/CM2mWWn6GNNF6WwFtpApCe+3rVwx7UY6ev+djKWGjKryrr22+8+TLywutMuViu4DHKQCA1TRx3omcW4L8Akhelei+K/DNlZNbot/J/aSYYrMQyovqSOaq+BNNt9Wur3SrrVPLkfL+YBwcdga3+uRdP2nbyK+otVPZ99tRngPRTdzCGeLyihLecjAYbHANV7y91C3kl0gs6bZG4VvvHnqe9aFlptvJqEmk2OomzuoWZGndgFf/AAqxoem6bp0txNrV6biFAwjWFd5mfPQHtXPKouZylr2VjsUJKCjHTu7/AIHvf7P3i+9v9AltdRt1SxsVVFuMhQO2CO9ezxyJKoaN1dT0KnIryL4R2HhXUfAf2SAoHm3tJDNIPMiyeM1yPxI8QQeDls4fD97NFLGuJGy3mdcFsHjFc8asoz5UtG9F2PPnQjVk2nZrfQ+h7mETRMMLu2kAn3FeZW39h/Dq6u77UNTEDSKd1qozkZyMD3rxzw/8etX0FZI7mNdUSQ7l8xjlfx/pXO6/42vfF+tya1qcTpZFfLCRgYXH8+tazoSb53oKjTabp3uj3HxD8ZtFvvC+qxae00OotEVijPLEHqwx6CvkrxfrTazLGfMmaKFQiCVicev61seKdRtkuZYrBNkYVVD5wX4/SufbTpUtdrIGyu7jk5z+ldmHhb35dSa0IwbpwOejfBUYzzWpaWtyoFxFAZEVuhGQR9K1tL8HXtzbQ3c0EiWr5bdjsOp+lWIdSZp1tomRUQCPei/eAPeuiVZSdoa23Ihh3FXqaX2L2g6Nc2NtLql3EkaFDJE+MhWzjHseamaG0lYySXDh3O5gF4ya7zVfHOjv4UudLfTY44nhVXZJORIB6dua8UOrTZO0kL25rioe1r3lJW/yO+rOnh0orVH1d4a06KRhe2rPDcJIeAOAwBxk961dZgms9NjvrO5iS5wTM7gKWJHp3+lWPEEcGiJJf6beRQ6WY8+SBnL/AOe9ebazdQX1hGsuoSPNO5dkXDBV9R6EV83CDqSvfT7z2VL2nvL7js2uri10G2vbRo1aORQsseVGe4IPau2tNYt9W0O1v2hie7nIjk2gnBHp9K88ttCX+w4Xtb+W5smCie2JIOM8tXr3hfw/Y2uiGG0KCKQ7laLHy/Srp03VvCBx46cKaU5b3OXttRt9LmvYYFlTy2HLggOWGflP6VNoeix+I9MvZdZkRpplaJFIxtXJx9asSaXqFnqEq63tv9MIHlS7QZFx2YAc/WuN1PU7fStSmvEEr2UZKDH/ACzOP5e1QounOzVxRSrxfs3Z99zxDx14fvfDevXMbRxopyFPXjtWD4e1ptJ1SC42sux92d34cV7L47UeLfDcU4WIXdscqB/EteGX1rNbBVmUZIznIOB2+le9hKqr0+We+zMMRTnQkpI+3Pht4mtfEXh5Wtpd91Go8wMfmPHB968u+IvhHxL4n16OIQJFp0jCJJCAAeepH9a8V8I+IJ9N1awLv+7Rl3KV3Blz0IPBFfa2i3Vvren2t/Dny8AjIwQeK56lOUJRjH5HNKSot1YrR/gePaN8A4o7cLqF4m9R8nl5OD+Nep+G9GtfC2nRWltINuNrMF+8w7k9T3rpEZWGVOar6iyrbMxmWEr8wZjxxVVafu817tHG8TOp7ktjB1TyLWaW9bz3M42heSFPbHpzXF+N/FOjWulyC6xBcmPIiLgFWHcj61u+MPFR0SymljR5nm2iMqAwPrgZ54r55+KNnHq3iGO/t5TJDeQiRecAcf1rzadONWdm9D18LSmoqbWq21NBdesHmd9UuoY0uU+4q5GRkgEtVQ6veajbRahCsdyISR5Lj5EXkdP1yaz9B8OTa/HaQaj5a7kLB887QcDmup1jwRayaNcWmmb475FDl1Y7Cv09+tbSdCnJRb1/BHsKVRq9tLfMxPDj2ln5l7uDOZdmWYttfOQcDtjivWdZ+IOmar4eht9RhtReyHyjHu354xkDH/6q8C0rw3qmlXhQSxupcpJHyuOvzY69qyb4Xzm4AutlvazeWqo2SnP3s9xW8sNGrJ2noclXVRnOn7yJvHuqpBqrW8dr5ZhO2aRwCZcH9OtctcywXKvOjbBklV/iLepHpXRT6Skqm4u3e6mkZUBQ8ZOOpPetbxNoa6Ytj5unNbaZtG+dFDn3yw981306tOmowW5y1qFWq5Tk9DiJNTnlhaJxGiSYRiy88c9e1Yqxl5MRlWJO3jvWzr1lbQtLNp9551uWwu5cE07wnB5115caKzNgF2OAnvXbGUYw5onlThOdVU5O7+8+jfgZ8J20K0sPEOtYW7lxJCg52Ajgn0NfRNinl2sa8k45J6k+tcj8MLmz1nwPYGCYzxxAxF88giuzVQoAHQDAryKUZym60+pniqmvs+w6sPxLolp4gtJrWYLu2lCTnKg+mK3K8v8AGXiq40bWtTku1dYoI1EEUIIaVepLN2GTVYmSjHXUnCUp1J+47NG1omiaHBD/AGTbJafbreIhdigmPIxz3rx74weFhos3hq2tvMmljlZSzEKGHBLfTnHPcV0MXjvwxp9zBPpEUkmt35CoUJYbiRkN9Oa4H4yx69NrN1f61OYLeaMJbPEMqRgZUenWuShy8yTVn08+h69KFVTve6/p6HGaYuo6rq2sPa+XFCoKKTwOO6muItdSuYftduixSliR5hGTjPNdHeXTWOlaZaLe3SWkoPnKU2sDnkKfesfUorO2hVktJDE53RburL0A4r1aKSbutHt8h4hycU07NXb+Z3+lfGq/0nwl/ZSw2twm0xqjLwBjmmfC/wCK/wDwjKah9nsbYaheMWExQdT0XHpmvGLslJyNmwZ+6eoqWyZVmV2k24Ocit/qVJJtLc8v61OUrS2Ppy0VNZ1hvFHjVfswQgFFUIv3fvcda4P4ijS9Q8SNeeEXW3jt4su5bZls9Vz+HSmW/j+FvB0VjqTNfggIUDEMOuD71gXNvYazFaGGV7YhtrllwBk569zXmUaVSFR1Kl108reh7FRU5QUabT0XUzrrQ9YvbqRpd8lwy5ctwWB6e9ZUCalpk8phWRHQYfjkV3N/JBZLbRC6uJLkDMdyDwcY696yfEMmoavHK87q92SqbI+C6nvXbTrSlpJKxjVwsI3cG+Zef9f8E5mS6uARKpbD/eZxyWxXpfgHVYTZRxXaIJAWCmZAUBx/OvP0e409BbXlmvlxncRMmWrX0q7s766tlSRw8Unmsj4VQo5xnvTxMFUha2nczwknTnvq9LM7rTrK2i06W1l1NLa5uWaZnOUMfp6dfavOtduhdx4ee4nu97BpZHJEgHvXfeJNdh8QSpdTWUDWtqRCPLbG/Pc1A2gS6VpsOoXdj5i24aRYZfukH0Ht71yUavs/enu+mm/9WOqrQ9orRtZdf6+Z5hYKdR1NLeKN5ARjYnGcVsyQy2mrRQxxusQ+URseDx1qvp1vdyy3Go6ZE9tE0vlqwGfm/ug/0roNP8MXMWqabL4pvUtbS5fZ8z5cDPcdutd1WrFPV9NupwUabtouu/SxleHfC2oeJvEP2KyGZWOQSOAK+grnUvBPwx0GLTbzTk1LXGjxOpx1PfJ6D2HpWfezQfCdJ7tIbW+lvoSdNZCC0YA6t7cjn2r5z1LXb/U9WnvrpzLcSsWLOcgE1ywU8ZK7+BfiyZuFJWW7O31X4lams5s28hrFw8axtEP3KueQMde3Jrnry2e2AfZG8bKShT0zxn3rAa3urmJ96MZFAfnsvrXQWmoxab4Wvba5i8yd9rROecD3NdXsY0rezXqOFR1L+0duqf6GBK8clvMbt2SZx8ijpx61hFiDgE4HvU11M8xAbGFGBiqpPNehCNjzKk7n2XcWsuv6H9msUBgs4tyI5wWbHOT3FeeadZ3eiaoI7yxcyZ8xXHzbT7Advavabe1vNH0h7jVhbrHbjy1ktwRuXsMeua8213WL++1CG8sYyYwPLVZFXJB7Enr618VQnJXhbQ+yhJSlzR6dvxL134y8tZIXAjJQRoCMOx4r1T4c6lfyaHA18FgjVdgjkTYW565PU1494d8MR6nLa3N+U81maIrMf9U5ycgD6V2WuTRSQwaHd+bLcWi/u41faHOPvE9PwpOUKbSp79THE0vbLkdj0W7muriaGONnVlcsX6hlrktb064vRfBLSKeOVjlAduQOuffisnwv4qlNslteTvHeRbljQHcD2AyK7rQpppA0Wro6Oy8kDg5rKXM5e89Tk5ZYXVJHHeG9IsdTmgtZIpECptBZf4u4J/GvE/ip4HuvC3iK4F0C2nuC0UiDgjsPY19FeD7Nz4k1BmW4MMUm2Nn4zjvXReOPCVp4v0WawvmClhmNwPut6nnkV6GA5oNtGOMxS9qoy2t+J8YaVp0lxd2EMMX7y4GVLsCv/wBavoP4K61exap/ZjxfugPKkWMlsEdGNcv4d8CT6L4yt7C6ihefIaNwD5bIOv8AKvaPB/hWPRNRubgbFlmYudh4APYD0rSrX9pUSj9/zLrSp06DT3a/r8TsAiqSQACetR3TRrAzTKGReSCM07zVEixkr5hGdue1YfiPXodIniiu4d9pKhMsgblB0zjHIrqqTjGD6Hh06cpySirs8i8W6tpU3iD7bbrcYtZdv3yIyD1IHr2rlbpv7Qv4/I0yKa3dRKCZSJFGTwD2/Guv19LXWdVj0jSdRso7GLEm0KGAz2Lep9ulVvEfw+16bw3DPpk1vHKvy7Ywwbbzj6/WvHjbmt1+eiPr6daFKnHmdjB8Sz6DBpss9tps1tqFqY0jtkc8Ln5ixB7iqFx4vgl120aexmhdYgFaM8yEDjPtXOsup+FIUlukW4luY5FmW4HQjqefyriL7WxqckZu5fNcARKB8mz3Brto4NVF3Xe4qmJjSXn2f+f/AA+p0cvitbTxpNO8NxMvmNvTfvyDzzWXI9te67c3Atpo4Z5DtjBxgHpxWCl1La3MkkBjZzHsJJyc+vP1rrPAkOnapqDLdzTw3UsRzPNIuC+ffpx+Nd86caMedLpY46dd1pqDfW5Uu11C5sJrGF2t7KL94ofq5H8+a0fCfiCzuLiHTddW6mtUAQxB8g9STjjH0qbVj/Y8DWyW0sls+8x3EufmPYr6jPNY/hK+h07WLuea2gkCxfM0+eCepUdKzsqlKTt6G0pclWNpWvoz0nWPDXgvxNpxj8KSwWckZaQw3RYMdoy2PqR0rw+4in06Z1MZtkc5CNkblz+orsYvGU9nII4EVo1fzAwXB69CPeun+NMlj4lt9H1eKSGBzaqZGUYDN/dVcduaMPKpQmoVNYy+djixEI1Fem9Udh+ztr+qaY1tY3V9ZTaZc42whwJIjnGcV9KbgQCCMGvzv0bVjpkkNwpRnt5AVyuCcdq+z/h/47tfE/go6ldtFYMnyPHC+Sgxxjv+lVV5qDbezPOr01VtKC16nV+KNetPDmky316JHVBxHGMu59AK+b/jZrMmq/YbmK92i8TzGt1OCg/umtbWvGEV34nkS51Kd9OiyM3HyjaB6d2ry/4gIl9qsf2AxRwXI3xuWyQB256etc0Jyq1o8yslqelRwaw9JzTvJnP6bcX0GqW6wowkTnhskfj2616z4t1DTdX8G6S1ncy+ZCrO8k7kru7gA9a8Ugs76HUXEUrBQDvkOQNp61vXoim0q1W1uNsTlw0aZ4IHf69a6cRRjOcZJ7F4eclGV1/WwsF3ceIru3sr8qywwkW5b5c56fWmapAdPvYrXWmM52gp5YACDn0qbTdTsU0qC2vLYm/hUrHMpOSvatjw3o0Q0t9W1q5SCN0PlITl3IPcelKcvZu7Vl2/yNqa9pFJO73b/RnnGr6NfmdpXiYxEblkIwGH171jWscQuFjuS0cecMQMkV9M2b+HvEehtpen6lbpeyLn7NImMewJ6fh61434+8AT+G79VDs9vJ92XqM4yRkcVthMeqjdOouV9DzsXglD95S97uca6o90FstxzwA3c11uliS4uYLHW1m/dr+5WADJ9c1x8UJSU4XnPU8VbF3Na3alJsHAAYEk4/Gu6pDnVkclCqqbvJfLodt4iuNNkVbe3nkE8SYG5duP9k1J8PrprGee6lS1uyg+aKX759Np9axtcm0Ke804WU1xJdMg+0zT8AN7Uyz/ALNtfEy+dcS/Z2+9NCvfHpXE6d6Thrseiq379VNNHbRnT+NvEOn69ATcR/Z7zIzEY8FAOgz1NeesJnuTNAY1lJ2hV49qt69b3C6rcSsjSq/KuRyB2JrNcvCquh2uV9icV0YelGnBKGxx4qtKpUbn0Na2vLvSrrN1ErsrBghPytj1re1DXtd8QWU0yKiQZEbQQE4P4d6tfDPT4fEE/wBh11XNrkOGRMy47hfrx1rd8WzWmmX9vYeDFmitmy7+fjdkDk4xx34rmq1Y+15OW8l16HTRhL2d+ZqD6dTgLrXbiC3gsQ0tu8ErSsS3G49wB0NR3+vxXOnxW8oluZ1O4yyMc81R1G0KziW5ZpDIS24Hrk1SuLcwyDCkZbHPT6V2xpwdmcM6lSLafp8jtfEF8b7TtO8uZY1htfLKkbmIz/WuSsrcfbShb93npn71behyLBLeLNCZgsOI8kbVJ6ZNQ6Fbw399dG4aKKYMNhJ+UdayhanFrov1N5x9rKMur/QueOWstJjhs9Mud80ijzzj7o/u5rmxqUlxpos3gTapA39/xp+qxIPOkdy9wHIwBkZFVoZ0+wOnlL5jEHcT2FbUqajBLd9znrVZSqN7LsUbuB7ado5Bhvb0qLymPIHFThVljHLbx1JPapBDFgYmb8q6OaxyOKb0P0N1NI9S08RyRtbwTsCEc4xz3x09a8n8Q+GP7M1nYbgSQSt+746Htj8q9C1y8gbw/NYJ563BQMyyISw964a41ywvLVrFYZJbi1C/v1Akw2emT/nmvg1UlJ3R9ZgYTh6X/pkmpLp2nWckqSB7xsdEGAfqKxPDeox+IPEkUOpC5QOMId67Xb2JqXWdIaSC1ksuNkobY5wCW/pW/wCBfCE194jF3eFLeW0CusKrlCDnBB9eOa0pKPK1u3951Yiapwcm9jt9K8Jmz1IajcRxSA4Plnqp9T2Nb+pRrcTr9n+UpjLgcZ/wrXgh2RhXbce9PWNE+4oXPPAxXfHBvlt3PlamMlOfPLVox4UngmSNIzKzODI4wMD/AD2rZ6A4pcYJx361Bd3CQINzBWbhc9zXRCkqEW2znlN1WtDFvrWNpo7mOMK0LElnXlh6CtaxJlHnuhQsBwy4P41WvpzHbI8OC25dyk9Rn1q/E4YgLjGM/SuahFKd7mtWTcFco3EBTWEvHB2LEy5/u968xvPGumXGr3drcXdm2mGL5gjZfnORk9c16vqLJ9mkSQHZIpXIGeteAXvgJbbVxNpr2D2SFvNjkUht3YfWpxXIpOEn5ndl0Yzu59NDoz8PtLvohqelWI3ud0csblNuBkGqen/GGLQ4rjTtcgH2qz/dGYNlN3QZNdL40u7rSINCi06YRpLxJGckYxn8s14d49s9O1QXl7JMzq8iiWCMhSz5/XisqHxpTbO+NJ4mm5SSa6f8Ew/iTrA8Tapc3ovLdbRHKRJFgiRcZY9PpXlVyP3xXG1FbIBOTW5rMMEV/LAkUqxoQwU46Y6cfzqn9ldwskUQELZ4br+dfQ4aKpQSWx5+KvUlZLYrSMhmgWHlmwMYxg5713a6NE2jSXNyRC4YKhwBv47c+v8AKuAhiYyhZCC6n5StdlbR6uWtNNSWOSDcJEZeVXjPPWliU9LOxeCavLmje50XiOX+2NC0AfZpI49N/dSTKmFYjHp7Vx+tBZNXSexUjfIxKycqADxgd+lei+EG+1CTT2hMtosZe4YAksRyeO/PFcn4kSS10W8dNM2o8oCTySchO2Frhw9Tln7O39M9HE0k4Od/P7jU0rTY9bSBmlt4bhRieJ0xlVx0P5V6Bf3fw98Q+F7jT7m6s7DVNOiK2z527wOgJx82Tx614ENfe4jt4WjWOOP5RtyM/WugtNAs59DbUGkCiIMCGYgM3X5TV1cPytSnJrtYw9r9Z0pLbVs5zWLFrGUt+7dXTcQpxtz04NX/AATPeRasnkXDwhVJ5yVOBnBFT3L2WoTBLu0li8uJVdwSTn1z0ArQ8M6BfWuswXkam9tIXDyeWS4K11Tqr2TU97HNDDv2ylT1Vz3qx8BweNfCSXE9zBZ3t2VmZ41zgkfdweelYGv/AA28P+Ebizm1S9m1GQKyrAnDMRjkD8RxXqPw78QaJrtpDb6ZbiFcbzB9zym78V5z8Uob5vF0EGlQ3C3lrICsrnKbTz1614NOc17l7LX5HVBzlWan01tZHnHiuSzMMmoSSvvjRYYUzjjB+Uj1Fcl4RuBKl4sskKNsPlvJ0Ug5OPeup+JenfYrO0aR45Li5LSzMgPytjGK4Z7XytNtbyJdsruV2Kuc4I5yK9bDKMqNr7/oGInKNe9tlr53Osmmstc8QaetxstIguGdBhSP8ev50z4lakbC8RLZI/KCFI2XjIxwRVyLSUEsBZf9K3KxErDAHBx6f/rrjfiHeNc6qTIirnjapyBj09qmhGM6sUtkjXFznRoTk/ibRzq3UykP5jHJ6huRXrPgyzv/AB9ozaRbyyT3NuvmxwSPw4HXB9a8djO1hyQK9G+GOozaDqD6tFd3FqURlV4kz14Oe2K7cZD3OaO62PHwU5czj3Rx/iESwX8tpdQNbywOYmjbqpBwc0wGykiUusr3AXox4PpVnxQ327Wbu4e7F07sX84ZO8k9z6/WsffvZH3LGVGBtBreCvFGE24zd9SpcnE2QMew7VLa3Hly7n+ZRjIbvTniwzeZ87kbsqOn1qsR84BXj2rfRqxzap3Oll1qe805rRju7oQOQPTNUNPsJ76ZIwskhzjA7CrmgOlnLLLNbl4ymBk4x71oR3fksZtOukiEoKN/sqT0rmb5LqCO1L2tpVHf+vM6K4sLzTvDfm2TSRzxHDCAEFh9ev16VyT33nzyLKsokIOEycgmvYtBZbPwPNd3hkmtIlKCWNwu4n68n8K8x0SJbjxMsm6LyWyB5ny9ffvXDh6t1NyW3U78TTTlBRdr9O3mR+GbSbWbhLSKHcqZbzCMsqjsB61S1bT3S5kLl/Mjm2bJIypx6kV6z4DWDwtBqV8j2v2kAzJI2GCoAei9c1xOveK7K8t4Xm+e9LM0jBc8k9Se5p06851XyL3SalCMKajVdmcUk7RvcQQyErLwAB1+lRWha2unQBTkbSGPWrC3Me6XaN0jklAV5H0rJvXcykSAiTPPbmvSir6HlzdrO5Z8sR3DJPJtzkArz/kVUnEcczrExZAMA1GZC7gyMeBjNOt1aRzGg3M3AHrWqVtTFu+iI1xkZPFOMqZP7sU+4tntwvmqVY9jVfNUrMh3R9+eF7FtZ0e6/tVjNq25kkkYFdozxgelch4dtdHsNfvhcTor7yqwAEjdzyeOpxXp3h2xjmaS/tJCqyxKpWN8hj3Jz37VyF7p2naf4jNokZbUbtPNbcvOM9OO5r4JxfJza6n1NCunOdNv/gFxdMs9TD3odmjiBBTGArAdf/10vgO5Md+twAGjYmIhAxYtnqRjgV2mmWaWNgIxEvkleVC8+4qzaWkdnZSyWse13Jc/X1x9K0oUJK0k9tTjq45SjKm9U9EamaR2wpOQMetZumXktxLJvKMmflKnpjrml1Kdo7SckfKAQT6V6ksUnByWx5HsWp8rMt/GWmC9kt1kyYc+aWONmP515142+IFlJffYIXkn8oh1dGwynqCD0496w/HPhXWFvLpdNgiaC8XeCSWbA9MfWvJltLywuntJzI24fvBt+9g9DXPBfWF70vkfQYfC0aclKKv5ntaeK49RsZLlLy4lGwsXUkGM/QcVqaL8Qn00w280gvpHAMgLYIz0OfpXz3ql/JpJlg3vC90B8y8gLjj5fWsey8Q6nFdsUuG5TYN4zuH0NVRwEl78Jeh0YmWHS9lOP/APtVNbt9at0UQuqMePm5z1IxWZ4m0qCayhs4laSRphLlThmHruHSvl/wAEeMNU07UrR5ZbieGItuhLELzxwK9t8JazeGC5urqdomK7xGnIQkZGB3ArnxcKlJ3qa+ZyUMNpz0XZLoR+JIWh1C3hlvrgzRxMsfmPlWX1HfPQYrzvTNEUXt0dTsrjULSVTOZYz0yfTseK0/F+pXdlNb6kLo31kCdkgUZGfvE+nI6VyFx4l1CKF7TTZVjju22+YvLR89TRQpVHH3Xuep7tOK5t/wDMqeKtL0Z9aeKzsr63QhfKRxkueMjJ9q6fTPDsDaLALK2PlXEzb5pgGYKOcYHQ571xNreXkviBYru+a48tt65xnd6n8q74315NC8+npbtZSELK2CGLewPpmunEe0hGMLjw6jLmnFeXmWvBXwr0jXZ7q4uPMeFJCZJrYgKnqvPce1azfCrTR4gex07VJ1tXA8ljglfXPTjP0rpvh6INHt9WR2kXTLdDK6BiQzFcnoOa4S91P7ReQ6mlyuxXCxop2Exk/wAQHJrmVepN6SZz+ybqyUbKy/r5nqF94aTQ9DhTR4or3VYgEMUTBN47nr6Z614R8Z3e2/s/SZdLmt1UvL98AspPAHsOa9BtPHFtHFKEvXju7JSPMZQWZSeRjvgV5t8Q7n/hMrxb3RTcTwafGUZ5XLFl6k4PI71pg4tVlOUbJevyMqkKsabg5czf+evyPPbbQEdgzsVQE4fruPpgVNrdlfaaY4ZIryKBvm2yA7SPUCmjX7mO3ijjih2QyB1Kjpz/AFr0TQTqPje4EL34BlQDEwDK+3sMDjFevVq1KVpztynLSpUKsXCm7M53Q9Ws50uFuYYmuFhCw4H329CO9d54Us5dBsW1GO48y2lAaa3VcbPc+1YHiH4fX+lXdvJZxRtkb2VflKgc5z/Kuts7RdPe7TVZXltmt18pFbG/PJGPTivMxNSnON6b0fQ9TDqe1TddS3reqaZ4buoNWs18qa8KyF4mJAUnoAP61q6r43udc0eC0h0qJpbhgBd84C5zj69B+NY+kXmnajY3GnWUIKvEQ9vIOI+eqk9aj0HS5NMtF0vWbkxxGbdbSSSfKc+h9vWuRcsVaS95d+3p5DnSUpKT26GFq+j67q8UpkhtHePIZUIDKPp64rG8NWCtcyebPB5luGijhcbQR9PXNe9yeCLeLwhBPZ3Fx9pCeaLq2BDO2e4JORjA59O1eLzeCZZPGIOoJfWrhDN5hwfMwO1dUKvuyhJ2XoY060akuemrtO2rF8HaTdJ4puobpY2VSp8xznC55wD7Zri/if4YmtdXv722VDYvKTG+7BPPOF69jXuXgHwXBc2d9d39w6g7jbCQFSOv3jXivjG9l0+5j06W8trxFcqpGSY1J5wfxrbC1JSrtxfQwxLpzpOEtl+b/M4j+yp7yaBLVVkkYDgHBOenFdL4i1O50fQo9EltxG6rt47Z5NZ3hzVrjT/EInsox5gfEZYfL6c1N4x0jUbm8S+ntJENwx7klm9RXpyd6sY1LW3XqcEFy0Zyo35no/Q4+NyqkA8MMGtaNY7S22zJHIXXORyVNV9RsLixuhBdQyQzKoyki4PtUlushtjOqLtUYbPPWuptNJrY4IJxbTWpmPcSGV1Z8r61NbrAw+beSe47f/WqzcxW91Ji2haNVXLL6+9VIQqyqcknuOmKu6aM2mnrqTTXLwu8EMheHoOMZq9o9mt0fLClXADnIz8vesmUFbg+XkI56kdq1YJbF4lhLGBowczbifM9sVM1ZaF02nLU9Xtdd07RvDUkNzZrE9xEyW4DBhwBgkds15/aNHM1uXdFIfmOHO9vU1o3dpJdeH7SeS/glghb91DtOR7nH9awLN5Le+urlAkUiggbVz19K4aNKMVJxep6Naq3KPMtDb8RKJrNnguGWJYRhJMBjk9OOuK4/ToHu5nRUDFYycEeldDaKupTwzaiJjAjASMBwFHXNU9Sns7Wa9XRpPMhf5VLDDAd63p3guRbmFblqNVHovxZz0ckjXQYNhhxn0rW1rTkZluBcIxdMsO4I4wf51mWNt57OZJNjZAAI6nNdNq9vLBoFt9ogjRVkKrtI35xzn2recuWSsctKHNCTfqcnfJEkgEJOMc5qfQ5Xt9RhnjIBRhye1VzC88hMQ3E84Fdn8N/BGqeJb1pbOEfZrf5pZZOET6k1VWpGFNuTM6cZTmuUq/EK+sNRvLMaWoVYoFSTAxufua5v+zpD3QfUiu18Ty6Vav/AGZlZru3JWS4hPyucngD26Vx5ubcE4EuPrWdBtQSia17Sm5S6n6H2FtcaRCluixojMXLhsAZPTmrGseHLTUtStdReIG9gG1WJ7V5yni668Yatpum27eVG8+SVzkhfmycduK9cmklSSONNpGMsSOT9K+Zp04qLUr2OnEe0pTUrpSd7ixxpFbBQwXcMbgf8abO6PaSbZdqgckdRVTV9Mi1qxiiaSSJFcNmM4PHYGrltawwRiKMbgp6scmulxe0VpY4rxSu3rcxNHjFrc3DIjS207mRXXordCKW9dNy2858lZSeW6Hnoa3YrcRIyoeC24Z7VFJp8c8ga6ImCnKqw4BrB4SpblN1iI83MylJPa6NaPc6jMkdrGo/eMMgCsjVbbwx4o0+W0hu7B5ZV3K8bLvHuO9XfHeiT67oE9nbMAzD7hOAfxxXyN4y0TVvDepRJdCeAsW5UkA47g9DXTTpRT9m/kaUYua9pGWqO38ffDywg1qa5a5LR7eX3htrAdeK8307wtcXl0JI5YxAScSyHPPOOKw21q8tJpltp5Wjfht5ySKsaT4uv9Jci3uDEjqAylAwHPHBzzW8MPiKcGoyv2PT+s0JW9otVv5nf+GfAeqXmViB3FTJ55XhQOw9zW7Z6/f+F7iS0uFV3ePAZgCEGeeT079areHPjhcW7wwapaRvB5YjeSP92Sc+3FT+MPEth4qsJLPR4bdNx3PLyTzzgdyeoxXnVY13O1ePus7KFWM7xglb1/zKdqbbU9I1WSC8EsUkhaeIL0AIyVP+FYmq2Nqltc3Wg3ry28LAASDDKSOhz75rRudBXT9DWy0uOa8MyGZguUIAPJIHfPr6VZ8F6HNq2qOb/T7iwsFhLTSFgC3HGSePWiMowTmpafL8jrk9Fzb28zgI9KeG4M1s6tMmPPBwTuJ6ZrrfDkNzq+oLppk8uIMGVVfDDnkL6nvWpqng6XS7e5vEIQCXzI3U71bHTJx+vvXJ3xC+JLFLe8aadMSNLCpQqx/h/wATW7qLEJ8r6bmUVGkvd6v5f13PW9Immt312xtLtniMBRfNhLMMAAn681h2eh6ZbaW9xf2ys/k71lTKndzjANaPgHQfsviySS7mkcyP5jYkJwMdD7ZrovEttba8l6lrPBa2+mSsoUDLZx6dhya8xz5JWi9NNRya5+WS36nhOoQTalJd6npkabSDG43ZYkew5rAtrLUdO0b+0rW8VFmdo2tgx3fl6V6lG2laMwAwJJ5druTgYPXGP0qnY+D9PlNxNdqJYldljijfEjZ5B/lXqQxagrNafmjOphOZ8y+JX8rM4f4ceHP+Ek1D7PNBL5TtumKL1GeAPzr16LwhpfgK6tbiZprMs52JLlmlz1AA/Cu9+Bum6bo2nva21xG8k2ZhCwBeHkjaT/SvQ9c0LT9Y2NfWcFxJGPkMi520q0pYlOal7vY8h4pYSoqbjt1PLvDVxeeJ9Ia/OnzxxrK0cHyhTKoGOe+Ca8a+J/iTVo9Y+z6nZxQLFG0ZtwuNo6Zz+NfYOnWi2dnDbjaVjHAVcAewFeE/GDRbPXfiLaWd5BJDZtCQ9wEADSHGBn+LtUUqMKEvaTWn5BSxk68nCGnZnh2jahf+XPf2yHkeWQTjcmMYB7mvTNH1R7fwhJLqFnFPf27DZDLg+WAcjnnPGK2m8KQeCtGa7uoTe6WZDCIVj/eKSfvLn8fwrJ0aysPG95LpdpBJpxiVt7udj3ALHAYd8AZpVqsa2vL7qe530pckdZX/AMz0zwd4xN/aWFhazRvdbRK5A+SOP+77fnVrSbO71fXjfzIWSIvDgcqoz3/CuJ8O+C9a8O6yV04291pUgWGRWwFDD6c49a7bw34evNC1S7tIr2ZvNdbgvvIR9x5Xn6VxTim9HeJhPkhzSp2TaN46Orpc2yy7rd8kKP4CRg818VfFDw3P4c8XXkE5d4w58uTGAynuPzr6l+J3j2fSw+kaDAw1FkEjTBMqq55C+pzXG+IEtvGfgSU+KYXhubZibeVYimc8cnnqe1d2HrLCSU909Gc0MPUrws/kfPegBL3UIoFG2AHMrhgcDuQTXp/hrUHkMOlwzq0kcu2JpTuHl9M/Wue8N+DkF/eMlvJLZW4IZvMwWYdcVmPr8Ohaxb32nkGO2f5Yn6sff2rtrcuJk4w1t+Z1UObDU+ep1/I1/iXZadB4ulWW9E7LFhxIjcuAMr7f/Wrl7y10+5tLFbGdlnfInRRkKK0fFvi2/wDEGtR6tr1vbSCaIERxoQF/Ad6wvsNzFGdWt7V7exkJQhW7exNb0YShCKk9V93octSpztu177736albUvDmqW1qb8W0iWpO0OO9YnlSxYcqyg9zXTWdxcTG4gtLiR7UpuEcrkYrV0mzi1W0uZtQspWs7aPJMJwQ2OCAevQ10e2lTV5nP9VhVa9ndeu3mclc6berp9vK8G6KUFkdWyce/pWayFcEjn+VdNo0zPemxgkZIZZNoZxyufSl8ceEbrw3epbzSxTllEm+MnGD0rSNW0+ST1exhUoXh7SGy3MGzu7iKKSGGR/Lf7yg9a9r+EHwnm8ULHf38ksWnyYKMuD5uM5HtXh0LmCXI69DX2t+y9rdpffD5bCF282wchw/YMc8e1Y4zm5UoO13qyaM+WLlu0fP/wAWbPRtP8Q3Gh6GtzYxxOROJXyrOBXAW2l4guZxIWgjxlgMZ57etdp4r12yk+IniG+vCl/JJO/ksy/LjceMfSsXWtWTXJbeOK2htLSEAbYQcn61NLnhFRW3V/1qdTUJrmlv0Ry9zCYBB5YIdiTg9RV3ULqaYC3lkEpRPlYk8D8ep5pmsxrFqexROI1Ixv6qPp9K7LQfBNv4j8N6tqcF19m+xRgxicYMpxk8/QVvOrGCUpf1cwjTk3KMTziN2tgcNtZTww6muvsviJrtp4bTRLGeO3sQdzJGmDIT3Y9T9K5C5sp1LMUbaDin2ttmF3IIZffnNbThCavLU54ucXZaFeYySyvLIfnYk/jUQRiMgfrW7pWkXF4PMtoGb5gpyOPxr6EtP2Zpp7WGV9ViR3RWKiLOCRnGc1FTFQpaMaotrmenqd38KNLtP+EkuNRjNxcJGCIWVCsak/ewP5V7LLGs0eWBBxx6iqWhWNvY2uLdArN9761pGvCoU3yPm6m2NxHtqvMuhTt3ECsGXZCPuk5z70RTo12eGUsOM8bvwq4QD1qu1pEblZyDvUYGOlU6c42UXojBSi7tlgdKAQRkHg0UDj3rpTMiK5VniIjkMZ9QM8V5L8ZZ7d9Ng0+9nhuLuVneJdgVo1I4zz2/XA+td34ovZ7Blk5ELYXeD/qye5HcV418TrWSwuJryQS3UkybTMpz+FefWrc0+Q9jLsPqqjZ5nqXwx1m6uJYNPt0uikIncxtjArzjWNHvLC/ltruBopUwGU8Yr2z4eeK9VtLie5snlMoCw4ZQUcf3Tn6etcz8UPElxqfjAy3ljbW88IxgqWDj0NduHxFaM/Zy1OnEYeE/f2i/6/rU84SNxEkjnCggBfc8c1NFqN7Y3MUkJaKaBwRtzjjvXSQpa30rjVXWFHXfF5Jzz6VHqfhy4ls4b+AtLZlsPIo/1WOgP4dq6fbxb5ZozeFlGPPTe33no/ww8VafrGqfYvFNx5LSHzI5sHKnsN3p7dK9X+JL2dt4WDaNqSNeyKHihRwfNwOrD0zXzDY6LqNzLI2ms00oUsQF2nb75/Guw0zRtZfQdT1GFjbNYQ4KzxbC5I5UDv0615VfDUVLmTX+R1xlOcoyqN6emv8AwT0r4Zapca9o95o+uzwt5yN5RRc+Vjg5HSvO/ENsdH8V2zWu2OZXZftSJuE6jgkZ4HpWJ8PfFl1Z6w93c7SsaYdVAHH0P8xXUeNp7HT10zVI1Wa0ct5RSTLpk5YkemazdKVGvyW0f+R1UZRlF1E9HZ6+W7O4sviLpEdveWeoo0V4sAUDAVt49++TiuW8W6rO630lmBZmWJZCEYnzsDnJ7GuJuJ21sT6iLlPtFu+UjeHgAdAT3yK7T+0tZ059GDWdrdwtGQVZgy/MPuketZPDxpNNLXs/vNqcUuaUVozzK98SWt29k0NmS0A2Nk5Jb1H416x4Ks5JVkntrwbpxv8Amg3SI2OxOTivLJ9KM3iW6Plpa+dJvKgfKmT2PTFep+HNQv7W1ls7FxNLEpXzIxtbHr610Y7l5EqZnh1VlzOp/kT+G9Y1XSHv2tPsTbz5ktyRtGevzDqDXY+HfE+rreabbakZo7thw0I3RTKW6kdR261xGr+GJ9Qt3bTpfJlkhD3MVxwHOOXB9q37PWxp+h2+sPOWewT7HOFO4Sjtz0wCB+dcbadnDd/f5EV6UJX9092nm8pVZopH+bHyLnHHWuK8feH21nULG6CSAWoL4K/Kccg+xz+leP8Aw++KHia88Xwac80b2NxO0pDLuKLz8ufSvUP+E51PVvElzpenadGlrbyeXLMW3kjHP0FehiJLlcZuztc8Kjh6tGopw1OZ8WeMNOuNIuoNNnmmuhKBFb42qHxzjI54zXP6RpmoeJbW21fR5Hs7+AiOe2iyuEBwWLYHJ9Kp+OvA4uvFkN1oTTWy3UnkO27cI5D3HcA+telaN4Cl0Dw3eK2pGUk+axUkbtvJBPviuRRhGKdPV/1c9J1Y0o8rdrm54f0y+05EikPnWE/7xpC3zBvf2x6Vlaz4h0y7huLTSdYX7ZEQJY+rM2DhEzj8SM12uhGDUfDdsFwYJYsYUnp9a8+8ZeCJLo20Gi6HaxGJ1ke6UhN23oOOfer9haKfc4KdaM6r59LM5/xXeTaH4dt9Va4jm1kOqx+cioIkI+6V9Aa+cPEfiXU7ya4F3fyzM0hYxq21OucgfWvf/jKl9dalDpos2uZUjQsViLEDvyPbpXkvi3wFDbXsc9rfW62zlF2zsA67uOn1zXRgHTp/xVqzsqxqVKadNnF6d4g1CcOk2oSRIw2k7jyPfFZ2rS2M2DbF/MA5OOCfWtTV9Ak0jUJjC8M8cQ3go2Qw/wAKzZNIuLp557ZVMIXzMj5R+Ga9mDp354uyPPqRrWdOSu/v+4bPqkuGRiHO0AN+FJLquo3ekLayTstpG24J0Gf61VNpMjobgbAQCDjOefavdPF2i+G5vg5pj6DZ2kl3Hta7ulYeYrY5GOvX+VTVqwpOKte7IhGrVUrt6dDyCznghEawyMSyfvApyM9ia9F0Lw9qI8P/AGyzmWKzcB5pJz8nX+Hv+FecaHZBdQikdgLaRtv3uSK9s0DULfWfBFzpVysjNayABLd0TcR0Jz7d65cdNwS5e+p24JXTcl6GEmtWuk6lYXuj6Xa3S28wZ51hwrP6HNfStpZeGvib4RE1zp0LxTgqx2AOj9yD1r5OvrrUbvw/JZwQGLTLeRneV/4m6BSehNdL8BvHy6FrsdveXUsVjI6xmFQW578fWs1RtHm7fP8ApmWKfO1Z2fT/ACJPEX7OviK31i8/soR3FguTA+8BmBJwCPUCu1+CSn4c2Wp3HiQm2sifKDAbsSDs2O9fQGj6vYazbG40y6iuYgdrFDnafQjsa81/aAENp8P30vToIVu9SuFWJFAUkg7mI/IfnVTlOolFy0OKnUV3Fx1Z8geKUuLfXZrxURRcSNKjA54JJz+tV9Jmubi8S0hTzJJWKg46luOKmfRtQuNZFncqY7guYyWPfvg19D/s7fDKS01WTW9aTzYYMrZq+CCf7+K7KlaMI2buy1GSvPZI8D1PQ76x8Q29lfxmOVmAKnjcOx57V3V9qkV3arp1payBIWCTysdqNgdMAYwOa9q/aC8Ewa/Y276XYg6qGJ8yIYJ44B/pXiNhe3mk6Dqmn3NnNcXCMsAEvBVmHPHfmuSc/aJdWv6udNCUWm3s9f8AgGRoWhnUtWFvptvM5kjG7zeFjc98ntWlofgezhF1qOpRSTJpzt5kSEbJGXqPpzXdXeseGfDemwprE7ya1c2KxyLAMeSMDAPvik8C+LfA1xthnW5RvIeBoZTkSZOc/X3rGVatKLlFOxry04tR0uin8OvEmnajqI+26dBZQNJiK3gX0PU19SQ3UIiQGTB2jivljU49M0vQJbvw3db5I3BkSZgJIkJ7ev8A9avNJ/HOqefJjW7sjcec+/1qadF1ZOVNWRnioRko+0lqff1Irq4yjBh0yDmsrSfEOm6tcXFvZXCyTQEq69CMUvh5AunwvHAbaNh/qickHPUmtFUTty7Hlum4p82jNVjhScE4GcCmodwyQQe4PanVEsbLNuBwhHKj19aqTaaM0OkTeB8zLg54p9R3EyQRM7kAD17mstfEFqLpIJjsZzhTnIJqXUhCVm9WaRpzmrxWxoahaRX1q0E6K6Njhhms+98PWF5YyW1xCjh+pIrYAHYdaKJ0oTd5IIVZw0i7Hz/428Of8I9qKRadCxSWUO4LBIsYwOPX6V454+gQfv7t501JmZXOwlDwMFT6V9PfF/QtM1bSYzPM8N9ExaDyzjJ75HSvnX4gtBPrRjkDAwJsMGcqxAHOffOa5qKVOtZM+io1XiMN72/mcbot1HDpksiOrSRcruAxk+xrsvgt48tPD2rT2fiCE3OlXPDAx7grZ4OO9ec348yeV4I1hV2wE6/hXR+GPC95eSJNLbEGNN5y+wDPKmvQrRp8jdTqc8HUqtU4Lb8T7J03w34ZEx1Gw0+BJZ1wHVDnBHYdqseI9Ig1fQby0jVI1mQozDAOO9eWeGvHuq2ltpj6nbJNCiCM+Uegxw3v716voE0F7p0kckqSNLuZ9rZVt3PB7ivG5lOXK0rswxFGth2pybdvmfD+saJa2+v6nFFLOtnC7LEWON2CRyfwrp/CVnBq/hW40zEs7iddmwDK9c8ntj1qD4mwmL4g6nDpwN3bwMdyRqWwQT0qr4IbVYtddraO6tlljYmKPjdx1xXpVXKdFSvqrM9HDcsallHe6+82NH8P3t3q02l6aDZLGNrCc5y3rx7AV2njLwldWdtDLpt2l5eRxht1uMg+vQ4B4rc+Futabql5qVnqLRJeoT8yqc5IHqM5HTHtXYeFbzS1vNQuZUijtoSIGRE3BmBxuP1NeRVr1PaJNWt/Wp0zrcl+VNpf0reh8qXGpz6Z4m+1XUbNKjZaKdT+grrbDWfP1ee+09vMuXjxFHE23bgdxXa/HrRNHn1Sxlto0imucH5cKWX2z3rifAVheJqVrp9hpbPKHZp3lXK4z1P0FehKpCpS57apW8icO535m/devmeteAtZXVfDlxZahDNHqSqY3uAudxb+HPase/uoRo2t+ErTTZhsjyJ0wWd+pHPb3rf1xh4G8MM9kGvbiSbfIkQHIPp34rM0v7Na6PcapqUkS/aA0lv5/wAp5XGCM/pXlXs3NLS+nqOKjJt9D5/sNRm0TXLeRXd3jcCWJeMgHOCa+xvB15o0fhEa7plsw+1RqZYY2yQ3THt/9avjjUILZ9Sn/eAPJKW8/Pyhewx616t8LviXN4Q0C905tMebLiWOTqMEAH6cjPevcr01K00tTy6kJyi4J6X2v/X9bHu3w2vLbUrC8dLSC3/fnCBizMAfvHNLr139i8VhMOkEloWuJHy0ZQHpjsevNeUfD7xPqeneJ9SuryylkubsqVtgR8qMeAB2+le0eIl0yS0jvdTzDs+V2xyF6lTXE0nBxW6MqlN063NJO0jV0NbX+yLT7CyyWxjBRl5BHtWT8RNdn8OeFLrUrQRm4jZAvmDKjLDOfwzVXRPGOjXDx2Wl2935aRl/lh2ogHXkn37V0B+w6xZqksaTwSKH2SLwR9DXZGUeXkT1OCUJQnzzTtc5jwzrTavbG6IEd3Ipw7J8u3HDA+lfOfjvxfbpqVzZS6Tp13diZlnmhQqWAPB9j/jX1tDp8ELfIihANqKB90eg9q8J+N3gbSdD8O6tqenROt7cyhncDdtVjyPYZFc9OlyyTqK534fEQ53yadj5s1KX7bLK1tbrAQ2/7+ePQe1Upr5kDrC7K0nyuOOnTA9qi+1y6RqbNbMrDG3J+YEVrajqx1aWIRada2zrGF3R8E+5J717Si42VrohzU7vmtLtb/IzNRtbrT5AAjhSoZSw6j1FaPh3UWgkMNy5aCYbZUC9qq3GowzaP9jkLvdI/ExbqvpWjY6fJDCGdnVZVAyYyQp7HJ6UpP3bTQRj+8vSen9aFy8urK30yaARqjBt0Gfv/UmrPwfV77x3b2FyrT2d6fKnjUn7p71V8QaVcanb25t28yS3XaxxgE5q54fudT8AyreLbrDqJB2SvggrjBAPrWDs6TjH4maTUvaKT0iup6x8W/As+g6adO0uBm0hM3CEHb8wH3WJ6+teReDrXTy17dys6SwxZ8sYyW9RWxc/EXVL6AW2oX019aXbeY8FxIGO4dcN1UVxtxruNRcWkMNorH51Rcrj0qadKooyh3EqsVyym72PoP8AZsvzp+s3trNcHyr0bwZG4LDp+NY37S/i+W+8XW2kWURkg0k7ndOvmMOeR0wMV5x4d8X3lrrNnczv9iS3O9WhUAuo7DP0pNf1+WK/1SS1a48jUh5rLMB5m4n7xPpRGE4zd1e//DEThTbVRPYyPFEhmltLuyt7mKMoPMO8sC3sa+if2Ztf1S6ebSLs/wCjQW3nFXyXBJAHPpivn2a4vNO0MWtm6X1pKFkaZVP7pzyVzX2P8GrGCPwPpmofZoY727gUyyIuCQOAPoKVTWMY26kV2oqTfXp0OseC5e+QkxLaDLFVHzFu2TWD430G0fwzq81jYRf2gYGZHjjG8sORiusoxlcMByOay5FbVHDGpKLTR+bmuS3p1S7lvPMNzISJN/XOeQah0+cBJZbYSLcA4yOgX0r6C+LnwgdPFlzf2V9aQadOTOElkw0ZxluPSvnm7j+y3dzAkqOuWVXU8NzXo0qsai5VujolFr3+jF1fWbmWfbnYAArKpwG96xTKxJJPWrd5GVEbSRleME561U3/AOyv5V1QiktEc9SUpP3j9DPCel2Om3ElxFvF0SQ79QQf/r1oXP8AwkEE2/RzaXNpLKFZbjIaJc8suOvrRp9ur3ZijQDvuxgdeldPFGI0C8e/HWvk8HCcjuxdVc93rfuOUnAyQW74pazb+WeMyGLgJggetS6Xcy3SSPLHsUNhe+R612wrJy9m9zidJqPP0K3iSJ5LIFOinnAyQPWuH1yezgt4nuIzLEzhQUXJQ5/+tXpVyM28g2lsqeB3ryrX3kkt7i0gRrbGdzAZ79frXnZhDlqKfc9XLHzrl7HZ+DNVlv0uoXt5I4YGCxu7ZLAjPNaOu35tLdlhVnncYAU8geuK8wtPEMumTw6fNcIu+MZl4XHOO1WrnUr/AFDxCltprxXbqhCspwEJ6hvypLGTVLkW/c1nlv77nfw7/wDDmb4zunvI5IbK6Wa7IxtmPQHvz0NeQfEy5t71LdbWzuYtQVQsjM3OV4NetjQNY8S+I7iG9sEsxagBWRj87f3t3TGD+nvx0dr8J7J5DLqVx5zk7iqg8H2P4elVhIyjJTtex11sRQp0vZuVj5M0PQ9Umv0lFu48tgW3HAA9c16frNk40+yltBLOWQJdSQSKQFxjoP5mum8S+Gbu18VizczW9vc7oV5xFIo5ABHT3qz4Yt7KyvpdPuGt7OIzNBGuQfNz2z+nNaYnFOclJrVdDfDU6dOk3F3RleGdHj0fQ3gvYzK8n7/cSWeNeRgDoTU1vqC6RBaSPfzT26W7mIL8vlt6N611C6fJPLOuoWHnQQjZCtsSH5/irl/HPhjUrHwlKYh5bsSyMrsSq5yVY/jXFGftZ+892dCqU0uU5KGe/ub6a/8AJhDsjl2j4KY/vZ6nFcpYazP4c1qC+ecyyeZkxyZO1T6jvxXTL4du0stOnmlSWC7JUgH5mb1+uc1Prnh2ztpBDqbPIhjXM0owUbscn+GvRhUppuL1T7CqQlKK5dGu5oeLr0aXFc6vpNqYheQefLcRjIJJGMjtV74Ya7qHjC1MUbGJIHDSxQxqu4devfOK5F4JItOuCbn/AEJ12PExO2ZegAHrWD4S8Tf8IszJbh4d5ZHZc7mGfl9sj1qVhlUouMVeS2ZnUm4TSbSVuvfoz3L4yLZ3mkxwXGLe9IAhfacAdwWxwa8o8M+IHtL60ks9QvBdoHt3iJ4cHoOfeqHirWY9YivdQTU7gSbgscTSZLcVwdmHg1iPfK7nduBXnnr36dK3wmD/AHTjNnLUrewcYJXT8/M9O1Dx7q81zLaasiK8b7SYyMoOxC+td1p2vabPHFDqckN3ZXEayYOAyFT93AyckkdK8OlF3FrE85gUSXEe5eMivWvgemn6trFy2u2Q85IMRIRhVwQcgVnisNThT50rW7FRrvWMru3SxxHxG0WXTNbFxLaJaRXwLLCrbtg7fjXcfAMvf6pPYahYx3FrPF5CzBR+7GCe3c4rqPif4bbxzHaRWU/l3EMvkwl0KqQcc5xyKu/BvwNqnhDxH5epWjlCrYnDZVsdD+p4xRCtGth1CXxbfic1WTg3La6b3Olu9B0fwUj3/wBpeC9kVgZXJdmGeAo56DFJNNqWr+GJZLbV7aWEISzPCSwyOQR7cnpmu38SWNrq2lkTRrcCJxIg3cbhx1/E1leENcsdVv7u0srfasCKXZkxljxioqUPf5YvRnFDEt0/aNXaPHbHxjLpNjqqxNFcbcj7QzGNeMDao9aZ4p8eMbaOWHUJLR44MRW5YqNx4JyByAOldp8Vfh2bq1u9S0q8is4lXdJbGEFD/ebPqa8K1TT59N1SeydVvdqAR+b/AALjPGfWiNGClZ6P9PyPTpVIYiPPFf8ADnpXw2+NV1Gy2XibfdqXCrOBh1XA5PrXpviyx0n4i+HZ7LTtV+aaElfJcdR/eH1NfFuutLEiXCzIUkJwqN9z2NXPDWvahpF/Fd6dqEkNwhxhWOCOMjivSnQco3TPMlTj7S0VZ/10OY8T6ZNpGsXVjcqBNBK0bEHIODiqFyWkjQqCAq44HFddrmrxalq8l1crEzs2XwMs5zyfrXZ6X4Ii8baJfXGi3MdstnFuS1lI3Oe/TpXVLEqlGLqK3mZrCqfPySPGIyyspz8wOQa+g/gZ43uNZ1S18Nazaw6gl2RErTBQqoo+7/OuF1P4UappWjwX2pPHEkyllCtn6ZrqfhZ8PNesfFeh3UYt4pt6zhZs5CAjnHfrWOJq4etT1afb1CjSrUm+i6n0/e+A9AbRr20stJtIWnQjJXJz9a+aviv4M1TTPDP2i+aNYYn8qJJWzInP619gk7Uyx6Dk15B+0ToVpN4TfU5ZWWSE7VQfxlu351zW5JxlEjD13K9Obvc+PbCw82ORnblQSCTwB9RSXFva2qxTAStKTl0K/Lj1zXZ6Tcpaw3VrDp0U0dzD+9BzlfbJxioH8Hy3Wr2mnXF0hMsPmRhMDZ/smu36wlJ8+iN/qrcVyK7/AFLT6JNqvhb+2dPgLJbKDNI+PkC9cL6cipvEmnwWsFhrVjqFjqAMYSWEEkse4xUum+MLPwtZ6npN7Yu6vmOSIPlZMcDPtWD4bj0a8sL03d21tKQTCFQsd3YD8a50qiblL4U9Ot0zXng/dVrvfpZr/M6n4V+Fb3xzrVlavIltpsM/mz2+3Hy9Tj+VfaFnbQWFnFbW0aRW8KBURRgKBXifwg0FvBHh86pqE8W655Z3Qh1TqSc/hUPjj406Ff6RqVlaRTTBSIwVYqXbPUH0rP2nPJ8qucdanKbS6Hu6urEhWBI6gGqmtana6NplxqGoSiK0t13yNgnA/wD14rybwnqU9j4StPEVpb5uLlxFsnmLZUnglu3pWL8Uvi9JZ6XPo1xpFvI97EVWVZt8ZXpuHHY0qc3P3bamcsM4vfQ8W+KnjvUvEfiC9u7qSW3tpBsto1OAqen415RLLlzjdkc5zWn4n1S61G7/ANMfc0aiNeMYA6VjHaAPp2r2KNPlijKrJN2WxeS7Z7fy8bju4yM1VMIJ71JD/wAs/LwG/nVouCSTHgnsFq9thfFuffug+JbWWMXAZ90iZ8uQlEQjsCRyTXRrrlntQu+wt0BI5rwbx/qV5Z6nardpFFAMSNbwOfmHYD0rJ1HxeL9vKhLWjuAFDINygcA818jQnWjFOGzPfqZdSqO97H04RDewEEB424NPggjgj2RLtX0zmvM/hf46ivIF0rUEaK5gRcyuwzIT3NeoAgjI6V6VKUZ6v4jxMRRnQk4PYWuX8ZaT5+ntNaRZYEeYiHaWXuR7+3euoprqHQqwBB7U61JVYOLIo1pUZqcT5+8TSGa1lN7bNbrE6JGrKCzKPb86paZqd/YJLqGjzC3achBAF+9joRnjnmvTPHWkwSylhZvLI7Bf3Scj0Oewrz7xdp1vpNky2MUvnoFEjElsc/yrw4+4+RrW59fRrwr0kmjqL74lNBe6Tb2ekz+a/wAtyZVwUBA+YEV11h480NrKWS61BFMMpic7TnPrgCvIJkmvfDR1u2vDAY0KTso3Hjt/L0rzmXQdZl0hr2yuUuYWJd1WQeYPciu/DTe7duh52IwNF6QX3Hs/jH4hab4gvrfT9KViI28wXEi459R/9euOuH+x+IrWTUpB9qkBMUqLhE5ODjpk8c14NeXd/b3uA8iOjEHnrjtWz/b97q9zbQ3cwQbgvXIArpq5fJy509Gi8Ji6VOHsVHqe56X40azvnsdR1CVrl5tu0oAApBIIOfp71YvfE8t7LNZXNzE6ohiaMn5nPYgA9/6V5jBq2nw601lewmdo5BJFcINwDdBn8a7vw/4Qh1rxRA0cqC6c/aSxHG3jjPr7e9ebUoRg9bq6PT/dRvU00/A4vXbu8l0nTrQQqs1nJnZGCCxJPJ98VPfXtxqJ+zT7FSYlFjumzs2dt3oa7r4i/DLVLa3N/ZGERgYdLdMbFHOSepzzk1Qt9NsPFNlbaUkJiv4mWTYEK5AGCfxxXRKSik2v+Ac8K8JXlB3X5mVZ20Wpalb6c8MbRiEbprdtxQDqWxXB67b2uneIpLMTedCzGSCQ5+YZ5Az+PWvd9C8KfZZp1s7NrT5hHKVHySoOSRXnHxl0rRNTtba70iaFLu3VluIYz8wIPp+BqMJWTrcutn/Vx4irzK8dWitFpvg5tOkJkna48ssqsmGDjn8a8avGePVHMoJ3Mdv6gV12mxC2gMrxXV1MU3+WpOVBGKfrvhua+0q01Kxtoo7dhl23ZMeP71erh2qEmpSbT7nHi4PEU1KCs1rZG69hNeaBZPbRRy3CwjzyjDKrk9T61f8ACfiDWtE1Fbx7JZvM2qiKBgKDzn04zzWZ4S1S80W2uZUjiuYHiA2AkFjnGQO5+ldJbam3k6ZcNLbQWpnYyuVCM6g8oRzgfXrXFUurwcU1/TO3Sor3adj3X4fazZeL08+OPyxBhmhz9xu1eiV45+z/AKhHqi6vc21u8Ft5m2EEcMO5z9a9jrXCU1BNW6nzGPf72y2M3U3j0/TLt7e3WRtrP5I43k+v1rF+G9zY3+gfbLG0htmkkYSLGc8gkVu6isaMrE4LHB965HwZpU2keJdYlyqWd5IJI4h0J7kemKzlNRq6rYIR5qL18zmf2h9VnXQ4tOs7kxu0gLw4I84Yz17gfzrxax1HSta0/UY9Zne2u1hAUsPm3DqQT/nivqTxl4f03xDbTLcQI19bxloZTn5CemfUcV8YeMDfabrN/aXEMCSFz5skSdc+/ofatow9rJwvrvc7cHXjTpXXo0YkPhq7uvONoyXQUMSEbnA71zWZo2MJYxkcEHivTPA97JYXEc6WYEyyIXYLuJjPUgdPxqxd+FJ/Euv6xey2ywxqrYwu0Arzk49q7VinCbVTYmWEU4KVPc8sa3nWHzQpKnuKs6XrN9pM6zWUzRSDryefrWqLqztbl7W5txKkbMFdW4J9axbiOP7SyLGwLHIXNdSfPpJaHHKPs7ShLU9W8JfEGfxXdQ6J4taS6hkZUtTHhQjZ6HHUGvqzQsQaRbDyh5sDC3/f/KygdNpx6Yr4B0tLuC8WW1RxLGw24GWB7Yr7G8N/GrR4vC9hHqi3c2rrAiyQiDaWkAGeSa83E4SKmuTRdvM1dac6dmrs9X02+M8z200TJPGMk5yrDsQf6VgfE3w/c69oSrYSAXNs5lRGXcH4xjHeksfiFoNzdW0D3UUEs8e4B26H0J7V0PmhJftEuoRCDJVVJUKc4xz6/j3rNNNcpzWlTmppWPjHXk8RWWrC2KvDLI3zJNCF56ccciqHjHTE0WKxmg1BbrWZ3Lz+W2BCR246V9X+OPAWiazfHXr8HdbQs7qpwrgAnJ9D718t+OLi2vLCKy0eFft8bM0jBfmce5qqcnzxVrd/67HpQqKrTbvd9v8AI4lrCfWL2UkomSWLs3ysfrXo3wj8C6Zd39rea5qaRWsbM/2YNtcsoyCc9s15jpaTyTrbHzfMZgHCjnrXvGr+HNb0XwPY3YsHnt4YmWOTI3IHPcEA10YucopU4u1zKioP35bmfa+P7nW726s7tTfNFKywqp2qU6bj7cVwrWsDR3DWVo4n81mly2UVO20dT35Nc/p+pXWi65HPbjy7hWHy/wBDXp3gfUtBun1Mag8cWpNHJIyMu1HY9FA6VjVh9WvKC00N6PLWXLJ6otQfFWI6Lb2yybWtoRCbRovkfsSMeg5rkPiULeex0+KyuB9oiBYoo4VWORj0+lY73SC5NzNbJC8RKRpFHgHI4OarzarO+orlYUmb/XCQDDEHt+VXTw6hNTgiZ1E4uL6+Rx2oQSpcqzkszDduIxmoHiLqXJBdjjArovEVwl3efK6lEG0bOw6kVllY2lMagqGXA+vavThNuKZ5tSCUmkyxZ6ZE+kPdmcJcxsFSI/xetbiaJesit9iDZGcgjn9a5y1Z7NP9NjdrcZ29vmq6fEsxJIkkA9B0FZTjUk/dZ0Up0Yr30fUXxei0tIbdxbTreXsSr5zZwuOi+g715deWccN062cUk8yRCSORJBhR3zmtNtV1DxFoEk2rXk0zwXBSPnAUYJrD1OP7IirE8hBYZ3MTkcDH0rwaEJQXK3r+B78Y2irkugahqVrdyQvMWllUGMSZy2e4NfTvhDxBdt4bgTVGX7UIwPNTlSa+V9DvJb9ZY7vbII5dikjnb6V7L4SnltfC01tG7GGNsoGOdvAOAayxspU9Y6MmeHhXpq+q899z01bm6tZGlimYovzNGcFT+fSuh0XVIdWs1uIMjPDKeoPpXlFzq12liskcgQSIVeNR8px7V0XwjYnw7FNk7nbkZ45NYYOvKErPZnBjcElSdR7o7u5WZpUERCp1bIzmqOp6Ra6hE6zRIu45ZygPT61D4h1S40+a28jYRJkMGGad4YvJb+wdrna5EhXkds11z5KlRwZ5kVOEFUTsV9R8LWU2hX9hp6JbC6U7ygGC2MZ/SvBbPw/rFhqsdtZ6LOsSq1vKwGQff/Cvp6oZIY3Y7kUk45xzWlSglH3TbC5hOje+p8C+LtJuoNfvA0DQSRyHMT/eGe9c9JHMqvNyVXqB2/CvvHxR4U0TUZ57i706CS4dADKR83XqD6185fHXwtp3hrxBZR6P50Ed7H++TfkN+ldVDF3kqLWpsoxrJ1I6f1/wTkfhqyC+mvL0ExLGdny7yXAyPp9a918Falo97bW+qNKx1EYQW44KY54FfO3h+GOC/kKru2RNtDE46Vb8GaldQeMdJaGTYXlVWwOCC3f/AD2rnxeF9tKUk7NI9GFXloxhLrp+J9z2l0k9jbvNhTMANrdz6VTnXTLK/aY2scc21VaZVA6ngVLaYkuTHIAyCJHAbkAn/wDVXC+LZ2sdfiaALvePezNkknIH8ia5a1Z+zTaR5GHoKpUcU7HR+Otlx4Q1W3s7preeOMnMLYbPXGff+teDeFtCOsXsNnqVkHvpFkZZZG/hAxhvTFes6lqs1vqlrbCOF4JByjKcdx6+1eTeItUu4NZlu7WU28yyrEpi+XCnqPxrFVnWfKtD18DTdKEkvUPhd8O9bXW2a7lit7ISSJMRw7DP8J9Olb/xF0mHSNKntEDmwmlCs0QxtXHU8epr13wjcNfRySTIgeE7FKDGR6n3rkfjNuGiTqGIAcMB1wetEpSqSjVl1aM6OKl7Z0VskfO1xZ6todxJNBHP5FvjyS0e5WDdx6HpRNDc2WlX8d/J5Ek8ivDbzJ80hJBJz6V2/jHWr2/8NmCaQKLiNWkaMbS2MYH04FefeMLia7ULcSvIYIVaNieV6V30JSq25kv+GsdNR8vN5f8ABPb/ANmnxCkVre+H7vMcsbh4dyYznqCfyxXvXevhPwhdT6Xrem6haTSLc74ySWODkjrX3VES0SMepAJrpUbSa+Z8/jIJNTXX9CrfqrmEAZkLYT0HB5NOjQDYZWVZBxgYGasYG4HAzjrXJeM7fdfWVys00bxnACPhTznkd6wqxUW5sxp3n7h1floXLkAkrt/CvFviN4OifxDdX8liHsZ4VXauBul5A/DAFdhoGvahd67qsU826G3h3RpjABBP49qf4H1e68QaTcPqhjl3zyR7dgAC+grCpVUl7uh10FPDS5nqkfLvjJPsOuiO1uFsrVosZx8oK5yB+NTWvj64s/DEiiBStxCYZiByx7MfSqvxOsIIbS8kQNvS+cKSeg9PpXndtczXLQxSSt5bYBUHArvo0IVqSctbHbXrypVGu6Ipo1mlabcyQtyP8KkYQwTRTRxnyThQWOSOetbFpBHvv4dg8sdBjpWROnkH5SSB0Dc13xlzaHBOHIr9z3P4Y6F4cezhnbUYba5c+a0r4JUg5wQa1/iZbwNr3kaZahJpkjaK8iA2SNx0/wARXlevRmy8N6MLWR41u4i8yg8MQeDXZ6HdXMvgiUPcyn7I48n5s7enTPT8K8adJxl7a97u2p6d+Z8m1ktiLVilrdR6b4os7i2mhXdFcYIaXPQE9xXJane6tdaqsNoklqIpVVVRyFHPGa96+G6Q/EDw1c2fiu3ivltiVjlbIkHXndnOa8G8ZaZb6T4j1GztfM8q2m2xlnJbGe5rXDTTk49V9xy1Xfc+j/iP4kbRfhHa2t4Vi1bUIkgWLdn03HPpj+dfL8922qam1xZFVuUfG1SQxHqK2vipfXLado9vJNJKkUWVMjFj+dcHY3k2nJcXFqwWV0wSRnGfSujD0m6al1JuqE3B7XudB4KtGuviDp9lHMyvd3CxMyE7lyRk59etfb3ibSjceF3sFcSIsYAMxyWI6c/Wvkf9muxgvviPYS3KbnjZpVP+0ATmvtg9KWJSlNx7I46lRx5Wu9z4U8TeBda0TXpE1628v7TueFtwOQOcjHp6V5/I1wb8fZFdpFzyOc89a+wLrUX8XX08WswwOlpM5i2JgrggYzzxzXz54cijj8e6oiIoWGSTYMcDB6U6GKb5uZbI6ZUeZRd7XZzNxZ6tEq6aDK13MyyeQnPbOazZY5LaIwXNs4vhJlnfOR7Yr0vw2xv/AIhTy3WHeOKQLwABjgVZ1rT7bR/Ftrb28QkScoXM/wA5O7r/ADq/rPK+VrpcpYf2mqfkcJpXg3U7qyS+EMwtZTtV9hI3e9QeK7O00q6+x2UqybEBabPVu4rsPHHjjXdNtbfRdOuha2ES7gkSAEk+pryjUyzyLI7FnbJJNa4f2lV883p0/wCCYVnCkuSK1NKOyu7+yLSSII403/P/ABH0HvWQ1qwJGCPwrW8MFrq7jtJWbyXIBAPNfW2mfCTwnNp1rLJZyl3iRmPmdSQPapxOOWEdpK9+wUsN7dXWlj//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Urine sediment showing multiple muddy brown granular casts. These findings are highly suggestive of acute tubular necrosis in a patient with acute renal failure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harvard Medical School.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 533px\">",
"   <div class=\"ttl\">",
"    Photomicrograph showing tubular epithelial cell casts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 513px; height: 171px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Epithelial cell cast containing cells that are larger than white cells.",
"    <br/>",
"    (B) Epithelial cell cast with free epithelial cells (arrow) in the urine sediment. Renal tubular epithelial cells are larger than white cell and have a single, large central nucleus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Frances Andrus, BA, Victoria Hospital, London, Ontario.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19800=[""].join("\n");
var outline_f19_21_19800=null;
var title_f19_21_19801="Pelosi cesarean technique 2";
var content_f19_21_19801=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68054&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68054&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Placement of the self-retaining abdominal retractor  as part of the Pelosi technique",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 486px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) At left, the protractor (Weck Closure Systems); at right, the Mobius (Apple Medical Corporation). (B) The inner ring is squeezed cephalad into the peritoneal cavity. (C) The inner ring springs open against the parietal peritoneum. A digital check is performed to assure that no tissue is trapped between the inner ring and the abdominal wall. The plastic sleeve is then placed on tension. (D) The outer ring is rolled into the plastic sleeve until the ring completely inverts. (E) The result is the creation of an atraumatic, circular, self-retaining area of retraction. (F) A small transverse incision is made with the scalpel approximately one cm above the vesicouterine peritoneal fold. The creation of the traditional bladder flap is avoided.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marco Pelosi, MD and Marco Pelosi III, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19801=[""].join("\n");
var outline_f19_21_19801=null;
var title_f19_21_19802="Treatment of pulmonary tuberculosis in HIV-negative patients";
var content_f19_21_19802=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of pulmonary tuberculosis in HIV-negative patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/21/19802/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/21/19802/contributors\">",
"     Timothy R Sterling, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/21/19802/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/21/19802/contributors\">",
"     C Fordham von Reyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/21/19802/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/21/19802/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/21/19802/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary goals of tuberculosis treatment include [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Eradicating M. tuberculosis infection",
"     </li>",
"     <li>",
"      Preventing development of drug resistance",
"     </li>",
"     <li>",
"      Preventing relapse of disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To achieve these objectives, combination therapy should be administered consisting of more than one drug to which the organism is susceptible. Successful treatment of individual cases facilitates reduction of transmission to others in the community. Directly observed therapy (DOT) is very important for facilitating adherence and preventing the development of drug resistance.",
"   </p>",
"   <p>",
"    The American Thoracic Society (ATS), Centers for Disease Control (CDC), and Infectious Disease Society of America (IDSA) statement on the treatment of tuberculosis is a key summary of treatment guidelines in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. The International Standards for Tuberculosis Care provides important treatment recommendations for international settings [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An overview of the therapy of tuberculosis, as well as features of specific antituberculous drugs, will be provided here. Issues related to the treatment of latent M. tuberculosis infection and tuberculosis in HIV-infected patients are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9432?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4298?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17272?source=see_link\">",
"     \"Monitoring the HIV-infected patient on antituberculous medications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chemotherapy for tuberculosis became available with the introduction of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    (SM) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    (INH) in the 1940s and 1950s, respectively. Observation of treatment failure with single agents (due to the emergence of drug resistance) and subsequent development of additional agents with activity against M. tuberculosis have led to successful treatment with combination therapy.",
"   </p>",
"   <p>",
"    Several trials were conducted in the 1970s and 1980s by the British Medical Research Council, British Thoracic Association, and Hong Kong Chest Service to evaluate the optimal combination and duration of antituberculosis therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]. These studies established the efficacy of short-course (six-month) regimens with the addition of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    (RIF) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"     pyrazinamide",
"    </a>",
"    (PZA) to a base regimen of daily INH and SM, that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/7/12406?source=see_link\">",
"     ethambutol",
"    </a>",
"    (EMB) was roughly as effective as SM (allowing all-oral therapy), and that PZA and EMB (or SM) was necessary only for the first two months of a six-month regimen using INH and RIF throughout.",
"   </p>",
"   <p>",
"    Initial therapy of tuberculosis should include four drugs; basic regimens for treating patients with tuberculosis caused by organisms known or presumed to be drug-susceptible are outlined in the Table (",
"    <a class=\"graphic graphic_table graphicRef50102 \" href=\"UTD.htm?23/25/23965\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. Each regimen has an initial phase of two months followed by a choice of several options for the continuation phase of either four or seven months. Drug doses are shown in the Tables (",
"    <a class=\"graphic graphic_table graphicRef55978 \" href=\"UTD.htm?25/12/25804\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73765 \" href=\"UTD.htm?26/21/26971\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef71883 \" href=\"UTD.htm?17/39/18043\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The choice of treatment in the initial phase is empiric, as susceptibility data are usually not available or are only available at the end of the initial phase of treatment. Susceptibility data should be available at the beginning of the continuation phase and should be used to direct therapy if drug resistance is identified.",
"   </p>",
"   <p>",
"    Directly observed therapy (DOT) is the preferred strategy for treatment of all patients with tuberculosis to assure completion of appropriate therapy and prevent emergence of drug resistance. DOT involves providing the antituberculosis drugs directly to the patient and watching as the patient swallows the medications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10341?source=see_link&amp;anchor=H6#H6\">",
"     \"Adherence to tuberculosis treatment\", section on 'Directly observed therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Initial phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial drug regimen is based on knowledge of the likely drug susceptibility. Four drugs (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    [INH],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    [RIF],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"     pyrazinamide",
"    </a>",
"    [PZA], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/7/12406?source=see_link\">",
"     ethambutol",
"    </a>",
"    [EMB]) are used in the initial phase of previously untreated tuberculosis because of concern for INH resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/9\">",
"     9",
"    </a>",
"    ]. This regimen is intended to decrease the secondary development of resistance to RIF in populations with a high rate of primary resistance to INH (4 percent or more). Treatment of tuberculosis with organisms resistant to both INH and RIF (multidrug-resistant tuberculosis [MDR-TB]) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/52/32586?source=see_link\">",
"     \"Diagnosis, treatment, and prevention of drug-resistant tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The initial phase of treatment usually consists of two months and may be administered in one of the following schedules (",
"    <a class=\"graphic graphic_table graphicRef50102 \" href=\"UTD.htm?23/25/23965\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Daily for eight weeks (Regimens 1 and 4)",
"     </li>",
"     <li>",
"      Daily for two weeks, then twice weekly for six weeks (Regimen 2). Regimen 2a is frequently used by public health departments because the twice-weekly dosing schedule facilitates administration of DOT.",
"     </li>",
"     <li>",
"      Three times weekly for eight weeks (Regimen 3)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If susceptibility results indicate the isolate is sensitive to INH, RIF, and PZA, then EMB can be discontinued as it does not affect or shorten the overall treatment duration [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. If PZA cannot be included in the initial phase of treatment (eg, in the setting of severe liver disease, gout, or pregnancy) the initial phase should consist of INH, RIF and EMB administered daily for two months and the total treatment duration extended (Regimen 4).",
"   </p>",
"   <p>",
"    Sputum AFB smears and cultures should be obtained at the time of completion of the initial phase of treatment in order to identify patients at increased risk of relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. Susceptibility testing should be pursued for positive cultures. Repeat chest radiography should be obtained for patients with negative initial cultures to evaluate for evidence of interval improvement. It may also be useful for patients with positive initial cultures but is not essential. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For cases in which it is not possible to establish a definitive laboratory diagnosis and presumptive therapy is initiated (eg, based on signs and symptoms, chest radiograph, positive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    , epidemiologic exposure, etc), treatment should be continued if initial cultures are found to be positive or there is a response to treatment (eg, clinically",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiographically). If culture-negative TB is suspected, a total four-month course of antituberculosis treatment should be administered (two months of INH, RIF, PZA, EMB followed by two months of INH and RIF for HIV-seronegative patients). If there is no evidence of active disease, latent tuberculosis may be inferred and treatment for LTBI should be continued accordingly. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Culture negative TB'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9432?source=see_link&amp;anchor=H7#H7\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\", section on 'Continuation of LTBI treatment after presumptive treatment for TB disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Continuation phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The continuation phase of treatment for pulmonary tuberculosis is administered for four or seven months and in most cases consists of INH and RIF (",
"    <a class=\"graphic graphic_table graphicRef50102 \" href=\"UTD.htm?23/25/23965\">",
"     table 1",
"    </a>",
"    ). Most patients are treated with a four-month continuation phase (total duration of treatment six months) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The six-month",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    -based treatment regimen is supported by USPHS Trial 21, a randomized trial of 1451 patients with pulmonary TB comparing the efficacy of six months of INH and RIF (with PZA for the first two months) with nine months of INH and RIF [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/11\">",
"     11",
"    </a>",
"    ]. Patients in the six-month regimen were more likely to complete therapy (61 versus 51 percent), and relapse rates two years after completing therapy were similar in the two groups (3.5 and 2.8 percent).",
"   </p>",
"   <p>",
"    Intermittent drug administration facilitates supervision of therapy and has been shown to be as effective as daily administration [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. Twice weekly dosing is frequently used by public health departments [Regimen 2a; (",
"    <a class=\"graphic graphic_table graphicRef50102 \" href=\"UTD.htm?23/25/23965\">",
"     table 1",
"    </a>",
"    )]. This practice is supported by a study of 160 patients treated with two weeks of daily directly observed therapy (INH, RIF, PZA, and EMB) followed by twice weekly directly observed therapy for a total over 62 doses administered over 32 weeks; the relapse rate was 1.6 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The continuation phase should be extended to seven months (nine months total duration of treatment) in the following circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with both cavitary pulmonary TB on initial chest x-ray and positive sputum culture after two months of initial phase treatment. The decision to prolong the continuation phase for patients with either cavitation or positive cultures (but not both) should be made on an individual basis.",
"     </li>",
"     <li>",
"      Patients whose initial phase of treatment did not include PZA",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This practice is based on evidence from USPHS study 22, which demonstrated that among patients on continuation phase twice weekly INH and RIF who had cavitation on initial chest radiograph and positive culture at the two month juncture, nearly 21 percent relapsed [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/13\">",
"     13",
"    </a>",
"    ]. Patients with only one of these factors (either cavitation or positive culture at two months) had relapse rates of 5 to 6 percent; patients with neither risk factor had relapse rates of 2 percent. A prolonged continuation phase for patients with cavitation and positive cultures at two months is supported by a study of patients with silicotuberculosis in whom extending treatment to eight months greatly reduced the rate of relapse (22 to 7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A chest radiograph at completion of therapy provides a baseline against which subsequent examinations can be compared, but is not essential.",
"   </p>",
"   <p>",
"    In the setting of culture-negative tuberculosis the continuation phase can be shortened to two months using INH and RIF (",
"    <a class=\"graphic graphic_table graphicRef50102 \" href=\"UTD.htm?23/25/23965\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1,15\">",
"     1,15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Culture negative TB'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Management of extrapulmonary tuberculosis consists of the same treatment regimen and duration as for pulmonary tuberculosis. Exceptions include concomitant bone and joint disease (six to nine months of therapy) and central nervous system disease (12 months of therapy). In addition, adjunctive corticosteroids are recommended in persons with tuberculous pericarditis or meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. These issues are discussed in further detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=see_link\">",
"     \"Skeletal tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/36/2633?source=see_link\">",
"     \"Tuberculous pericarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28713?source=see_link\">",
"     \"Central nervous system tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, it is recommended that sputum be obtained for microscopic examination and culture at monthly intervals until two consecutive culture specimens are negative [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. Obtaining sputum culture after two months of treatment is particularly important because of the association with increased relapse risk if positive. Results also have implications for the duration of the continuation phase of treatment. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Continuation phase'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Treatment guidelines issued by the World Health Organization (WHO), which pertain to all global settings, recommend repeat sputum smear two months after initiation of therapy. If smear-positive, sputum smear microscopy should be repeated at the end of the third month of treatment, and, if positive, sputum culture and drug susceptibility testing should be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A meta-analysis has noted that both microscopy and culture during tuberculosis treatment have low sensitivity and modest specificity for predicting failure and relapse; better markers are needed [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Interrupted therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Completion of treatment is determined by both the duration of therapy and the total number of doses administered. In some cases the specified number of doses cannot be administered within the target time period (eg, due to drug toxicity or nonadherence). In general, all of the doses for the initial phase should be delivered within three months, the doses for the four-month continuation phase should be delivered within six months, and the six-month continuation phase should be completed within nine months [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For circumstances in which the specified number of doses cannot be administered within the targeted period, a determination should be made regarding continuing treatment for a longer duration or restarting treatment from the beginning. Reinstitution of therapy must take into account the burden of disease, the point when the interruption occurred, and the duration of the interruption (",
"    <a class=\"graphic graphic_algorithm graphicRef69315 \" href=\"UTD.htm?11/4/11343\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In general, continuous treatment is more important in the initial phase of therapy, when the organism burden is highest and the chance of developing drug resistance is greatest [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/18\">",
"     18",
"    </a>",
"    ]. The earlier in the course treatment and the longer the duration of interruption, the more serious the effect and the greater the need to restart therapy from the beginning.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     BASELINE AND FOLLOW UP EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of patients with tuberculosis requires careful monitoring for adverse drug effects. Since hepatotoxicity may be caused by INH, RIF or PZA, patients receiving antituberculous therapy with first-line drugs should undergo baseline measurement of hepatic enzymes (transaminases, bilirubin and alkaline phosphatase). In addition, testing for hepatitis B and C should be pursued for patients with epidemiologic risk factors. Patients with hepatitis B carrier state (and normal baseline transaminase levels) appear to be more likely to develop hepatotoxicity during antituberculous treatment than patients without hepatitis B [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/19\">",
"     19",
"    </a>",
"    ]. (See related topics).",
"   </p>",
"   <p>",
"    Other baseline tests prior to initiation of therapy should include complete blood count, serum creatinine, and uric acid [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, counseling and testing for HIV infection should be performed. When treatment includes EMB, baseline testing of visual acuity and red-green color discrimination should be obtained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Hepatic monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeated monthly hepatic enzyme measurements are not necessary for patients with normal baseline results. They should be obtained in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abnormal baseline results",
"     </li>",
"     <li>",
"      A drug reaction is suspected",
"     </li>",
"     <li>",
"      Liver disease (eg, hepatitis B or C, alcohol abuse)",
"     </li>",
"     <li>",
"      Pregnancy and the first three months postpartum",
"     </li>",
"     <li>",
"      Combination therapy including",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"       pyrazinamide",
"      </a>",
"      in continuation phase",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients must be educated about the symptoms of hepatic toxicity, including anorexia, nausea, vomiting, dark urine, icterus, rash, pruritus, fatigue, fever, abdominal discomfort (particularly right upper quadrant discomfort), easy bruising or bleeding, and arthralgias [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/20\">",
"     20",
"    </a>",
"    ]. Patients should be directly questioned at monthly visits for these symptoms. In addition, they should report any signs or symptoms that occur in the interval between the monthly visits immediately. All patients with such complaints should be fully evaluated, including serum testing for hepatic injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Hepatotoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatotoxicity may be caused by INH, RIF, or PZA. An asymptomatic increase in AST concentration occurs in nearly 20 percent of patients treated with the standard four-drug regimen; in most patients asymptomatic aminotransferase elevations resolve spontaneously [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/21\">",
"     21",
"    </a>",
"    ]. Occasionally there are also disproportionate increases in bilirubin and alkaline phosphatase; these are consistent with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    hepatotoxicity.",
"   </p>",
"   <p>",
"    In general, antituberculosis agents should be discontinued if a patient's transaminase level exceeds three times the upper limit of normal in association with symptoms, or five times the upper limit of normal in the absence of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. Drug-induced hepatitis is a diagnosis of exclusion; other possible etiologies must also be assessed such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , alcohol, and hepatitis A, B, or C.",
"   </p>",
"   <p>",
"    The optimal approach to resumption of antituberculous therapy is uncertain and expert consultation should be obtained. In general, in cases where there should be no interruption in therapy, three new drugs (eg, an aminoglycoside and two oral agents such as EMB and a fluoroquinolone) could be started until the transaminase concentration returns to less than two to three times the upper limit of normal (or to near baseline levels). In a study of 1191 patients with hepatotoxicity due to first-line antituberculosis regimens,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    caused no additional hepatotoxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thereafter, the first line medications can be restarted one at a time. RIF (perhaps together with EMB) should be restarted first [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. If there is no increase in hepatic transaminases after one week, INH may be restarted. If symptoms recur or hepatic transaminases increase, the last drug added should be stopped. For those who have experienced prolonged or severe hepatotoxicity, but tolerate reintroduction with RIF and INH, rechallenge with PZA may be hazardous. In this circumstance, PZA may be permanently discontinued, with treatment extended to 9 months. Although PZA can be reintroduced in some milder cases of hepatotoxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/23\">",
"     23",
"    </a>",
"    ], and a regimen of RIF, PZA, and EMB can be given for 6 months [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ], the benefit of a shorter treatment course may not outweigh the risk of severe hepatotoxicity from PZA rechallenge. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Interrupted therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    It may be acceptable for INH, RIF, and PZA to be reintroduced simultaneously for nonpregnant patients whose transaminases and serum bilirubin have improved, in the absence of concomitant hepatotoxic medications, underlying acute viral hepatitis, chronic liver disease, alcoholism, or human immunodeficiency virus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/24\">",
"     24",
"    </a>",
"    ]. This is based on a small prospective study; further evaluation is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Alternative regimens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Expert consultation should be sought for the management of patients requiring alternative regimens. Options for treatment of infection due to susceptible strains in the setting of drug intolerance include [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who cannot tolerate INH, a six-month regimen of RIF, PZA, and EMB may be given. This regimen is nearly as efficacious as an INH-containing regimen [",
"      <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/7,9\">",
"       7,9",
"      </a>",
"      ]. Alternatively, RIF and EMB may be used for 12 months, preferably with PZA during at least the initial two months [",
"      <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/7,25\">",
"       7,25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For patients who cannot tolerate",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      , alternative regimens include 12 to 18 months of INH and EMB. A fluoroquinolone (usually",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      [500 to 1000 mg oral or intravenous once daily] or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"       moxifloxacin",
"      </a>",
"      [400 mg oral or intravenous once daily]) can also be given, though such a regimen has not been studied. PZA could be given during at least the first two months [",
"      <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. An injectable agent may be added for the first two to three months in persons with extensive disease or to shorten the overall treatment duration to 12 months.",
"     </li>",
"     <li>",
"      For patients who cannot tolerate PZA, nine months of INH and RIF should be administered (supplemented by EMB until INH and RIF susceptibility are demonstrated). This approach requires that the M. tuberculosis strain be susceptible to both INH and RIF [",
"      <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For patients with severe unstable liver disease who require a regimen with no hepatotoxic agents, SM, EMB, a fluoroquinolone and another second line oral drug may be used for a duration of 18 to 24 months. The optimal approach as to the choice of agents or the duration of treatment is uncertain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other adverse effects",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Ocular toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients taking EMB should be questioned about possible visual disturbances including blurred vision or scotomata at monthly intervals. Monthly testing of visual acuity and color discrimination is recommended for patients taking doses greater than those listed in the Table (",
"    <a class=\"graphic graphic_table graphicRef71883 \" href=\"UTD.htm?17/39/18043\">",
"     table 4",
"    </a>",
"    ) and for patients receiving the drug for longer than two months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Rash",
"    </span>",
"    &nbsp;&mdash;&nbsp;All antituberculous drugs can cause rash. Minor pruritic rashes affecting a limited area can be managed symptomatically with antihistamines and continuation of antituberculous therapy. A petechial rash in patients taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    should prompt consideration of hypersensitivity; if thrombocytopenia is present, rifampin should be stopped and the platelet count monitored until it returns to baseline. In such circumstances rifampin should not be resumed.",
"   </p>",
"   <p>",
"    Generalized erythematous rash should prompt discontinuation of all drugs immediately (particularly if associated with fever",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mucous membrane involvement). In the setting of severe tuberculosis, three new drugs (eg, an aminoglycoside and two oral agents) should be started. When the rash is substantially improved the first line medications can be restarted one at a time, at intervals of two to three days. If no rash appears after the first three drugs have been restarted, the fourth drug should not be restarted unless it is considered essential for therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Drug fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever observed in the setting of microbiological and radiographic improvement after several weeks of therapy should prompt consideration of drug fever; in such cases patients generally look and feel well despite high fever (often greater than 39&deg;C). Eosinophilia may or may not be present. Other causes of fever include tuberculosis (may persist as long as two months after therapy has been initiated) and paradoxical reaction in the setting of HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17272?source=see_link\">",
"     \"Monitoring the HIV-infected patient on antituberculous medications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If alternative causes of fever are excluded all drugs should be stopped; drug-related fever usually resolves within 24 hours. Once the fever has resolved, the protocol for restarting drugs should be followed as described in the preceding section. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Rash'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ADVERSE OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adverse outcomes include treatment failure (positive cultures after four months of treatment) and relapse (recurrent tuberculosis at any time after completion of treatment with apparent cure). Repeat sputum smear and culture two months after initiation of therapy is important for identifying patients at risk of relapse and treatment failure. Patients with positive cultures two months after initiation of therapy should undergo careful evaluation to determine the cause, and drug susceptibility testing should be repeated.",
"   </p>",
"   <p>",
"    Possible reasons for adverse outcomes include impaired adherence to treatment (for patients who have not been receiving DOT), high burden of clinical disease (including presence cavitary disease, bilateral disease",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    extrapulmonary disease), drug resistance, malabsorption, and malnourishment [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/13,30-32\">",
"     13,30-32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Relapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Relapse is defined by recurrent tuberculosis at any time after completion of treatment and apparent cure [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. Recurrence of tuberculosis may occur either as a result of relapsed infection due to the same M. tuberculosis strain, or due to exogenous reinfection with a new strain [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/33\">",
"     33",
"    </a>",
"    ]. In settings with high incidence of tuberculosis, exogenous reinfection is more likely to account for recurrent disease than in settings with low rates of tuberculosis, where recurrent disease is more likely due to relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/11,33-35\">",
"     11,33-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most relapses occur within the first 6 to 12 months following completion of therapy. Among patients treated with rifamycin-containing regimens using DOT, relapses generally occur with susceptible organisms. For other patients, the risk of acquired drug resistance is substantial. If initial drug susceptibility testing was not performed and the patient fails or relapses with a rifamycin-containing regimen given by DOT, there is high likelihood that the organisms were resistant from the outset.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Treatment failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment failure is defined as continuous or recurrently positive cultures during the course of appropriate antituberculous therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. After three months of a regimen containing INH and RIF for pulmonary tuberculosis caused by drug-susceptible organisms, 90 to 95 percent of patients have negative cultures and demonstrate clinical improvement. Presumptive treatment should be continued in such circumstances.",
"   </p>",
"   <p>",
"    Patients with positive cultures after three months of effective treatment must be evaluated carefully to identify the cause of the delayed conversion. Patients whose sputum cultures remain positive after four months of treatment should be considered treatment failures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;If relapse or treatment failure occurs, early consultation with an expert should be pursued. A single drug should never be added to a failing regimen, as this may lead to acquired resistance to the new drug. Retreatment should be administered with DOT whenever feasible.",
"   </p>",
"   <p>",
"    The clinical M. tuberculosis isolate should be sent promptly to a reference laboratory for drug susceptibility testing to both first and second line agents. The possibility of acquired drug resistance must be considered when determining the initial treatment regimen. The regimen should be based on the prior treatment regimen(s) and the severity of disease. Once the susceptibility test results return the treatment regimen should be based on the susceptibility of the organism identified.",
"   </p>",
"   <p>",
"    For patients who did not receive DOT, were not treated with a rifamycin based regimen, or had irregular treatment, it is prudent to infer that drug resistance is present. An expanded regimen with INH, RIF and PZA plus an additional two or three new drugs to which susceptibility could logically be inferred should be added, to minimize the probability of developing further resistance.",
"   </p>",
"   <p>",
"    For patients whose epidemiologic circumstances provide strong suspicion of exogenous reinfection as the cause of apparent relapse, the susceptibility profile of the putative source case may be used to guide selection of an initial regimen, pending susceptibility results of the patient's own isolate.",
"   </p>",
"   <p>",
"    For patients with drug susceptible disease treated with DOT, initiation of the standard four drug regimen may be appropriate until drug susceptibility test results are available. However, in the setting of life threatening forms of tuberculosis (eg, meningitis or miliary disease), at least three additional drugs from different drug classes to which the patient has not been exposed should be included in the empiric treatment regimen. Empiric retreatment regimens may include a fluoroquinolone, an injectable agent such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    (if not used previously and the patient is not from an area of the world with high rates of SM resistance), and an additional oral agent such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15141?source=see_link\">",
"     para-aminosalicylic acid",
"    </a>",
"    (PAS),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/30/43492?source=see_link\">",
"     cycloserine",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/16/42244?source=see_link\">",
"     ethionamide",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18375?source=see_link\">",
"     \"Second-line antituberculous therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Once drug susceptibility results are available, the treatment regimen can be adjusted according to the susceptibility results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/52/32586?source=see_link\">",
"     \"Diagnosis, treatment, and prevention of drug-resistant tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18375?source=see_link\">",
"     \"Second-line antituberculous therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SPECIAL CIRCUMSTANCES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Drug resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial drug regimens need to be modified in areas with a known high prevalence of drug resistant TB and in treatment of patients with known drug resistant disease. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/20/7497?source=see_link\">",
"     \"Epidemiology and molecular mechanisms of drug-resistant tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/52/32586?source=see_link\">",
"     \"Diagnosis, treatment, and prevention of drug-resistant tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/53/5978?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of extensively drug-resistant tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Culture negative TB",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States about 17 percent of reported new cases of pulmonary tuberculosis have negative cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. Failure to isolate M. tuberculosis from appropriately collected specimens from patients suspected to have pulmonary TB (on clinical or radiographic grounds) does not exclude a diagnosis of tuberculosis.",
"   </p>",
"   <p>",
"    In such cases presumptive therapy should be initiated as outlined in the preceding sections. At the end of the initial phase, continuation phase treatment should be pursued if initial cultures are found to be positive or there is a response to treatment (eg, clinically",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiographically). In the setting of culture-negative tuberculosis the continuation phase can be shortened to two months using INH and RIF (",
"    <a class=\"graphic graphic_table graphicRef50102 \" href=\"UTD.htm?23/25/23965\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1,36\">",
"     1,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If there is no evidence of active disease, latent tuberculosis may be inferred and treatment for LTBI should be continued accordingly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9432?source=see_link&amp;anchor=H7#H7\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\", section on 'Continuation of LTBI treatment after presumptive treatment for TB disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of tuberculosis in children is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link\">",
"     \"Tuberculosis disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Pregnant women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of tuberculosis in pregnancy is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29096?source=see_link\">",
"     \"Tuberculosis in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of TB among patients with diabetes has been noted to be approximately two- to fourfold higher than in those without diabetes, although these data come from surveys performed prior to 1960 [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data regarding the effect that underlying diabetes may have on efficacy of treatment for TB are limited. In a study of 737 Indonesian patients with pulmonary TB between 2000 and 2005, clinical characteristics and outcome were compared between patients with and without underlying diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/39\">",
"     39",
"    </a>",
"    ]. After six months of treatment, the odds ratio of having a positive sputum culture for M. tuberculosis was sevenfold higher in diabetic patients than in patients without diabetes. The severity of disease at presentation was comparable in both groups. It is unclear whether better glycemic control could improve sputum sterilization in diabetic patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Renal insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alteration in dosing of antituberculosis agents, particularly EMB and PZA, is necessary in patients with renal insufficiency (",
"    <a class=\"graphic graphic_table graphicRef63357 \" href=\"UTD.htm?42/34/43563\">",
"     table 5",
"    </a>",
"    ). Lengthening the dosing interval is preferable over reducing the dose to optimize peak serum concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. Administration of all antituberculosis drugs immediately after hemodialysis facilitates DOT (three times weekly) and minimizes premature removal of the drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with renal disease may have additional clinical conditions (such as diabetes with gastroparesis) that may affect the absorption of antituberculous drugs, or may be taking concurrent medications that interact with these drugs. Therefore, a careful clinical and pharmacological assessment is necessary, and in some cases serum drug concentration monitoring may be warranted to determine optimal drug dosing [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Hepatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of tuberculosis in patients with unstable or advanced liver disease is challenging. The likelihood of drug induced hepatitis may be increased, and the implications of adverse drug effects for patients with marginal hepatic reserve are potentially life threatening. Therefore, regimens with fewer potentially hepatotoxic agents may be needed, together with expert consultation. However, standard anti-tuberculosis therapy is generally initiated in patients with underlying hepatic disease, and hepatic transaminases and bilirubin are monitored closely. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Alternative regimens'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Tuberculosis itself may involve the liver, causing abnormal liver function that improves with effective treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV infection is common in patients with tuberculosis. All persons suspected of having active tuberculosis who are not known to be HIV-positive should undergo HIV counseling and testing [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/42\">",
"     42",
"    </a>",
"    ]. Issues related to treatment of tuberculosis in the setting of HIV infection, including indications for HIV antiretroviral therapy, are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Malnutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of micronutrient supplementation for patients with tuberculosis in developing countries is uncertain. Supplementation has included a number of agents (including vitamins A, B complex, C, D, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    ) and has been associated with the following benefits [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/43-46\">",
"     43-46",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Enhanced rate of smear conversion",
"     </li>",
"     <li>",
"      Reduced risk of TB recurrence",
"     </li>",
"     <li>",
"      Reduced mortality in HIV infected individuals",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, other studies have shown no effect on mortality or other outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. These discordant findings may be related to differences in the types of micronutrients supplemented, gender, age and other factors including effectiveness of antituberculosis therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/50\">",
"     50",
"    </a>",
"    ]. Further study is needed in resource limited settings; results may or may not be applicable to patients in developed areas.",
"   </p>",
"   <p>",
"    The role of macronutrient supplementation (eg, supplemental calorie or protein intake) in the treatment of tuberculosis is uncertain. In a small study of 36 HIV-seronegative subjects with TB, those who received high energy supplements had significantly greater increases in body weight and total lean mass compared to controls, although the effects on TB endpoints (cure, failure, death) are uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     ANTITUBERCULOUS AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major drugs used to treat tuberculosis, along with the appropriate doses, are listed in the Tables (",
"    <a class=\"graphic graphic_table graphicRef55978 \" href=\"UTD.htm?25/12/25804\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73765 \" href=\"UTD.htm?26/21/26971\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef71883 \" href=\"UTD.htm?17/39/18043\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. The first-line antituberculous medications should be administered together as a single dose to optimize peak serum concentrations. Drugs should be administered on an empty stomach if tolerated, but dosing with food is acceptable to ameliorate gastrointestinal upset and is preferable to dividing doses or changing to second-line agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Isoniazid",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     Isoniazid",
"    </a>",
"    (INH) is bactericidal, easily tolerated orally in a single daily dose, and inexpensive. The major toxicity is hepatitis, which is age-dependent; it is rare in persons younger than 20 years of age, and the risk increases with age and alcohol use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19142?source=see_link\">",
"     \"Isoniazid: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41943?source=see_link\">",
"     \"Isoniazid hepatotoxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Peripheral neuropathy can occur due to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    and can be minimized by using pyridoxine. The risk is increased in persons with conditions that may be associated with neuropathy such as nutritional deficiency, diabetes, HIV infection, renal failure, and alcoholism, as well as for pregnant and breastfeeding women. Pyridoxine supplementation (25 to 50 mg per day in adults) is recommended for high-risk patients with these conditions to help prevent neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Rifampin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     Rifampin",
"    </a>",
"    (RIF) is bactericidal for M. tuberculosis; it is given as a single daily oral dose and is well tolerated. Hepatic toxicity is less common than with INH. Rifampin induces hepatic microsomal enzymes and may increase hepatic clearance, decreasing the effectiveness of several drugs including oral contraceptives,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    , corticosteroids, and HIV antiretroviral therapy. Rifampin is excreted as a red-orange compound in urine, tears, sweat, and stool, and may permanently stain contact lenses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/26/24998?source=see_link\">",
"     \"Rifampin and other rifamycins\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The other rifamycins used to treat tuberculosis, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/51/15160?source=see_link\">",
"     rifapentine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/63/32760?source=see_link\">",
"     rifabutin",
"    </a>",
"    , are used in special circumstances and are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/26/24998?source=see_link\">",
"     \"Rifampin and other rifamycins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Pyrazinamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"     Pyrazinamide",
"    </a>",
"    (PZA) is bactericidal for M. tuberculosis at an acidic pH (eg, inside cells). It is effective orally as a single daily dose; gastrointestinal upset is fairly common. The major toxicity is hepatic injury [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/54\">",
"     54",
"    </a>",
"    ]. Hyperuricemia is a frequent consequence of PZA use due to decreased renal uric acid excretion; gouty flares may also occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/62/34788?source=see_link\">",
"     \"Pyrazinamide: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Ethambutol",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/7/12406?source=see_link\">",
"     Ethambutol",
"    </a>",
"    (EMB) is mostly bacteriostatic at standard doses although may have some bactericidal effect. It is administered as a single daily oral dose and is usually well tolerated. The major toxicity is optic neuritis, which is relatively uncommon with standard dosing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/2/30757?source=see_link\">",
"     \"Ethambutol: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Fixed dose combinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fixed dose combinations (FDC) containing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    (INH) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    (RIF) [Rifamate], and INH, RIF, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"     pyrazinamide",
"    </a>",
"    (PZA) [Rifater] are available. These combinations decrease the likelihood of inappropriate ingestion of a single drug and may decrease the development of drug resistance during therapy. They are often used when DOT cannot be provided.",
"   </p>",
"   <p>",
"    A four drug FDC (containing rifampicin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"     pyrazinamide",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/7/12406?source=see_link\">",
"     ethambutol",
"    </a>",
"    ) was compared with a regimen of four separately administered medications in a noninferiority trial among 1585 adults at 11 sites in Africa, Asia, and Latin America; the patients enrolled were predominantly HIV negative [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/55\">",
"     55",
"    </a>",
"    ]. The four drug FDC satisfied noninferiority criteria in two of three analyses. The potential advantages related to administration and adherence using the FDC may make this a preferred approach compared with non-FDC regimens, particularly in resource limited settings where DOT is not provided.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Fluoroquinolones",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fluoroquinolones show promise as possible first-line antituberculosis agents that could shorten treatment duration. They are being evaluated in phase 3 trials that assess tuberculosis relapse rates.",
"   </p>",
"   <p>",
"    Data are conflicting regarding whether substituting",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    for EMB (in addition to treatment with INH, RIF and PZA) hastens sputum culture conversion at eight weeks. In one randomized trial of 336 patients with pulmonary tuberculosis, outcomes for eight-week sputum sterilization were equivalent (70 percent culture-conversion) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/56\">",
"     56",
"    </a>",
"    ], although in a subsequent randomized trial of 170 patients treated similarly, sputum conversion at eight weeks was observed more frequently among those who received moxifloxacin than those who received",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/7/12406?source=see_link\">",
"     ethambutol",
"    </a>",
"    (80 versus 63 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A subsequent study of 328 participants randomized to receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    or INH (in addition to RIF, EMB and PZA) demonstrated comparable rates of culture negativity after eight weeks (55 and 60 percent), with no advantage for moxifloxacin [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pending further data, fluoroquinolones should be used only in persons with intolerance of or resistance to first-line agents [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"     1",
"    </a>",
"    ]. The optimal duration of TB regimens that include fluoroquinolones is uncertain.",
"   </p>",
"   <p>",
"    The possibility of fluoroquinolone resistance should be considered in patients who have received fluoroquinolone monotherapy for treatment of other infections prior to diagnosis of tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/59\">",
"     59",
"    </a>",
"    ]. Among 116 patients with tuberculosis who had fluoroquinolone exposure in the 12 months prior to diagnosis, fluoroquinolone resistance was observed in 2.5 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/59\">",
"     59",
"    </a>",
"    ]. Among patients with more than 10 days of fluoroquinolone exposure that occurred more than 60 days before tuberculosis diagnosis, fluoroquinolone resistance was observed in 20 percent of cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Second-line drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other drugs may be used to treat tuberculosis when the major drugs are not tolerated or when drug resistance is present. These drugs are less effective and more toxic than the major antituberculous drugs outlined above, and should be used only by medical personnel who have experience in treating such patients with these agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18375?source=see_link\">",
"     \"Second-line antituberculous therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     RESOURCE LIMITED SETTINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, the approach outlined in the preceding section should be utilized as feasible. Documents summarizing recommendations in countries where mycobacterial laboratory facilities (for culture and susceptibility testing) and chest radiography are not widely available have been issued by the World Health Organization (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. These organizations recommend a control strategy called \"DOTS\" (Directly Observed Treatment, Short Course) in which direct observation therapy is one of five key elements. The components include [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/62\">",
"     62",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Government commitment to sustained tuberculosis (TB) control activities",
"     </li>",
"     <li>",
"      Case detection by sputum smear microscopy among patients self reporting to health services",
"     </li>",
"     <li>",
"      Standardized treatment regimen of six to eight months for at least all confirmed sputum smear positive cases, with directly observed therapy for at least the initial two months",
"     </li>",
"     <li>",
"      A regular, uninterrupted supply of all essential antituberculosis drugs",
"     </li>",
"     <li>",
"      A standardized recording and reporting system that allows assessment of treatment results for each patient and of the TB control program overall",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The International Standards for Tuberculosis Care also provide important guidelines for tuberculosis management in all settings [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AFB smear is the primary tool in resource limited settings for diagnosis, classification and monitoring response to therapy, as access to reliable culture facilities is limited and the AFB smear identifies patients who are most likely to transmit infection. However, smear conversion is not always a useful determining factor for identifying patients with MDR TB. In one study of 93 adults in Peru, persistent 60 day smear positivity had a positive predictive value for detecting multi drug resistance of only 67 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/63\">",
"     63",
"    </a>",
"    ]. Drug susceptibility testing is not performed routinely for new patients in the setting of limited funds and facilities. However, a new rapid diagnostic test performed directly on sputum shows promise for the detection of tuberculosis as well as resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/52/32586?source=see_link&amp;anchor=H6#H6\">",
"     \"Diagnosis, treatment, and prevention of drug-resistant tuberculosis\", section on 'Rapid testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The WHO recommends susceptibility testing for patients who fail the initial treatment regimen (eg, sputum smear positive in month 5 of treatment or later) and for those who fail a supervised treatment regimen. Assessment of cure is based on clinical response and on sputum AFB smear (or culture when available) at completion of treatment. Chest radiography is recommended by the WHO and IUATLD only for patients with negative sputum smears, and is not recommended for follow up.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In resource limited settings, the WHO favors an initial phase of daily INH, RIF, PZA and EMB (or SM) for two months followed by a continuation phase of daily or three times weekly INH and RIF for four months by DOT [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/65\">",
"     65",
"    </a>",
"    ]. Twice weekly regimens are discouraged as there is a narrow margin of safety if doses are missed [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, it is felt that RIF should always be administered by DOT. For circumstances in which administration of RIF by DOT during the continuation phase is not available, the WHO recommends daily INH and EMB for six months (self administered), though it should be noted that this regimen is less effective. As an alternative to a RIF-based continuation phase, the IUATLD recommends a six-month continuation phase of daily INH and thiacetazone (self administered; this drug was formerly commonly used and is still available in many parts of the world; it remains listed as an \"essential\" first line drug by WHO but should not be used in the setting of HIV as it is associated with high rates of toxicity) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/66\">",
"     66",
"    </a>",
"    ]. These regimens would preserve RIF for use in retreatment regimens if needed and are less expensive than INH and RIF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Monitoring and followup",
"    </span>",
"    &nbsp;&mdash;&nbsp;Baseline and followup laboratory testing is recommended by WHO or IUATLD. Patients should be taught to recognize the symptoms associated with drug toxicity and report them promptly.",
"   </p>",
"   <p>",
"    Patients with initial positive smears have repeat smear examination at two months, five months, and at completion of treatment (either six or eight months) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. The IUATLD recommends that for patients with positive smears at two months, the initial phase should be extended for one month.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     Relapse and failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach in the setting of relapse and failure in the absence susceptibility testing data is an area of considerable controversy. The WHO and IUATLD have standard re-treatment regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. Individualized regimens must be determined depending on clinical circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?19/21/19802/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39475?source=see_link\">",
"       \"Patient information: Tuberculosis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary goals of tuberculosis treatment include eradicating M. tuberculosis, preventing development of drug resistance, and preventing relapse of infection. Directly observed therapy (DOT) is the preferred strategy for treatment of all patients with tuberculosis to assure completion of appropriate therapy and prevent emergence of drug resistance. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial phase of treatment usually consists of two months; we recommend initial therapy with four drugs (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). The regimen typically consists of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"       isoniazid",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"       pyrazinamide",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/7/12406?source=see_link\">",
"       ethambutol",
"      </a>",
"      &nbsp;(",
"      <a class=\"graphic graphic_table graphicRef50102 \" href=\"UTD.htm?23/25/23965\">",
"       table 1",
"      </a>",
"      ). Drug doses are shown in the Tables (",
"      <a class=\"graphic graphic_table graphicRef55978 \" href=\"UTD.htm?25/12/25804\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef73765 \" href=\"UTD.htm?26/21/26971\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef71883 \" href=\"UTD.htm?17/39/18043\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef63357 \" href=\"UTD.htm?42/34/43563\">",
"       table 5",
"      </a>",
"      ). Sputum AFB smears and cultures should be obtained at the time of initiation and completion of the initial phase of treatment; the latter will help identify patients at increased risk of relapse. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Initial phase'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The continuation phase in most cases consists of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"       isoniazid",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      administered for four months (six months total duration of treatment) (",
"      <a class=\"graphic graphic_table graphicRef50102 \" href=\"UTD.htm?23/25/23965\">",
"       table 1",
"      </a>",
"      ). Intermittent drug administration facilitates supervision of therapy and has been shown to be as effective as daily administration in most patients. The continuation phase should be extended to seven months (nine months total duration of treatment) in the circumstances outlined above. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Continuation phase'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In general, continuous treatment is most important in the initial phase of therapy, when the organism burden is highest and the chance of developing drug resistance is greatest. The earlier in the course and the longer the duration of treatment interruption, the more serious the effect and the greater the need to restart therapy from the beginning. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Interrupted therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment requires careful monitoring for adverse drug effects. Baseline laboratory evaluation should include measurement of hepatic enzymes (transaminases, bilirubin and alkaline phosphatase), complete blood count, serum creatinine, and uric acid. Testing for hepatitis B and C should be pursued for patients with epidemiologic risk factors, and counseling and testing for HIV infection should be performed on all patients. Visual acuity and red-green color discrimination testing should be obtained when treatment includes",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/7/12406?source=see_link\">",
"       ethambutol",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Baseline and follow up evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients must be educated about the symptoms of hepatic toxicity. In general, antituberculosis agents should be discontinued if a patient's transaminase level exceeds three times the upper limit of normal in association with symptoms, or five times the upper limit of normal in the absence of symptoms. Alternative treatment regimens are available for patients who cannot tolerate or are resistant to first-line therapy. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Hepatic monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adverse outcomes include treatment failure (positive cultures after four months of treatment) and relapse (recurrent tuberculosis at any time after completion of treatment with apparent cure). If relapse or treatment failure occurs, early consultation with specialty expertise should be pursued. A single drug should never be added to a failing regimen, as this may lead to acquired resistance to the new drug. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Adverse outcomes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/1\">",
"      Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/2\">",
"      Hopewell PC, Pai M, Maher D, et al. International standards for tuberculosis care. Lancet Infect Dis 2006; 6:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/3\">",
"      Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report. Lancet 1973; 1:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/4\">",
"      Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. The results up to 30 months. Am Rev Respir Dis 1977; 115:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/5\">",
"      Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Lancet 1976; 2:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/6\">",
"      A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association. Am Rev Respir Dis 1982; 126:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/7\">",
"      Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis 1987; 136:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/8\">",
"      Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis 1991; 143:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/9\">",
"      Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/10\">",
"      Johnson JL, Hadad DJ, Dietze R, et al. Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. Am J Respir Crit Care Med 2009; 180:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/11\">",
"      Combs DL, O'Brien RJ, Geiter LJ. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. Ann Intern Med 1990; 112:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/12\">",
"      Cohn DL, Catlin BJ, Peterson KL, et al. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med 1990; 112:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/13\">",
"      Benator D, Bhattacharya M, Bozeman L, et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet 2002; 360:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/14\">",
"      A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Hong Kong Chest Service/tuberculosis Research Centre, Madras/British Medical Research Council. Am Rev Respir Dis 1991; 143:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/15\">",
"      Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ 1982; 60:555.",
"     </a>",
"    </li>",
"    <li>",
"     WHO. Treatment of tuberculosis guidelines (4th edition). whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf (Accessed on June 11, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/17\">",
"      Horne DJ, Royce SE, Gooze L, et al. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect Dis 2010; 10:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/18\">",
"      Mitchison DA. Role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Dis 2000; 4:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/19\">",
"      Lee BH, Koh WJ, Choi MS, et al. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy. Chest 2005; 127:1304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/20\">",
"      Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006; 174:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/21\">",
"      Steele MA, Burk RF, DesPrez RM. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest 1991; 99:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/22\">",
"      Ho CC, Chen YC, Hu FC, et al. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens. Clin Infect Dis 2009; 48:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/23\">",
"      D&oslash;ssing M, Wilcke JT, Askgaard DS, Nybo B. Liver injury during antituberculosis treatment: an 11-year study. Tuber Lung Dis 1996; 77:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/24\">",
"      Sharma SK, Singla R, Sarda P, et al. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity. Clin Infect Dis 2010; 50:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/25\">",
"      Bobrowitz ID. Ethambutol-isoniazid versus streptomycin-ethambutol-isoniazid in original treatment of cavitary tuberculosis. Am Rev Respir Dis 1974; 109:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/26\">",
"      Ziganshina LE, Vizel AA, Squire SB. Fluoroquinolones for treating tuberculosis. Cochrane Database Syst Rev 2005; :CD004795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/27\">",
"      Gosling RD, Uiso LO, Sam NE, et al. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 2003; 168:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/28\">",
"      Drugs for tuberculosis. Treat Guidel Med Lett 2004; 2:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/29\">",
"      Kiblawi SS, Jay SJ, Stonehill RB, Norton J. Fever response of patients on therapy for pulmonary tuberculosis. Am Rev Respir Dis 1981; 123:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/30\">",
"      Sterling TR, Alwood K, Gachuhi R, et al. Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons. AIDS 1999; 13:1899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/31\">",
"      Chang KC, Leung CC, Yew WW, et al. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med 2004; 170:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/32\">",
"      Korenromp EL, Scano F, Williams BG, et al. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis 2003; 37:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/33\">",
"      Verver S, Warren RM, Beyers N, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med 2005; 171:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/34\">",
"      Sonnenberg P, Murray J, Glynn JR, et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358:1687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/35\">",
"      Jasmer RM, Bozeman L, Schwartzman K, et al. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? Am J Respir Crit Care Med 2004; 170:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/36\">",
"      Dutt AK, Moers D, Stead WW. Smear- and culture-negative pulmonary tuberculosis: four-month short-course chemotherapy. Am Rev Respir Dis 1989; 139:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/37\">",
"      Root, H. The association of diabetes and tuberculosis. N Engl J Med 1934; 210:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/38\">",
"      BOUCOT KR, DILLON ES, COOPER DA, et al. Tuberculosis among diabetics: the Philadelphia survey. Am Rev Tuberc 1952; 65:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/39\">",
"      Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007; 45:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/40\">",
"      Ellard GA. Chemotherapy of tuberculosis for patients with renal impairment. Nephron 1993; 64:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/41\">",
"      Peloquin CA. Using therapeutic drug monitoring to dose the antimycobacterial drugs. Clin Chest Med 1997; 18:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/42\">",
"      Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/43\">",
"      Villamor E, Mugusi F, Urassa W, et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. J Infect Dis 2008; 197:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/44\">",
"      Karyadi E, West CE, Schultink W, et al. A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. Am J Clin Nutr 2002; 75:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/45\">",
"      Range N, Changalucha J, Krarup H, et al. The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two-by-two factorial trial in Mwanza, Tanzania. Br J Nutr 2006; 95:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/46\">",
"      Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/47\">",
"      Range N, Andersen AB, Magnussen P, et al. The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomized controlled trial in Mwanza, Tanzania. Trop Med Int Health 2005; 10:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/48\">",
"      Semba RD, Kumwenda J, Zijlstra E, et al. Micronutrient supplements and mortality of HIV-infected adults with pulmonary TB: a controlled clinical trial. Int J Tuberc Lung Dis 2007; 11:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/49\">",
"      Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/50\">",
"      Benn CS, Friis H, Wejse C. Should micronutrient supplementation be integrated into the case management of tuberculosis? J Infect Dis 2008; 197:1487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/51\">",
"      Paton NI, Chua YK, Earnest A, Chee CB. Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. Am J Clin Nutr 2004; 80:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/52\">",
"      Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med 2001; 345:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/53\">",
"      Handbook of anti-tuberculosis agents. Introduction. Tuberculosis (Edinb) 2008; 88:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/54\">",
"      Yee D, Valiquette C, Pelletier M, et al. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 2003; 167:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/55\">",
"      Lienhardt C, Cook SV, Burgos M, et al. Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial. JAMA 2011; 305:1415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/56\">",
"      Burman WJ, Goldberg S, Johnson JL, et al. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 2006; 174:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/57\">",
"      Conde MB, Efron A, Loredo C, et al. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 2009; 373:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/58\">",
"      Dorman SE, Johnson JL, Goldberg S, et al. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med 2009; 180:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/59\">",
"      Devasia RA, Blackman A, Gebretsadik T, et al. Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure. Am J Respir Crit Care Med 2009; 180:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/60\">",
"      World Health Organization. Treatment of tuberculosis: guidelines for national programs, 4th ed. WHO/HTM.TB/2009.420. Geneva, Switzerland. World Health Organization 2009.",
"     </a>",
"    </li>",
"    <li>",
"     International Union Against Tuberculosis and Lung Disease. Management of tuberculosis: A guide to the essential of good practice, 6th ed, 2010.",
"    </li>",
"    <li>",
"     file://www.who.int/tb/dots/en/ (Accessed on August 04, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/63\">",
"      Fitzwater SP, Caviedes L, Gilman RH, et al. Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis 2010; 51:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/64\">",
"      Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363:1005.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Treatment of tuberculosis: guidelines for national programmes, 3rd edition. WHO/CDS/TB/2003.313. Geneva, Sitzerland: World Health Organization; 2003. file://www.who.int/tb/publications/cds_tb_2003_313/en/index.html (Accessed on June 11, 2010).",
"    </li>",
"    <li>",
"     International Union against Tuberculosis and Lung Disease. Management of tuberculosis: a guide for low income countries, 5th ed, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/21/19802/abstract/67\">",
"      Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348:119.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8015 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-D1AB04EF24-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19802=[""].join("\n");
var outline_f19_21_19802=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H42\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Initial phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Continuation phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Interrupted therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      BASELINE AND FOLLOW UP EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Hepatic monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Hepatotoxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Alternative regimens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other adverse effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Ocular toxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Rash",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Drug fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ADVERSE OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Relapse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Treatment failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SPECIAL CIRCUMSTANCES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Drug resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Culture negative TB",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Pregnant women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Renal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Hepatic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Malnutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      ANTITUBERCULOUS AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Isoniazid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Rifampin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Pyrazinamide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Ethambutol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Fixed dose combinations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Fluoroquinolones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Second-line drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      RESOURCE LIMITED SETTINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Monitoring and followup",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      Relapse and failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8015\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8015|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?11/4/11343\" title=\"algorithm 1\">",
"      Management of treatment interruptions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8015|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/25/23965\" title=\"table 1\">",
"      Drug regimens for tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/12/25804\" title=\"table 2\">",
"      First-line TB drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/21/26971\" title=\"table 3\">",
"      Pyrazinamide dosing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/39/18043\" title=\"table 4\">",
"      Ethambutol dosing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/34/43563\" title=\"table 5\">",
"      Renal dosing of antituberculous agents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10341?source=related_link\">",
"      Adherence to tuberculosis treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28713?source=related_link\">",
"      Central nervous system tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/53/5978?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of extensively drug-resistant tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/52/32586?source=related_link\">",
"      Diagnosis, treatment, and prevention of drug-resistant tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/20/7497?source=related_link\">",
"      Epidemiology and molecular mechanisms of drug-resistant tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/2/30757?source=related_link\">",
"      Ethambutol: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41943?source=related_link\">",
"      Isoniazid hepatotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19142?source=related_link\">",
"      Isoniazid: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17272?source=related_link\">",
"      Monitoring the HIV-infected patient on antituberculous medications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39475?source=related_link\">",
"      Patient information: Tuberculosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/62/34788?source=related_link\">",
"      Pyrazinamide: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/26/24998?source=related_link\">",
"      Rifampin and other rifamycins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18375?source=related_link\">",
"      Second-line antituberculous therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=related_link\">",
"      Skeletal tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4298?source=related_link\">",
"      Treatment of latent tuberculosis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9432?source=related_link\">",
"      Treatment of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=related_link\">",
"      Treatment of pulmonary tuberculosis in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=related_link\">",
"      Tuberculosis disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29096?source=related_link\">",
"      Tuberculosis in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/36/2633?source=related_link\">",
"      Tuberculous pericarditis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_21_19803="Insulin algorithm 2";
var content_f19_21_19803=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F83952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F83952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Insulin algorithm: Regular insulin, example 2",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Blood glucose values",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Change in dose, units of regular insulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        mg/dL",
"       </td>",
"       <td class=\"subtitle2\">",
"        mmol/L",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;80",
"       </td>",
"       <td>",
"        &lt;4.4",
"       </td>",
"       <td>",
"        - 1 R",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        80 to 120",
"       </td>",
"       <td>",
"        4.4 to 6.7",
"       </td>",
"       <td>",
"        &plusmn; 0 R",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        121 to 140",
"       </td>",
"       <td>",
"        6.7 to 7.8",
"       </td>",
"       <td>",
"        + 0.5 R",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        141 to 160",
"       </td>",
"       <td>",
"        7.8 to 8.9",
"       </td>",
"       <td>",
"        + 1 R",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        161 to 200",
"       </td>",
"       <td>",
"        8.9 to 11.1",
"       </td>",
"       <td>",
"        + 1.5 R",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;200",
"       </td>",
"       <td>",
"        &gt;11.1",
"       </td>",
"       <td>",
"        + 2 R",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19803=[""].join("\n");
var outline_f19_21_19803=null;
var title_f19_21_19804="Histoplasma meningitis";
var content_f19_21_19804=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50806&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50806&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for evaluation of suspected histoplasma meningitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Specimen type, class of case, recommended test or procedure",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       CSF; all cases, repeat at least once, and preferably twice, if there is no diagnosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Culture of a large-volume sample (&gt;10 mL)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Histoplasma antigen testing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Anti-histoplasma antibody testing by complement fixation, beginning with undiluted CSF",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Blood; all cases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Fungal culture, 3 sets",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Histoplasma antigen testing, to assist in determination if CSF antigen positivity may have been caused by contamination of the CSF with blood",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Anti-histoplasma antibody testing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Urine; all cases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Histoplasma antigen testing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Biopsy of non-CNS site, if there is a clinical or laboratory finding indicating involvement at the site",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Histopathologic examination for fungi",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Fungal culture",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Cisternal or ventricular fluid, if the diagnosis is uncertain after the performance of the evaluations above",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Microscopic examination for fungi",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Fungal culture",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Histoplasma antigen",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Anti-histoplasma antibody",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Brain or meninges, if the diagnosis is uncertain after the performance of the evaluations above",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Histopathologic examination for fungi",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Fungal culture",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wheat, LJ,Musial, CE, Jenny-Avital, E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005; 40:844. Copyright&copy; 2005 University of Chicago Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19804=[""].join("\n");
var outline_f19_21_19804=null;
var title_f19_21_19805="Risk death MI unstable angina";
var content_f19_21_19805=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F65662&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F65662&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Short-term risk of death or nonfatal MI in patients with UA/NSTEMI",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        High risk (at least one of the following features must be present):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        History:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Accelerating tempo of ischemic symptoms in preceding 48 h",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Character of pain:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prolonged ongoing (&gt;20 min) rest pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Clinical findings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pulmonary edema, most likely due to ischemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        New or worsening MR murmur",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        S",
"        <sub>",
"         3",
"        </sub>",
"        or new/worsening rales",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypotension, bradycardia, tachycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Age &gt;75 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        ECG:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Angina at rest with transient ST-segment changes &gt;0.5 mm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bundle-branch block, new or presumed new",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sustained ventricular tachycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Cardiac markers:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Elevated cardiac TnT, TnI, or CK-MB (eg, TnT or TnI &gt;0.1 ng per ml)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Intermediate risk (no high-risk feature but must have one of the following):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        History:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prior MI, peripheral or cerebrovascular disease, or CABG; prior aspirin use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Character of pain:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prolonged (&gt;20 min) rest angina, now resolved, with moderate or high likelihood of CAD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rest angina (&gt;20 min) or relieved with rest or sublingual NTG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nocturnal angina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        New-onset or progressive CCS class III or IV angina in the past&nbsp;two weeks without prolonged (&gt;20 min) rest pain but with intermediate or high likelihood of CAD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Clinical findings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Age &gt;70 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        ECG:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        T-wave changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pathological Q waves or resting ST-depression less than 1 mm in multiple lead groups (anterior, inferior, lateral)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Cardiac markers:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Slightly elevated cardiac TnT, TnI, or CK-MB (eg, TnT greater than 0.01 but less than 0.1 ng per ml)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Low risk (no high- or intermediate-risk features, but may have any of the following features):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Character of pain:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Increased angina frequency, severity, or duration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Angina provoked at a lower threshold",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        New onset angina with onset&nbsp;two weeks to&nbsp;two months prior to presentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        ECG:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Normal or unchanged ECG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Cardiac markers:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Normal",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50:e1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19805=[""].join("\n");
var outline_f19_21_19805=null;
var title_f19_21_19806="Tzanck prep skin lesion answer";
var content_f19_21_19806=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F54430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F54430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Herpes zoster",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 355px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tzanck preparation from the base of a vesicular skin lesion (Giemsa stain, x1000) shows multinucleated giant cells indicative of infection with a herpesvirus. This preparation was obtained from a patient with herpes zoster.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19806=[""].join("\n");
var outline_f19_21_19806=null;
var title_f19_21_19807="Rachitic Rosary";
var content_f19_21_19807=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rachitic rosary",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 340px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph of a patient with rickets, demonstrating a \"rachitic rosary\". Observe the opaque, bulbous indentations of the lung adjacent to the enlarged costochondral junctions (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Yochum TR, Rowe LJ, Yochum and Rowe's Essentials of Skeletal Radiology, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_21_19807=[""].join("\n");
var outline_f19_21_19807=null;
